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STELLINGEN 
1. Verschillen in toxiciteit tussen sterol 14a-demethyleringsremmers (DMIs) voor een 
bepaalde schimmel worden voor een gedeelte bepaald door verschillen in affiniteit van 
deze fungiciden voor het cytochroom P450-afhankelijke sterol 14a-demethylase van 
het desbetreffende organisme. 
Dit proefschrift. 
Biochemische screeningstoetsen, waarmee structuur-activiteit-relaties van potentiele 
sterol biosynthese-remmers (SBIs) kunnen worden bestudeerd met als doel de 
remmende werking van deze middelen te optimaliseren, dienen bij voorkeur te worden 
uitgevoerd met cel-vrije extracten van het pathogeen, waartegen men een SBI-
fungicide wil ontwikkelen. 
Dit proefschrift. 
3. Spectrofotometrische studies naar de interactie van azool-fungiciden met het cyto-
chroom P450-afhankelijke sterol 14a-demethylase zijn niet bruikbaar om de in vitro 
toxiciteit van deze middelen te evalueren, wanneer gebruik gemaakt wordt van 
microsomale preparaten van filamenteuze schimmels. 
Yoshida and Aoyama, In: In vitro and in vivo evaluation of antifungal agents, ed. H. Vanden 
Bossche, Elsevier Science Publishers BV., Amsterdam, 1986, pp. 123-134. 
Dit proefschrift 
4. De algemeen gebezigde terminologie van "P450 isozymes" ter aanduiding van 
verschillende cytochroom P450-afhankehjke enzymen, die verschillende reacties 
katalyseren, is conform de wetenschappelijke definitie van het begrip "isozyme" 
onjuist. 
Lehninger, In: Biochemistry. Ed. Lehninger, Worth Publishers Inc., New York, 1979, pp. 
244-245. 
5. Chemische gewasbescherming zal de komende decennia onontbeerlijk blijven voor een 
doelmatige beheersing van ziekten en plagen in de land-en tuinbouw. 
6. De voortgaande achteruitgang van vleermuispopulaties in Nederland is meer het 
gevolg van schaalvergroting en intensivering van het agrarisch landgebruik dan van de 
toepassing van pesticiden en is daardoor sterk regio-gebonden. 
Limpens and Kapteyn. Myotis 29 (1991) 39-48. 
Kapteyn. Zoogdier 3 (1993) in press. 
De introductie van transgene ziekte-resistente gewassen in land-en tuinbouw zal niet 
realiseerbaar zijn, indien niet meer aandacht wordt besteed aan professionele publieks-
voorlichting over de biologische veiligheid van genetisch gemodificeerde organismen. 
Van Veen, In: De biologische veiligheid van genetisch gemodificeerde organismen in de 
natuur, een zwaartepunt in het DLO-onderzoek, Dienst Landbouwkundig Onderzoek, 
Wageningen, 1991. 
8. Glucomannoproteinen spelen een essentiele rol in de celwandsynthese van schimmels 
behorende tot de Ascomyceten en de Basidiomyceten. 
Van Rinsum et al. Yeast 7 (1991) 717-726. 
9. Korfbal zal publicitair de concurrentie met andere (zaal)sporten pas volledig aankun-
nen, wanneer de amusementswaarde van deze sport middels spelregelwijzigingen 
wordt verhoogd en het wordt toegelaten tot de Olympische spelen. 
10. De door het Ministerie van Verkeer en Waterstaat gefmancierde televisiespotjes, 
waarin autogebruikers worden gewezen op gevaarlijk rijgedrag, is pure kapitaalvernie-
tiging zolang bewindslieden zelf straffeloos het slechte voorbeeld blijven geven. 
Stellingen behorend bij het proefschrift: 
Biochemical mechanisms involved in selective fungitoxicity of fungicides 
which inhibit sterol 14a-demethylation. 
Wageningen, 20 april 1993 Hans Kapteyn 
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CHAPTER 1 
GENERAL INTRODUCTION 
1.1. General aspects of fungicides 
Plant pathogens cause considerable crop losses which are cautiously estimated at about 
10 percent world-wide.1 Several practices of modern agriculture have enhanced the 
destructive potential of diseases and made disease management with use of fungicides 
inevitable. Two of the most important practices are the use of genetically similar crop 
plants in continuous monoculture and the use of plants susceptible to pathogens. In 
addition, the increasing human population, especially in developing countries, also 
necessitates the use of fungicides in effective disease management.1,2 
While in 1900 only sulphur and copper fungicides were applied in agriculture, 
nowadays approximately 100 different antifungal compounds are available, which differ 
markedly in their fungitoxic spectrum, field performance and biochemical mode of 
actions.3 
With respect to their mode of action fungicides can be divided in two classes: 
compounds with non-specific and specific mode of actions. The non-specific fungicides 
are characterized as multi-site inhibitors. Their selective action between fungi and plants 
is based on differences in uptake by plants and fungi. Most of these fungicides are 
protective, lack eradicative or curative activity and therefore, have to be applied 
repeatedly to remain effective. Development of resistance to these multi-site inhibitors 
based on changes at the sites of action is generally of low probability in practice, since a 
fungus cannot escape from all inhibitory effects without loosing its fitness.3,4 However, 
resistance to these inhibitors may occur due to detoxification or reduced accumulation.4 
Sulphur, copper, mercurials, dithiocarbamates (maneb, zineb, thiram), phthalimides 
(captan, folpet) and quinoxaline derivatives are well known examples of non-specific 
inhibitors.3,5 
Compounds with a specific mode of action interfere with only one or very few sites of 
fungal metabolism. Other characteristics of this group are that most of these chemicals are 
systemic and have protective and curative activity. The specific mode of action and the 
selective fungitoxicity make those chemicals often suitable for application in modern 
integrated plant protection strategies with use of biological control measures, soil and 
hygiene techniques and cultivation of resistant plant cultivars. The disadvantage of 
specific site inhibitors is the relatively high risk of resistance development.3,4,6 However, 
the speed of resistance development is different among the single-site inhibitors and 
depends on the fungal genetic control mechanisms. Fungal resistance to some single-site 
inhibitors such as benzimidazoles, phenylamides and carboxamides developed rapidly in 
one step as a result of mutation in one gene, which has a major effect on the affinity of 
the target site for the fungicide. A more gradual, stepwise development of resistance is 
characteristic for the sterol 14a-demethylation inhibitors (DMIs). This feature of DMI 
fungicides may be explained by the fact that resistance to DMIs is under polygenetic 
control which implies that several mutant genes are required to achieve a resistance level 
which may lead to failure of disease control.7 
1.2. Aimes and outlines of the present study 
Relatively little is known about the mechanisms of natural insensitivity and acquired 
(field or laboratory) resistance of fungi to DMI fungicides. Therefore, the present study 
was undertaken to get a better fundamental understanding of the physiological/biochemical 
parameters which are involved in the selective fungitoxicity of DMIs. In most of these 
studies prochloraz was used as the test fungicide, since this compound possesses a 
different spectrum of activity from other DMIs, controlling Pseudocercosporella 
herpotrichoides, Alternaria spp., Septoria spp., Sclerotinia spp., Monilinia spp. and 
Botrytis spp. as well as cereal powdery mildews.8,9 Extension of knowledge on the basis 
of DMI-selectivity may eventually guide synthesis of entirely new fungicides or lead to 
improvement of the existing DMIs. In addition, it may help to design anti-resistance 
strategies and increase our knowledge on fungal biochemistry and physiology, which is 
still relatively limited. Before presenting the results obtained in this study a literature 
review on the mode of action and on the mechanisms of selective fungitoxicity of modern 
single-site inhibitors is given (Chapter 2). In this chapter ample attention is paid to sterol 
biosynthesis in fungi, its inhibition by DMI fungicides and the interaction of DMIs with 
their target site, cytochrome-P450 dependent sterol 14a-demethylase. It is assumed that 
the molecular mechanisms of natural insensitivity of fungi to DMIs may be closely related 
to those involved in acquired resistance such as differential accumulation, metabolism and 
affinity for the target enzyme.10 Therefore, at first, differential accumulation and 
metabolism of DMIs by various fungal pathogens, including the laboratory-generated 
DMI-resistant isolates of Penicillium italicum, were studied (Chapter 3). Chapter 4 
describes the energy-dependent DMI-efflux system, a proposed resistance mechanism in 
P. italicum, in more detail. Special attention was paid to the role of the membrane 
potential in mediating this efflux system. A major part of the study was spent on the 
isolation of microsomal P450 isozymes from Ustilago maydis and the spectrophotomtric 
analysis of their interaction with several DMIs (Chapter 5). The isolation of microsomal 
P450 isozymes from fungal plant pathogens has only recently been described for the first 
time.11 Hence, further information on P450 isozymes from plant pathogens was highly 
desirable. Guan et al.n also developed a method to prepare cell-free extracts from P. 
italicum, in which activity of the target enzyme, P45014DM, could be demonstrated. These 
developments made it possible to study the affinity of various compounds, including 
prochloraz and its analogues, for P45014I)M from this fungus according to enzymatic and 
spectrophotometric methods (Chapter 6). Chapter 7 covers the development of a cell-free 
sterol 14a-demethylase system from the economically important fungal pathogen Botrytis 
cinerea. The success of this assay opened the opportunity to investigate the affinity of 
prochloraz and its analogues for B. cinerea P45014DM and to undertake some structure-
activity relationship studies (Chapter 8). Chapter 9 gives a final discussion of the results 
obtained. 
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CHAPTER 2 
SELECTIVE FUNGICIDES WITH A SPECIFIC MODE OF ACTION. 
2.1. Review of fungicides with a specific mode of action. 
Benzimidazoles and benrimidazole generating compounds. The benzimidazoles 
(benomyl) and benzimidazole-generating compounds (thiophanate-methyl) were introduced 
in the late 1960's. They are effective inhibitors of a broad range of fungi consisting of 
Ascomycetes, Basidiomycetes and Deuteromycetes, but none of the Oomycetes.1 Their 
primary mode of action is inhibition of microtubule assembly due to their interaction with 
the protein B-tubulin, an important constituent of microtubules. Therefore, mitosis, cell-
division and other microtubule-dependent processes are impaired.2 The biochemical basis 
for the selective fungitoxic action of benzimidazoles is due to their differential affinity for 
the tubulin from the different fungal species. Acquired fungal resistance to benzimidazoles 
is caused by a single gene mutation resulting in slightly changed tubulin with reduced 
affinity for these compounds.2 
2-Aminopyrimidines. 2-Aminopyrimidines (ethirimol) are characterized by a selective 
and systemic activity against powdery mildews. Their mode of action is inhibition of 
adenosine deaminase catalysing the deamination of adenosine. As a consequence, fungal 
purine metabolism is disturbed leading to prevention of appressoria and haustoria 
formation.3 Adenosine deaminase is present in many fungi, but only the enzyme from 
powdery mildews is sensitive. This may account for the high selective toxicity towards 
powdery mildews.3 The mechanism of acquired field resistance in powdery mildews is not 
known. 
Phenylamides. The group of phenylamides (metalaxyl, furaxyl) consists of highly 
active, systemic fungicides against fungi of the order of Peronosporales. They inhibit r-
RNA synthesis of Oomycetes by specific interference with a chromatin bound RNA-
polymerase complex.4 Fungal resistance to phenylamides is based on reduced affinity of 
the target enzyme complex for these fungicides due to a single gene mutation.4 It is not 
known why phenylamides act selectively against Oomycetes. 
Carboxamides. The carboxamides (carboxin) represent systemic fungicides controlling 
mainly Basidiomycetes, like smuts, bunts and rusts.5 They specifically interfere with the 
succinate-ubiquinone oxidoreductase system of the fungal mitochondrial electron transfer 
chain.6 The selectivity of carboxamides between different fungal species is primarily due 
to differences in sensitivity of the target site for the chemicals. Acquired carboximide 
resistance was attributed to a single gene mutation resulting in an altered structure of the 
succinate-ubiquinone oxido-reductase complex.78 
Aromatic hydrocarbon fungicides (AHFs). AHFs like quintozene and chloroneb are an 
heterogenous group of compounds which are highly active against some soil-borne fungi 
and used against postharvest diseases.9 Their primary toxic effect is probably an induced 
lipid peroxidation of membranes caused by inhibition of electron transport from flavin 
enzymes such as cytochrome c-reductase to substrates. The basis of the selective 
fungitoxicity has not yet been elucidated.10 
Dicarboximides. Iprodionine and vinclozolin are well known examples of this type of 
fungicides which are mainly used against B. cinerea, Monilinia and Sclerotinia spp.11 
Dicarboximides are supposed to have a similar mode of action as the AHFs. Like for the 
AHFs, the reason for the selectivity of dicarboximides is not yet clear.10 Strains of several 
pathogens, for example B. cinerea, which are cross-resistant to dicarboximides and 
AHFs, can easily be isolated in the laboratory, but have also been observed in practice.12 
Organophosphorous fungicides. Organophosphorous fungicides are classified in three 
chemical classes: phosphoric acid amides (triamiphos), phosphorothionates (pyrazophos) 
and phosphothiolates (Kitazin-P). The first two groups are primarily active against 
powdery mildews, whereas the last one predominantly acts against rice diseases e.g. 
Pyricularia oryzae.13 The primary targets of the phosphoric acid amides and 
phosphorothionates are not yet understood. The phosphothiolates interfere in phospholipid 
synthesis by inhibition of the conversion of phosphatidyl ethanolamine to phosphatidyl 
choline by transmethylation of S-adenosylmethionine. This leads to drastic alterations of 
membrane structure and function.14 Studies on the mechanisms of Kitazin-P resistance of 
P. oryzae showed that besides fungal detoxification of the fungicide by cleavage of its S-
C bond, other resistance mechanisms must be involved.15 The mechanism of resistance to 
pyrazophos was most probably related to the inability of resistant strains to activate 
pyrazophos to its hydrolysis product, PP-pyrazophos.16 
Polyene macrolide antibiotics. The polyene macrolide antibiotics (nystatin, pimaricin 
and amphotericin A or B) are produced by Streptomyces spp. and used as antimycotics in 
medicine. They are selective toxicants of cell membranes and preferably bind with the 
fungal sterols of membranes. This results in increase of membrane permeability, leakage 
of cellular constituents and altered transport of nutrients.17 The mechanism of resistance is 
still unknown, but resistance might be ascribed to changes in lipid and sterol 
compositions.18'19 
Polyoxins and nikkomycin. The polyoxins and nikkomycin are closely related 
antibiotics, synthesized by Streptomyces spp. The polyoxins are specific inhibitors of 
chitin synthase. Therefore, these compounds are highly selective inhibitors of fungi 
containing chitin in their cell walls.2021 Oomycetes which contain cellulose as cell wall 
constituent are insensitive. The natural sensitivity of fungal species was correlated to the 
extent of penetration of polyoxins into the fungal cells,22 whereas acquired fungal 
resistance could be related to reduced polyoxin accumulation.23 The differences in 
sensitivity among fungi and resistance mechanisms may be attributed to structural changes 
of peptides involved in polyoxin uptake mechanisms.24 
Melanin synthesis inhibitors (MSIs). The MSIs (tricyclazole) display their mode of 
action in pigmented Ascomycetes and Deuteromycetes. Rice blast caused by P. oryzae is 
excellently controlled by these chemicals.25 Inhibition of melanin synthesis is regarded as 
the primary mode of action of MSIs, which causes a lack of appressoria melanization 
leading to a loss of pathogenicity.26"28 
Sterol biosynthesis inhibitors (SBIs). The first representatives of this type of fungicides 
were introduced 25 years ago. Nowadays, they are the most widely used antifungal 
compounds in agriculture and in medicine. SBIs are highly active at low doses against 
fungi belonging to Ascomycetes, Basidiomycetes and Deuteromycetes. SBIs can be 
subdivided into several classes of structurally unrelated compounds which specifically 
inhibit sterol biosynthesis at different steps in the pathway.29,30 
2.2. Ergosterol biosynthesis in fungi and its inhibition. 
Sterol composition. Most species of Ascomycetes, Basidiomycetes and Deuteromycetes 
produce ergosterol as the abundant sterol. However, in rust fungi and powdery mildews 
other C14-desmethyl sterols are synthesized. Most Oomycetes such as the Pythiaceous 
fungi Pythium and Phytophihora do not synthesize sterols or do not require them for 
vegetative growth.31,32 The role of sterols is twofold; first, they are involved in 
maintaining proper membrane fluidity and integrity. For this 'bulk' membrane function 
large quantities of sterols are needed, but structural requirements are in this case less 
specific. Second, they have a regulatory or 'sparking' function, for which small amounts 
are needed and structural requirements are more demanding. C14-desmethyl sterols like 
ergosterol appear to satisfy both functions in fungi.31,32 
Ergosterol biosynthesis. Many aspects of fungal ergosterol biosynthesis were reviewed 
by Mercer,33 Kato,34 and summarized by Vanden Bossche35 and Weete.32 The first sterol 
structure occurring in the sterol pathway, lanosterol, is formed by cyclization of 2,3-
epoxysqualene, which originates from mevalonic acid via the isoprenoid pathway (Fig. 1). 
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Fig. 1. Ergosterol biosynthesis pathway in fungi and its inhibition steps by various compounds. 1, 
Lanosterol; 2, 24-Methylenedihydrolanosterol (Eburicol); 3, 4,4-Dimethyl-ergosta-8,14,24(28)-trienol; 4 ; 
4,4-Dimethyl-ergosta-8,24(28)-dienol; 5, 4,4-Dimethyl-cholesta-8,14,24-trienol; 6, 4,4-Dimethyl-cholesta-
8,24-dienol; 7, Cholesta-8,24-dienol (Zymosterol); 8, Ergosta-8,24(28)-dienol (Fecosterol); 9, Episterol; 10, 
Ergosta-5,7,24(28)-trienol; 11, Ergosta-5,7,22,24(28)-tetraenol; 12, Ergosterol (FromKato, 1986). 
However, an important difference between yeasts and filamentous fungi arises in the 
pathway following lanosterol metabolism. In filamentous fungi alkylation at the C24-
position is the first step (A) leading to the production of 24-methylenedihydrolanosterol 
(eburicol). Eburicol is subsequently demethylated at C14 (B) which is mediated by 
cytochrome P450-dependent sterol 14a-demethylase. Then the A14<15) double bond of the 
demethylation product, C44-dimethylergosta-8,14,24(28)-trienol, is reduced (C), followed 
by demethylation of C4 (D) resulting in the synthesis of ergosta-8,24(28)-dienol 
(fecosterol). In yeasts, however, the alkylation at the C^-position occurs after C14-
demethylation (E), reduction of the A14(15) double bond (F) and C4-demethylation (G). The 
fecosterol conversion to ergosterol is similar for yeasts and filamentous fungi. The A8(9) 
double bond of fecosterol is isomerized to a A7 double bond (I), followed by an 
introduction of a A5 double bond (J), a A22 double bond (K) and the introduction of a 
A24(28) d o u b l e b o n ( J ( L ) 
Inhibition of ergosterol biosynthesis. Ergosterol biosynthesis may be impaired at 
different steps. Representative inhibitors are categorized as follows:25'30,34 
a) squalene epoxidase inhibitors: allylamines, terbinafine and naftifine.36 
b) 2-3-oxidosqualene cyclase inhibitors: 2-aza-2,3 dihydrosqualene and 2,3 imino-
squalene.31,32 
c) C24-sterolmethyltransferase inhibitors (step A and H): 25-azacholesterol and 24-
epiiminolanosterol.31'32 
d) sterol 14a-demethylase inhibitors (step B and E): imidazole, triazole, pyrimidine and 
pyridine derivatives.35 
e) A 14(15)-reductase inhibitors (step C and F): morpholine derivatives.37,38 
f) A7-A8-isomerase inhibitors (step I): morpholine derivatives.37,38 
g) A22-desaturase inhibitors (step K): triarimol.32,34 
h) A24(28)-reductase inhibitors (step L): 25-azacholesterol.32,34 
In economical respect, the sterol 14a-demethylation inhibitors (DMIs), especially 
imidazoles and triazoles, are the most important group of sterol biosynthesis inhibitors 
applied in agriculture and medicine. Examples of widely used agricultural fungicides are 
triadimenol, propiconazole, prochloraz and imazalil. Itraconazole, ketoconazole and 
fluconazole are well known antimycotics used in clinical and veterinary medicine.29 Only 
a limited number of derivatives of piperazine, pyrimidine and pyridine are developed as 
DMIs. 
Inhibition of sterol biosynthesis by DMIs results in direct depletion of ergosterol and 
accumulation of abnormal sterol intermediates. These changes in sterol composition alter 
membrane fluidity, permeability and activities of membrane-bound enzymes, since the 
fluidity of membranes is an important regulatory factor for these kind of enzymes.32 
Examples of membrane-bound enzyme activities which are disturbed by DMIs are 
microsomal ATPases, mitochondrial cytochrome oxidase, cytochrome c peroxidase and 
fatty acid coenzyme A desaturase.35 A major consequence of ergo-sterol depletion and/or 
accumulation of 14a-methylsterols is the increased and uncoordinated activation of chitin 
synthase. The increased and irregular disposition of chitin disturbes the processes of cell-
division and -separation in yeasts leading to chains and clusters of cells. In filamentous 
fungi it stimulates branching and causes misformed, swollen hyphae due to an 
uncoordinated formation of septa and cell walls.35,39 
Development of resistance to DMIs. Like for all site-specific fungicides, DMIs are 
more prone to resistance than conventional multisite inhibitors. Under laboratory 
conditions DMI-resistant mutants of fungi can easily be obtained, but most of these strains 
show reduced fitness with regard to spore germination, mycelial growth and 
pathogenicity.41*42 However, experiments with Sphaerotheca fidiginea demonstrated that 
DMI-resistance is not always associated with reduced fitness.43 It is now generally 
accepted that the polygenic nature of DMI-resistance may explain the still limited number 
of DMI-resistant plant pathogens observed in the field, rather than reduced fitness of 
DMI-resistant strains. In the polygenic control of DMI-resistance the effect of individual 
genes is generally small. Therefore, a highly resistant strain may only be obtained by 
crossing different first step mutants or by stepwise selection of several mutant genes 
interacting with each other in the same nucleus.44,45 
DMI-resistance may in theory be based on a single gene mutation leading to a non-
functional cytochrome P450 sterol Ma-demethylase.46 This phenomenon has been 
described for nystatine-resistant mutants of U. maydis, Candida albicans and Saccharomy-
ces cerevisiae which are cross-resistant to DMIs.4750 These mutants were relatively 
tolerant to the accumulated 14a-methylsterols, but their growth rate as well as their 
morphology were greatly impaired. Therefore, this type of resistance is unlikely to occur 
in the field. Only a gene mutation resulting in unimpaired binding of the substrate 
lanosterol, but a decreased affinity for DMIs might lead to resistant strains with 
unimpaired sterol composition and competitive fitness.46,51 In this respect, Vanden Bossche 
et a/.,52,53 demonstrated that azole-resistant isolates of C. albicans did contain P450 
isozymes with less affinity to various DMIs than the azole-sensitive ones. These resistant 
isolates were less pathogenic than the sensitive strains. Target site mutations, however, 
have not yet been observed with filamentous fungi. In filamentous fungi, like Aspergillus 
nidulans, P. italicum, Monilinia fructicola and Nectria haematococca var. cucurbitae, 
DMI-resistance is probably based on an increased energy-dependent efflux of the 
fungicides, by which accumulation is reduced.42,54"57 Other potential mechanisms like 
tolerance to toxic sterols, failure to toxify accumulated 14a-methylsterols,58 disability to 
activate the fungicides,59,60 deposition of fungicides in lipid droplets or vacuoles61 and an 
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induced resistance response related to a transient accumulation of sterol precursors62 seem 
to have limited relevance. 
Selectivity of DMIs. Numerous species of P450 enzymes exist in mammals and higher 
plants. Therefore, azole antifungals are required to have a high selective affinity for 
fungal cytochrome P450-dependent sterol 14a-demethylase to avoid inhibitory effects on 
host P450 isozymes.63 The observed inter-species selectivity of DMIs is most probably 
due to significantly lower binding affinities to related cytochromes P450 operative in 
mammals and plants.3546'64 However, despite their high target specificity, DMIs also show 
a remarkable selective toxicity to fungi, reflected by the spectrum of diseases controlled 
by a particular DMI-fungicide.29 The reason for the selective action of particular DMIs is 
still not well understood, but could be due to differences in the sterol 14a-demethylase 
resulting in differential binding affinity for the various inhibitors.65 This supposition is 
supported by studies which demonstrated that the sterol 14a-demethylase from S. 
cerevisiae showed differences in affinity for various DMIs.66"68 Similar results were found 
with the enzyme from C. albicans, Aspergillus fumigatus and P. italicum.69n Pye & 
Marriott72 showed that drastic differences with regard to the binding affinities of DMIs to 
P450s14DM from three Candida species could partly explain their selective activities. 
However, in the case of Mucor rouxii, lack of sensitivity to DMIs cannot be ascribed to a 
low affinity of the DMIs for the target enzyme because abnormal sterols readily 
accumulated at concentrations well below those needed to inhibit growth.73 This capacity 
to tolerate 14a-methylsterols is also a plausible mechanism which can account for the 
selective fungitoxicity of DMIs.73 The natural insensitivity of several fungi to triadimefon 
was attributed to the extent of its metabolic activation to triadimenol and the fungal 
sensitivity to the individual enantiomers of triadimenol produced.74 In case of triforine, 
the selective fungitoxic action is based on either differences in fungal accumulation or 
metabolism.75 
2.3. Cytochrome P450 
To comprehend the biochemical basis which determines the affinity of DMIs for fungal 
sterol 14a-demethylase an overview of cytochrome P450 is required. This is detailed in 
the following sections. 
Definition, function and distribution of P450. Cytochrome P450 (P450) is the 
collective name given for a special class of haem containing proteins which show after 
reduction with dithionite and in the presence of carbon monoxide (CO) a maximal 
absorption at 450 nm.39,76,77 This unique spectre-photometric feature of P450 is due to 
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binding of a thiolate anion (S) from a cysteine residue in the apoprotein and of CO to the 
reduced haem iron to its fifth and sixth ligand, respectively (Fig. 2). 
Fig. 2. Proposed perspective drawing of the iron protoporphyrin in interaction with carbon monoxide (CO). 
The fifth ligand is a thiolate anion of cysteine. The sixth coordination position of the haem is CO (From 
Vanden Bossche, 1985). 
P450s are present in most eukaryotes and in a few bacteria. Molecular weights range 
between 45 and 60 Kd. In animals and plants the enzyme system has been detected in 
almost all tissues examined. The eukaryotic P450s are mainly located in the 
endoplasmatic reticulum and mitochondria. Bacterial P450s have no apparent membrane 
association.77 P450s can be divided in two classes. The first group consists of P450s 
involved in regiospecific monooxygenation of many physiologically important endogenous 
lipophilic substrates like steroids, fatty acids, prostanoids, and secondary metabolites of 
plants and microbial species. An example is lanosterol 14a-demethylase in sterolbiosyn-
thesis. Characteristic of this class of P450s is that these enzymes are generally substrate-
specific and not greatly affected by foreign chemicals, although they might be able to 
metabolize these chemicals at a low rate. The second class is represented by P450s which 
are induced to detectable levels after chronic exposure to xenobiotics such as drugs, 
pesticides, food-additives ect.39'76 However, besides substrate monooxygenations many 
other reactions are catalyzed by P450s like for example epoxidation, N-, S-, and O-
dealkylation, desulfurization, deamination, dehalogenation and isomerization.77 To 
metabolize such diverse substrates P450 shows considerable molecular multiplicity. It is 
not known how many forms of P450 exist, but the figure might be between 30 and 200. 
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The catalytic mechanism of P450. The monooxygenase reaction catalyzed by P450 
requires NADPH and molecular oxygen. In general, the reaction equation is as follows: 
RH + NADPH + H+ + 02 -» ROH + NADP+ + H20 
The essential components of the cytochrome P450-dependent monooxygenase in 
microsomal membranes are: the NADPH-cytochrome P450-reductase with FAD and 
FMN as flavin prosthetic groups, P450 and phospholipids. Cytochrome b5 may also be 
involved. The function of the P450-reductase is to transfer electrons from NADPH to 
P450. P450 provides the oxygen- and the substrate-binding site. Phospholipids mediate 
the interactions between P450 and the reductase. They also facilitate electron transfer and 
stabilize and/or induce functionally active conformation of P450.39 The catalytic sequence 
can be summarized as follows: 1) binding of a substrate (RH) to P450, 2) reduction of the 
two flavin prosthetic groups of P450-reductase by NADPH, 3) transfer of one of the two 
electrons to P450 and consequent reduction of the haem iron, 4) binding of molecular 
oxygen to form a Fe2+-cytochrome-P450 dioxygen complex, 5) transfer of the 2nd 
electron from P450-reductase or from cytochrome b5 to the latter complex, 6) Splitting of 
the oxygen-oxygen bond with the incorporation of the distal oxygen into a molecule of 
H20, 7) incorporation of the 2nd oxygen atom into the substrate, 8) dissociation of the 
product (ROH).396476 
Substrate-induced spectral changes of P450. In the oxidized state, P450s exist in either 
a low-spin hexacoordinate form or a high-spin pentacoordinate form. In the low-spin 
hexacoordinate form of P450 the sixth haem ligand is most probably the oxygen atom 
from water, whereas such a ligand is absent in the pentacoordinate form (Fig. 3). The 
equilibrium between the low- and high-spin configuration is affected by the accessibility 
of water to the haem iron which is determined by the hydrophobicity and steric 
hinderance of the haem pocket. Most P450s have been found to be extensively low-spin in 
their resting form.77 Binding of a substrate to oxidized P450 causes certain spectral 
change of the cytochrome. The substrate-induced spectral change is caused by removal or 
exchange of the sixth ligand of oxidized P450 concomitant with the binding of a substrate. 
Two different types of spectral changes can be distinguished. If a lipophilic substrate 
(AH) binds to the substrate site near the sixth coordination position, the accessibility of 
water to the haem is reduced. In consequence, the cytochrome moves from the 
hexacoordinated low-spin to the pentacoordinated high-spin configuration showing an 
absorbance maximum at approximately 385 nm. This spectral change is shown by the 
type-I difference spectrum (Fig. 3). In contrast, if a substrate which is bound to the 
substrate site also acts as an external sixth haem ligand (AXH) instead of water, the 
cytochrome P450 is converted to an artificial low-spin complex. The type II spectral 
change is induced by this kind of substrate binding (Fig. 3). The wavelengths of maximal 
and minimal absorption of a low-spin complex of P450 not only depends on the nature of 
the sixth ligand, but also on the spin state of the cytochrome. Since microsomal P450 
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consists of a mixture of low- and high-spin forms, the absorbance maxima and minima in 
type II difference spectra may vary from 425 to 430 nm and 390 to 410 nm, 
respectively.76 The type II spectral change can be induced by all kinds of amines, such as 
pyridines, imidazoles, triazoles, isonitriles, amides and anilines.39'78"79 
Sterol 14a-demethylase (P45014Dt} in fungi. Studies on fungal sterol 14a-demethylase 
(P450i4DM) are generally not very extensive. Only P45014DM from the yeasts S. cerevisiae 
and C. albicans is studied in great detail. Spectral characteristics indicated that the 
oxidized form of P45014DM from these yeasts is in a low-spin state and its reduced CO 
Ligand Structure Difference Spectrum 
385 
Type lib 
( H ) <l_) 
Fig. 3. Spin-state equilibrium, substrate binding, and the substrate-induced spectral change of cytochrome 
P450 in relation to ligand structure of the cytochrome. S~ represents the thiolate fifth ligand characterizing 
the cytochrome. Spin state of each structure is represented by H (high-spin) or L (low-spin). The substrate-
free resting form is in equilibrium between the high- spin (penta-coordinate) and the low-spin (water-ligated) 
forms (reaction 1). Reaction 2 indicates binding of a substrate that has no coordinating group (AH) to the 
low-spin form. This interaction converts the water-ligated low-spin form to the penta-coordinate high-spin 
form and induces the type I spectral change. Reactions 3 and 4 represent binding of another type of 
substrate (AXH), which contains a coordinating atom (X), to the low-spin and high-spin forms, respectively. 
In these cases, X coordinates to the haem-iron, an artificial low-spin complex is formed, and the type II 
spectral change is induced. The shape of the type II difference spectrum is affected by the spin state of the 
substrate-free form, and they are discriminated as type Ha and type lib in this figure (From Yoshida, 1988). 
14 
complex has an absorption peak at 447 nm. Molecular weights were estimated to be 58 
and 51 Kd, respectively. Studies using reconstituted model membrane systems with 
P45014DM and NADPH-cytochrome P450-reductase from both yeast species indicated that 
three NAD(P)H-dependent oxygenase reactions are involved in the removal of the 14a-
methylgroup from lanosterol.64,76,80 It is noted that the Candida enzyme prefers NADH 
rather than NADPH, as co-factor.81 In the first step the 14a-methylgroup (CH3) is 
oxidized to a 14a-hydroxymethyl group (CH2OH), in the second step the hydroxymethyl-
group is oxidized to a formaldehyd group (CHO) and in the third step the latter is 
oxidized and lost as formate (HCOOH). The cytochromes P45014DM from both yeasts 
catalyzed the entire process of demethylation in which the initial hydroxylation of the 
14a-methylgroup is the rate-limiting step.39,64'76'80 The reconstituted system of S. 
cerevisiae was also used to unravel the mechanisms which determine the substrate-
specificity of P45014DM. It was demonstrated that the 3-hydroxy group, the A8<9) double 
bond and the terminal part of the side chain of lanosterol are essential for orienting the 
substrate in the active site of P45014DM.63,8284 There are hardly any data available on 
P450i4DM from filamentous fungi. This is most probably due to the unstable nature and 
relatively low content of this enzyme in these organisms.71,85,86 However, a few papers on 
the isolation of microsomal P450 from the filamentous fungi A. fumigatus and P. italicum 
have recently been published.85"87 The complexes of CO with reduced microsomal P450 
isozymes from these fungi were characterized by absorption maxima at 451 and 449 nm, 
respectively.85"87 In addition, several reports appeared on the preparation of cell-free 
extracts from the same two filamentous fungi and from U. maydis which are able to 
synthesize ergosterol from [14C]mevalonate.69'71'88 To date, no reports have appeared on 
the purification of P45014DM or on reconstituted systems with this enzym from filamentous 
fungi. This is a prerequisitive for further characterization of the enzyme from these fungi. 
It is known that sterol 14a-demethylation in filamentous fungi occurs after methylation at 
CM of lanosterol,33 which takes place in mitochondria.89 This may have been the reason 
why so far, one has failed to develop reconstituted membrane systems from filamentous 
fungi, which are able to synthesize desmethylsterols. 
Interaction of fungal P45014DM with DMIs. Azole antifungal agents induced type II 
spectral changes of purified P45014DM from S. cerevisiae and C. albicans.16*0 Type II 
spectra were also obtained with microsomal preparations of C. albicans, A. fumigatus and 
P. italicum upon addition of various DMIs.52,85,86 This means that an azole nitrogen atom 
(N3 of imidazole; N4 of triazole) coordinates with the haem iron of ferric P450 to form an 
artificial low-spin complex. The spectral studies with purified yeast P45014DM further 
demonstrated that the DMIs formed one-to-one complexes with the ferric cytochrome.76,80 
This conclusion was supported by findings that several azole antifungals completely 
inhibited reconstituted sterol 14a-demethylase activity when added at a concentration 
equal to that of P45014DM.S668,80 However, P450MDM also showed type II spectral changes 
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with simple, non-toxic pyridines and imidazoles, but not at equimolar concentrations. 
Consequently, affinity of these ligands is far less than reported for the azole antifungal 
agents suggesting that the azole fungicides or antimycotics interact not only with the haem 
iron, but also at some region of the apoprotein.76 In addition, reconstituted demethylase 
activity of S. cerevisiae and binding of CO to reduced P45014DM was differentially 
inhibited by various DMIs, including stereoisomers of diniconazole and triadimenol. This 
inhibition correlated with their inhibitory effects on growth.63,66"68,90 Similar results were 
also found when the inhibitory effects of various DMIs on CO binding were studied with 
microsomal cytochrome P450 isozymes from C. albicans.i5,52M,n Based on these results it 
was deduced that the affinity of DMIs for P45014DM is predominantly determined by their 
Nx substituent regulating their mobility in the haem crevice and most probably their 
interaction with the substrate binding site.35'63'64,6768 Consequently, inhibition of sterol 
14a-demethylase activity by DMIs is supposed to result from interaction at two sites of 
the enzyme: first, the DMIs inhibit substrate binding by occupying the substrate binding 
site at the apoprotein located near the haem. Second, the azole moiety of the DMIs 
coordinates with the ferric haem, containing the cytochrome in its low spin-state, thereby 
preventing the transition to the high spin-state, which is required for enzyme activity.80 
Methods for determining the potency of DMIs against P45014DM. The most common 
method to evaluate the potency of azoles to inhibit activity of P45014DM is by measuring 
the incorporation of [14C]mevalonic acid into desmethylsterols of azole-treated cell-free 
extracts or reconstituted sterol 14a-demethylase systems.80 Reconstituted systems have 
been described for S. cerevisiae and C. albicans, whereas cell-free bioassays have been 
reported for U. maydis, A. fumigatus and P. italicum. As already mentioned before, both 
enzyme assays revealed that the differential inhibition of P450j4DM activity by a number of 
DMIs correlated with their fungicidal activity or in vitro sterol biosynthesis inhibition in 
intact cells.63,66"71,88 
The affinity of DMIs for P45014DM can also be examined spectrophotometrically by 
measuring the ability of DMIs to induce type II spectral changes of the cytochrome. 
According to Wiggins & Baldwin92 the increase in value of A A (maximuum absorption -
minimum absorption) in type II spectra after successive additions of various isomers of 
diclobutrazol to partly purified yeast P450, as well as the final saturation value ( A A ^ J 
reflected their fungicidal activity. Yoshida & co-workers also demonstrated that the 
differences in affinity of various stereoisomers of diniconazole and triadimenol for yeast 
P45014DM determined by type II spectral analysis correlated with their inhibitory effects on 
P45014DM activity.66,68 In principle, from the results of the spectral titration of the 
cytochrome with DMIs the affinity of these compounds for the enzyme can be calculated 
using Lineweaver-Burke double reciprocal plots and expressed in binding constants (Kj 
values). However, determination of K,, values of DMIs is often hampered by technical 
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difficulties due to their extremely high affinity for P45014DM and to the fact that accurate 
spectrophotometry analysis can not be done with P450 concentrations below 0.1 /iM.66"68 
In contrast, Vanden Bossche et a/.91 suggested that the ability of an azole derivative to 
induce a type II spectrum is not necessarily indicative for a possible inhibitory effect on a 
P450-dependent reaction. This view was supported by the finding that various DMIs 
induced similar type II spectral changes of purified yeast P45014DM, although they differed 
in their fungitoxicity.67 Guan et a/.86 also concluded that the induction of type II spectral 
changes of microsomal P450 isozymes from P. italicwn by several DMIs did not give a 
clue on their fungitoxicity. 
Spectrophotometric studies in which the displacement of DMIs from reduced P450-
DMI complexes by CO is examined, were suggested to give a better indication of the 
interaction between P45014DM and DMIs.52'76 This suggestion was based on the fact that 
inhibition of CO binding to reduced P45014DM from S. cerevisiae and reduced microsomal 
P450 isozymes from C. albicans by DMIs correlated with their inhibitory effects on in 
vitro and in vivo sterol 14a-demethylation.52'S6~68'90,91 However, such a correlation could 
not be found when CO displacement experiments were conducted with purified P45014DM 
from C. albicans and microsomal preparations of A. fumigatus and P. zta//'cMm.70,80,85"87 
References 
1. Delp, C.J., Benzimidazole and related fungicides. In: Lyr, H. (Ed.), Modern Selective Fungicides, 
Properties, Applications, Mechanism of Action. VEB Gustav Fischer Verlag, Jena, Germany, 1987, p . 
233-244. 
2. Davidse, L.C., Biochemical aspects of benzimidazole fungicides, action and resistance. In: Lyr, H. 
(Ed.), Modern Selective Fungicides, Properties, Applications, Mechanisms of Action. VEB Gustav 
Fischer Verlag, Jena, Germany, 1987, p. 245-258. 
3. Hollomon, D.W., Target Sites of Hydroxypyrimidine Fungicides. In: Koller, W. (Ed.), Target Sites of 
Fungicide Action, CRC Press Inc., Boca Raton Ann Harbor, London, 1992, p . 31-42. 
4. Davidse, L.C., Biochemical aspects of phenylamide fungicides, action and resistance. In: Lyr, H. 
(Ed.), Modern Selective Fungicides, Properties, Applications, Mechanisms of Action. VEB Gustav 
Fischer Verlag, Jena, Germany, 1987, p. 275-282. 
5. Schewe, T. & Lyr, H., Mechanism of action of carboxin fungicides and related compounds. In: Lyr, 
H. (Ed.), Modern Selective Fungicides, Properties, Applications, Mechanisms of Action. VEB Gustav 
Fischer Verlag, Jena, Germany, 1987, p. 133-142. 
6. White, G.A., A potent effect of 1,4-oxathiin systemic fungicides on succinate oxidation by a parti-
culate preparation from Ustilago maydis. Biochem. Biophys. Res. Commun. 44 (1971) 1212-1219. 
7. Georgopoulos, S.P., Chrysayi, M. & White, Carboxin resistance in the haploid, the heterozygous 
diploid, and the plant parasitic dicaryotic phase of Ustilago maydis. Pestic. Biochem. Physiol. 5 
(1975) 543-551. 
8. White, G.A. & Georgopoulos, S.G., Target Sites of Carboxamides. In: Koller, W. (Ed.), Target Sites 
of Fungicide Action, CRC Press Inc., Boca Raton Ann Harbor, London, 1992, p . 1-30. 
9. Lyr, H., Aromatic hydrocarbon fungicides. In: Lyr, H. (Ed.), Modern Selective Fungicides, Properties, 
Applications, Mechanisms of Action. VEB Gustav Fischer Verlag, Jena, Germany, 1987, p . 63-74. 
10. Edlich, W. & Lyr, H., Target Sites of Fungicides with Primary Effects on Lipid Peroxidation. In: 
Koller, W. (Ed.), Target Sites of Fungicide Action, CRC Press Inc., Boca Raton Ann Harbor, 
London, 1992, p . 53-68. 
17 
11. Pommer, E.-H. & Lorenz, G., Dicarboximides. In: Lyr, H. (Ed.), Modern Selective Fungicides, 
Properties, Applications, Mechanisms of Action. VEB Gustav Fischer Verlag, Jena, Germany, 1987, p . 
91-106. 
12. Leroux, P. & Fritz, R., Antifungal activities of dicarboximides and aromatic hydrocarbons and 
resistance to these fungicides. In: Trinci, A .PJ . & Ryley, J.F. (Eds.). Mode of Action of Antifungal 
Agents. Cambridge, 1984, p . 207-237. 
13. Schreiber, B., Organophosphorous fungicides. In: Lyr, H. (Ed.), Modem Selective Fungicides, 
Properties, Applications, Mechanisms of Action. VEB Gustav Fischer Verlag, Jena, Germany, 1987, p . 
299-308. 
14. Kodama, O., Yamashita, K. & Akatsuka, T., Edifenphos, inhibitor of phosphatidylcholine biosynthesis 
m Pyricularia oryzae. Biol. Chem. 44 (1980) 1015-1021. 
15. Uesugi, Y., Kodama, O. & Akutsaka, T., Inhibition of fungal metabolism of some organo-
phosphorous compounds by pieronyl butoxide. Agric. Biol. Chem. 42 (1978) 2181-2183. 
16. De Waard, M.A. & Van Nistelrooy, J.G.M., Mechanism of resistance to pyrazophos in Pyricularia 
oryzae. Neth. J. PL Path. 86 (1980) 251-258. 
17. Hamilton-Miller, J.M.T., Fungal sterols and the mode of action of the polyene antibiotics. Adv. Appl. 
Microbiol. 17 (1974) 109-134. 
18. Fryberg, M., Oehlschlager, A.C. & Unrau, A.M., Sterol biosynthesis in antibiotic sensitive and 
resistant Candida. Arch. Biochem. Biophys. 173 (1976) 171-177. 
19. Dekker, J., The development of resistance to fungicides. Progr. Pest. Biochem. Toxicol. 4 (1985) 165-
218. 
20. Endo, A. & Misato, T., Polyoxin D, a competitive inhibitor of UDP-N-acetylglucosamine: chitin N-
acetylglucosaminyltransferase in Neurospora crassa. Biochem. Biophys. Res. Commun. 37 (1969) 718-
722. 
21. Bowers, B. , Levin, G. & Cabib, E., Effect of polyoxin D on chitin synthesis and septum formation in 
Saccharomyces cerevisiae. J. Bacteriol. 119 (1974) 564-575. 
22. Cabib, E. & Bowers, B., Timing and function of chitin synthesis in yeast. J. Bacteriol. 124 (1975) 
1586-1593. 
23. Misato, T., Kakiki, K. & Hori, M., Mechanism of polyoxin resistance. Neth. J. PI. Path. 83 (Suppl. 
1) (1977) 253-260. 
24. Gooday, G.W., In: Lyr, H. & Polter, C. (Eds.). Systemic fungicides. Abhandl. der Akad. Wissensch. 
DDR No.2, Akademie, Berlin, 1979, p. 159-168. 
25. Buchenauer, H., Physiological Reactions in the Inhibition of Plant Pathogenic Fungi. In: Haug, G. & 
Hoffmann, H. (Eds.), Chemistry of Plant Protection, Vol. 6, Controlled Release, Biochemical 
Effects of Pesticides, Inhibition of Plant Pathogenic Fungi. Springer-Verlag, Berlin, Germany, 1990, 
p. 217-292. 
26. Woloshuk, C.P., Sisler, H.D., Chrysayi Tokousbalides, M. & Dutky, S.R., Melanin biosynthesis in 
Pyricularia oryzae: site of tricyclazole inhibition and pathogenicity of melanin-deficient mutants. Pestic. 
Biochem. Physiol. 14 (1980) 256-264. 
27. Kubo, Y., Suzuki, K., Furusawa, I., Ishida, N. & Yamamoto, M., Melanin synthesis as a pre-
requisite for penetration by appressoria of Colletotrichum lagenarium: Site of inhibition by melanin-
inhibiting fungicides and their action on appressoria. Pestic. Biochem. Physiol. 23 (1985) 47-55. 
28. Yamaguchi, I. & Kubo, Y., Target Sites of Melanin Biosynthesis Inhibitors. In: Target Sites of Fungi-
cide Action, CRC Press Inc., Boca Raton Ann Harbor, London, 1992, p. 101-118. 
29. Scheinpflug, H. & Kuck, K.H., Sterol biosynthesis inhibiting piperazine, pyridine, pyrimidine and azole 
fungicides. In: Lyr, H. (Ed.), Modern Selective Fungicides, Properties, Applications, Mechanisms of 
Action. VEB Gustav Fischer Verlag, Jena, Germany, 1987, p . 173-204. 
30. Koller, W., Antifungal Agents with Target Sites in Sterol Functions and Biosynthesis. In: Koller, W. 
(Ed.), Target Sites of Fungicide Action, CRC Press Inc., Boca Raton Ann Harbor, London, 1992, p . 
119-206. 
31. Burden, R.S., Cooke, D.T. & Carter, G.A., Inhibitors of sterol biosynthesis and growth in plants 
and fungi. Phytochem. 28 (1989) 1791-1804. 
32. Weete, J.D., Structure and function of sterols in fungi. Adv. Lipid Res. 23 (1989) 115-167. 
33. Mercer, E.I., The biosynthesis of ergosterol. Pestic. Sci. 15 (1984) 133-155. 
18 
34. Kato, T., Sterol-Biosynthesis in Fungi, a Target for Broad Spectrum Fungicides. In: Haug, G. & Hoff-
mann, H. (Eds.), Chemistry of Plant Protection, Vol. 1, Sterol Biosynthesis, Inhibitors and Anti-
Feeding Compounds. Springer-Verlag, Berlin, 1986, p . 1-24. 
35. Vanden Bossche, H. , Mode of action of pyridine, pyrimidine and azole antifungals. In: Berg, D. & 
Plempel, M. (Eds.), Sterol Biosynthesis Inhibitors, Pharmaceutical and Agrochemical Aspects. Ellis 
HorwoodLtd., Chichester, UK, 1988, p . 79-119. 
36. Ryder, N.S. , Squalene epoxidase as a target for the allylamines. Biochem. Soc. Trans. 19 (1991) 774-
777. 
37. Kerkenaar, A., Mechanism of action of morpholine fungicides. In: Lyr, H. (Ed.), Modern Selective 
Fungicides, Properties, Applications, Mechanisms of Action. VEB Gustav Fischer Verlag, Jena, 
Germany, 1987, p. 159-172. 
38. Mercer, E.I., The mode of action of morpholines. In: Berg, D. & Plempel, M. (Eds.), Sterol Biosyn-
thesis Inhibitors, Pharmaceutical and Agrochemical Aspects. Ellis Horwood Ltd., Chichester, UK, 
1988, p . 120-150. 
39. Janssen. P.A.J. & Vanden Bossche, H., Mode of action of cytochrome P-450 monooxygenase inhibi-
tors. Focus on azole derivatives. Arch. Pharm. Chem. Sci. Ed. 15 (1987) 24-40. 
40. De Waard, M.A. & Fuchs, A., Resistance to ergosterol-biosynthesis inhibitors II. genetic and phy-
siological aspects. In: Dekker, J. & Georgopoulos, S.G. (Eds.), Fungicide resistance in crop 
protection. Pudoc, Wageningen, The Netherlands, 1982, p. 87-100. 
41 . Hollomon, D.W., Butters, J.A. & Hargreaves, J.A., Resistance to Sterol Biosynthesis-Inhibiting 
Fungicides. In: Green, M.B., Le Baron, H.M. & Moberg, W.K. (Eds.), Managing Resistance to Agro-
chemicals, from fundamental Research to practical Strategies. ACS Symposium Series 421 (1990) 199-
214 
42. Kalamarakis, A.E., De Waard, M.A., Ziogas, B.N. & Georgopoulos, S.G., Resistance to fenarimol in 
Nectria haematococca var. cucurbitae. Pestic. Biochem. Physiol. 40 (1991) 212-220. 
43. Schepers, H.T.A.M., Fitness of isolates of Sphaerotheca fuliginea resistant or sensitive to fungicides 
which inhibit ergosterol biosynthesis. Neih. J. PI. Path. 91 (1985) 65-76. 
44. Georgopoulos, S.P., Genetics and population dynamics. In: Delp, C.J. (Ed.), Fungicide Resistance in 
North America, APS Press, St. Paul, Minnesota USA, 1988, p. 12-13. 
45. De Waard, M.A. & Van Nistelrooy, J.G.M., Stepwise development of laboratory resistance to DMI 
fungicides in Penicilium italicum. Neth. J. PI. Path. 96 (1990) 321-329. 
46. Koller, W., Sterol demethylation inhibitors: mechanism of action and resistance. In: Delp, C.J. (Ed.), 
Fungicide Resistance in North America, APS Press, St. Paul, Minnesota, USA, 1988, p . 79-88. 
47. Walsh, R.C. & Sisler, H.D., A mutant of Ustilago maydis deficient in sterol C-14 demethylation, 
characterization and sensitivity to inhibitors of ergosterol biosynthesis. Pestic. Biochem. Physiol. 18 
(1982) 122-131. 
48. Aoyama, Y., Yoshida.Y., Nishino, T., Katsuki, H., Maitra, U.S. , Mohan, V.P. & Sprinson, D.B., 
Isolation and characterization of an altered cytochrome P-450 from a yeast mutant deficient in 
lanosterol 14a-demethylation. J. Biol. Chem. 262 (1987) 14260-14264. 
49. King, D.J., Wiseman, A., Kelly, D.E. & Kelly, S.L., Differences in the cytochrome P-450 enzymes 
of sterol C-14 demethylase mutants of Saccharomyces cerevisiae. Curr. Genet. 10 (1985) 261-267. 
50. Bard, M., Lees, N.D. , Barbuch, R.J. & Sanglard, D., Characterization of a cytochrome P450 deficient 
mutant of Candida albicans. Biochem. Biophys. Res. Commun. 147 (1987) 794-800. 
51. Sisler, H.D. & Ragsdale, N.N., Molecular design and target site analysis in fungicide development. In: 
Magee, P.S., Henry, D.R. & Block, J.H. (Eds.), Probing bioactive mechanisms. American Chemical 
Society, Washington, DC, 1989, p . 198-213. 
52. Vanden Bossche, H., Marichal, P. , Gorrens, J., Bellens, D. , Verhoeven, H., Coene, M - C , Lauwers, 
W. & Janssen, P.A.J., Interaction of azole derivatives with cytochrome P-450 isozymes in yeast, fungi, 
plants and mammalian cells. Pestic. Sci. 21 (1987) 1-13. 
53. Vanden Bossche, H., Marichal, P. , Gorrens, J., Bellens, D., Moereels, H. & Janssen, P.A.J., 
Mutation in cytochrome P-450-dependent 14a-demethylase results in decreased affinity for azole anti-
fungals. Biochem. Soc. Trans. 18 (1990) 56-59. 
54. De Waard, M.A. & Van Nistelrooy, J.G.M., Differential accumulation of fenarimol by a wild type and 
fenarimol-resistant isolates of Penicillium italicum. Neth. J. PI. Path. 90 (1984) 143-153. 
19 
55. De Waard, M.A. & Van Nistelrooy, J.G.M., Inhibitors of energy-dependent efflux of the fungicide 
fenarimol by Aspergillus nidulans. Exp. Mycol. 11 (1987) 1-10. 
56. De Waard, M.A. & Van Nistelrooy, J.G.M., Accumulation of SBI fungicides in wild-type and 
fenarimol-resistant isolates of Penicillium italicum. Pestic. Sci. 22 (1988) 371-382. 
57. Ney, C , Untersuchungen zur Resistenz von Monilinia fructicola (Wint) Honey gegenfiber Ergosterol-
Biosynthesehemmern. Thesis, University of Basel, Switzerland, 1988, 92 pp. 
58. Watson, P.F. , Rose, M.E., Ellis, S.W., England, H. & Kelly, S.L., Defective C5-6 desaturation and 
azole resistance: a new hypothesis for the mode of action of azole antifungals. Biochem. Biophys. Res. 
Commun. 164 (1989) 1170-1175. 
59. Fuchs, A. & De Vries, F.W., Diastereomer-selective resistance in Cladosporium cucumerinum to 
triazole-type fungicides. Pestic. Sci. 15 (1984) 90-96. 
60. Kalamarakis, A.E., Ziogas, B.N. & Georgopoulos, S.G., Resistance to ergosterol biosynthesis inhibi-
tors in Nectria haematococca. In: Abstracts of 6th Int. Congr. Pest. Chem., IUPAC, Ottawa, 
Canada, 1986, 3E-06. 
61. Hippe, S., Combined application of low temperature preparation and electronic microscopic auto-
radiography for the localization of systemic fungicides. Histochemistry 87 (1987) 309-315. 
62. Smith, F.D. & Koller, W., The expression of resistance of Vstilago avenae to the sterol demethylation 
inhibitor triadimenol is an induced response. Phytopathol. 80 (1990) 584-590. 
63. Yoshida, Y. & Aoyama, Y., Sterol 14a-demethylase and its inhibition: structural considerations on 
interaction of azole antifungal agents with lanosterol 14a-demethylase (P-450HDM) of yeast. Biochem. 
Soc. Trans. 19 (1991) 778-800. 
64. Vanden Bosche, H., Marichal, P. , Gorrens, J., Coene, M - C , Willemsens, G., Bellens, D., Roels, I., 
Moereels, H. & Janssen, P.A.J., Mycoses 32 (Suppl.l) (1989) 35-52. 
65. Burden, R.S., Cooke, D.T. & Carter, G.A., Review - Mechanism of action of herbicidal and fungi-
cidal compounds on cell membranes. Pestic. Sci. 30 (1990) 125-140. 
66. Yoshida, Y., Aoyama, Y., Takano, H. & Kato, T., Stereo-selective interaction of enantiomers of 
diniconazole, a fungicide, with purified P450/14DM from yeast. Biochem. Biophys. Res. Commun. 137 
(1986) 513-519. 
67. Yoshida, Y. & Aoyama, Y., Interaction of azole antifungal agents with cytochrome P-45014DM purified 
from Saccharomyces cerevisiae microsomes. Biochem. Pharmacol. 36 (1987) 229-235. 
68. Yoshida, Y. & Aoyama, Y., Stereoselective interaction of azole antifungal agent with its target, lano-
sterol 14a-demethylase (cytochrome F-45014DM): a model study with stereoisomers of triadimenol and 
purified cytochrome P-45014DM from yeast. Chirality 2 (1990) 10-15. 
69. Ballard, S.A., Ellis, S.W., Kelly, S.L. & Troke, P.F. , A novel method for studying ergosterol bio-
synthesis by a cell-free preparation of Aspergillus fumigatus and its inhibition by azole antifungal 
agents. J. Med. Vet. Mycol. 28 (1990) 335-344. 
70. Hitchcock, C.A., Dickinson, K., Brown, S.B., Evans, E.G.V. & Adams, D.J., Interaction of azole 
antifungal antibiotics with cytochrome P-450-dependent 14a-sterol demethylase purified from Candida 
albicans. Biochem. J. 266 (1990) 475-480. 
71. Guan, J., Stehmann, C , Ellis, S.W., Kerkenaar, A. & De Waard, M.A., Ergosterol biosynthesis in a 
cell-free preparation of Penicillium italicum and its sensitivity to DMI fungicides. Pestic. Biochem. 
Physiol. 41 (1992) 262-270. 
72. Pye, G.W. & Marriott, M.S., Inhibition of sterol C14 demethylation by imidazole-containing anti-
fungals. Sabouraudia 20 (1982) 325-329. 
73. Weete, J.D. & Wise, M.L., Effects of triazoles on fungi. V. Response by a naturally tolerant 
species, Mucor rouxii. Exp. Mycol. 11 (1987) 214-222. 
74. Deas, A.H.B., Carter, G.A., Clark, T., Clifford, D.R. & James, C.S., The enantiomeric composition 
of triadimenol produced during metabolism of triadimefon by fungi. III. Relationship with sensitivity to 
triadimefon. Pestic. Biochem. Physiol. 26 (1986) 10-21. 
75. Gasztonyi, M. & Josepovits, G., Biochemical and chemical factors of the selective antifungal effect of 
triforine. I. The causes of selectivity of the contact fungicidal action. Acta Phytopath. Acad. Sci. Hung., 
10 (1975) 437-446. 
76. Yoshida, Y., Cytochrome P450 of Fungi, Primary Target for Azole Antifungal Agents. In: McGinnis, 
M.R. (Ed.), Current Topics in Medical Mycology. Springer-Verlag, Berlin, Germany, 1988, p . 388-
418. 
20 
77. Black, S. D. & Coon, M.J., P-450 Cytochromes: Structure and Function. Adv. Enzymol. 60 (1988) 35-
87. 
78. Schenkman, J.B., Sligar, S.G. & Cinti, D.L., Substrate interaction with cytochrome P-450. Pharmacol. 
Ther. 12 (1981) 43-71. 
79. Testa, B. & Jenner, P. , Inhibitors of cytochrome P-450s and their mechanism of action. Drug Metab. 
Rev. 12 (1981) 1-117. 
80. Hitchcock, C.A., Cytochrome P-450-dependent 14a-sterol demethylase of Candida albicans and its 
interaction with azole antifungals. Biochem. Soc. Trans. 19 (1991) 782-789. 
81. Goosey, M.W. & Moore, D.J., Sterol biochemistry in filamentous fungi: a coming of age. Biochem. 
Soc. Trans. 19 (1991) 769-799. 
82. Aoyama, Y., Yoshida, Y., Sonoda, Y. & Sato, Y., Role of the 8-double bond of lanosterol in the 
enzyme-substrate interaction of cytochrome P-45014DM (Lanosterol 14a-demethylase). Biochim. 
Biophys. Acta 1001 (1989) 196-200. 
83. Aoyama, Y., Yoshida, Y., Sonoda, Y. & Sato, Y., The 3-hydroxy group of lanosterol is essential f o r 
orienting the substrate in the substrate site of cytochrome P-45014DM (Lanosterol 14a-demethylase). 
Biochim. Biophys. Acta 1006 (1989) 209-213. 
84. Aoyama, Y., Yoshida, Y., Sonoda, Y. & Sato, Y., Role of the side chain of lanosterol in substrate 
recognition and catalytic activity of lanosterol 14a-demethylase (cytochrome P-45014DM) of yeast. 
Biochim. Biophys. Acta 1081 (1991) 262-266. 
85. Ballard, S.A., Kelly, S.L., Ellis, S.W. & Troke, P.F. , Interaction of microsomal P-450 isolated 
from Aspergillus fumigatus with fluconazole and itraconazole. / . Med. Vet. Mycol. 28 (1990) 327-334. 
86. Guan, J., Braks, H.M.J., Kerkenaar, A. & De Waard, M.A., Interaction of microsomal cytochrome 
P450 isozymes isolated from Penicillium italicum with DMI fungicides. Pestic. Biochem. Physiol. 42 
(1992) 24-34. 
87. Marichal, P. , Vanden Bossche, H., Gorrens, J., Bellens, D. & Janssen, P.A.J., Cytochrome P-450 of 
Aspergillus fumigatus - Effects of itraconazole and ketoconazole. In: Schuster, I. (Ed.), Cytochrome P-
450: biochemistry and biophysics. Taylor & Francis, London, UK, 1988, p. 177-180. 
88. Peacock, G.A. & Goosey, M. W., Separation of fungal sterols by normal-phase high-performance 
liquid chromatography. Application to the evaluation of ergosterol biosynthesis inhibitors. J. 
Chromatogr. 469 (1989) 293-304. 
89. Vanden Bossche, H., Importance and role of sterols in fungal membranes. In: Kuhn, P.J., Trinci, 
A.P.J., Jung, M.J., Goosey, M.W & Copping, L.G. (Eds.), Biochemistry of cell walls and membranes 
in fungi. Springer-Verlag, Berlin Heidelberg, 1990, p. 135-157. 
90. Yoshida, Y. & Aoyama, Y., Interaction of azole fungicides with yeast cytochrome P-450 which cata-
lyzes lanosterol 14a-demethylation. In: Iwata, K., Vanden Bossche, H. (Eds.), In In vitro and In vivo 
Evaluation of Antifungal Agents. Elsevier Science Publishers B.V., Amsterdam, The Netherlands, 
1986, p . 123-134. 
91. Vanden Bossche, H., Bellens, D., Cools, W., Gorrens, J., Marichal, P. , Verhoeven, H., Willemsens, 
G., De Coster, R., Beerens, D., Haelterman, C , Coene, M - C , Lauwers, W. & Le Jeune, L., Cyto-
chrome P-450: target for itraconazole. Drug Dev. Res. 8 (1986) 287-298. 
92. Wiggins, T.E. & Baldwin, B.C., Binding of azole fungicides related to diclobutrazol to cytochrome 
P450. Pestic. Sci. 15 (1984) 206-209. 
93. Vanden Bossche, Biochemical targets for antifungal azole derivatives: hypothesis on the mode of action. 
In: McGinnis, M.R. (Ed.), Current topics in medical mycology, vol.1. Springer-Verlag, New York 
Berlin Heidelberg Tokyo, 1985, p . 313-350. 
2 1 
CHAPTER 3 
BIOCHEMICAL MECHANISMS INVOLVED IN SELECTIVE 
FUNGITOXICITY OF TWO STEROL 14a-DEMETHYLATION 
INHIBITORS, PROCHLORAZ AND AN EXPERIMENTAL 
TRIAZOLE. 
ACCUMULATION AND METABOLISM STUDIES. 
Johan C. Kapteyn", John B. Pillmoorb and Maarten A. De Waard" 
"Department of Phytopathology, Wageningen Agricultural University, Binnenhaven 9, 
6709 PD Wageningen, The Netherlands. 
b
 Schering Agrochemicals Ltd., Chesterford Park Research Station, Saffron Walden, 
Essex CB10 1XL, UK. 
(Accepted by Pesticide Science) 
Abstract 
The selective fungitoxic actions of prochloraz (an imidazole) and an experimental 
triazole fungicide 3-(2,4-dichlorophenyl)-2-(lfl-l,2,4 triazol-lyl)-4(3fl)-quinazolinone (II) 
were studied with selected phytopathogenic fungi. With the exception of Ustilago maydis, 
all the fungi tested were more sensitive to prochloraz than to H. A number of DMI-
resistant mutants of Penicillium digitatwn and P. italicum showed positive cross-resistance 
to both DMIs, but except for P. italicum isolate H17, the levels of resistance to II were 
much higher than to prochloraz. 
The generally higher toxicity of prochloraz to the fungi investigated, as compared to n , 
could not be ascribed to the slightly higher accumulation of prochloraz. With regard to 
prochloraz, there was no general correlation between the sensitivity of the fungi tested 
and the amount of fungicide accumulated. A similar situation was evident for n . 
However, the DMI-resistant mutants of P. italicum did show a reduced accumulation of 
both azoles, which may account for a low level of acquired DMI-resistance in this fungus. 
However, since accumulation levels of the test compounds in the isolates with different 
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degrees of resistance were the same, additional mechanisms of resistance may be involved 
in isolates with relatively high degrees of DMI-resistance. 
No detectable amounts of fungicide metabolites were found in most fungi tested over a 
16 hour incubation period. Therefore, fungal metabolism is not generally responsible for 
the differences in sensitivity between fungi to each azole tested. It also does not generally 
explain the differential toxicities of prochloraz and II to each individual species. The 
exception to this was Rhizoctonia solani which metabolized prochloraz to a non-fungitoxic 
compound. This correlated with its low prochloraz sensitivity. 
Introduction 
Sterol biosynthesis inhibitors (SBIs) are widely used in agriculture as fungicides 
combating plant diseases like powdery mildews, rusts and scabs. The primary mode of 
action of most SBIs is inhibition of sterol biosynthesis caused by binding of the fungicides 
to cytochrome P-450 dependent sterol Ma-demethylase.1 Therefore these SBIs are called 
demethylation inhibitors (DMIs). The other major group of SBIs are the morpholine and 
piperidine derivatives which inhibit the A14-reductase and A8-A7-isomerase in sterol 
biosynthesis.2'3 
Relatively little is known about the mechanisms of natural insenstivity and acquired 
(field or laboratory) resistance of fungi to DMIs. A high degree of natural DMI 
insenstivity is shown by Peronosporales like Pythium and Phytophthora because these 
fungi do not synthesize sterols or do not require them for vegetative growth.4 Growth of 
Mucor species, which do contain ergosterol as the main desmethylsterol, is also relatively 
insensitive to DMIs. This may be ascribed to the qualitative and quantitative requirements 
for sterols being less in Mucor than in more sensitive fungi.5 Natural insensitivity of fungi 
to triforine appears to be based on either differences in fungal accumulation or 
metabolism of the compound.6,7 Deas et al} demonstrated that natural insensitivity of a 
number of fungi to triadimefon depends on the extent of metabolic activation of 
triadimefon to triadimenol and the sensitivity to the individual enantiomers of triadimenol 
produced. 
The mechanisms of natural fungal insensitivity to DMIs may be closely related to those 
which account for acquired resistance. To date, decreased sensitivity to DMIs in practice 
has been observed in pathogens like Erysiphe graminis f.sp. hordei, E. graminis 
f.sp. tritici, Sphaerotheca fuliginea, P. digitatum, Venturia inaequalis, 
Pseudocercosporella herpotrichoides and Rhynchosporium secalis.912 Most of these 
pathogens are either difficult to cultivate in vitro or are obligate pathogens. Therefore, 
studies on mechanisms of acquired resistance to DMIs have mainly been carried out with 
model fungi which are relatively easy to cultivate in vitro, like Aspergillus nidulans, P. 
italicum, Monilinia fructicola and Nectria haematococca.1311 In laboratory-generated 
mutants of these fungi, DMI-resistance is often based on an increased energy-dependent 
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efflux of the fungicide, by which accumulation is decreased.13"17 A second proposed resis-
tance mechanism involves an altered sterol composition, as has been found for a 
morpholine-resistant laboratory mutant of Ustilago maydis producing a yet unknown 
desmethylsterol instead of ergosterol.18 Altered sterol composition has also been observed 
in DMI- and nystatine-resistant, sterol 14a-demethylation deficient mutants of U. maydis, 
Candida albicans and Saccharomyces cerevisiae.19'73 Watson et al.24 concluded that 
resistance of S. cerevisiae might be based on defective sterol C5^ desaturation, as a result 
of which resistant isolates accumulated 14a-methylfecosterol, and, in contrast to sensitive 
strains, lacked the ability to synthesize toxic diols of 14a-methylsterols. Another possible 
mechanism of DMI-resistance may be reduced affinity of the target enzyme cytochrome-
P450 for DMIs. In this respect, Vanden Bossche et al.25'21 demonstrated that azole-
resistant isolates of C. albicans contained cytochrome-P450 isozymes with less affinity for 
various azole DMIs than the azole-sensitive strains. 
The present study describes the selective toxicity of two DMI-fungicides, prochloraz 
and the experimental compound 3-(2,4-dichlorophenyl)-2-(l.ff-l,2,4 triazol-lyl)-4(3fl)-
quinazolinone (Fig.l), to selected phytopathogenic fungi and attempts to determine 
whether the variation in biological activity of these azoles results from differences in 
accumulation and metabolism. 
ci 
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Fig. 1. Structural formulae of prochloraz (I) and 3-(2,4-dichlorophenyl)-2-(lff-l,2,4-triazol-lyl)-
4(3fl)-quinazolinone (II). 
Materials and Methods 
Fungal isolates. The fungi used were Botrytis cinerea, Cladosporium cucumerinum, 
Fusarium culmorum, Fusarium oxysporum f.sp. lycopersici, Glomerella cingulata, 
Rhizoctonia solani and U. maydis. P. italicum W5 (wild-type) and the laboratory isolates 
A10-9 (low degree of DMI-resistance), E300-3 (medium degree of DMI-resistance) and 
H17 (high level of DMI-resistance) have been described before.28,29 P. herpotrichoides 
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wheat- and rye-type (field isolates) were provided by Schering Agrochemicals Ltd. 
Penicillium digitatum W (wild-type) and the imazalil-resistant packing house isolates 5 
and FMC originated from Janssen Pharmaceutica (Beerse, Belgium). 
Chemicals. Technical prochloraz (I) and 3-(2,4-dichlorophenyi)-2-(lfl-l,2,4 triazol-
lyl)-4(3fl)-quinazolinone (II) were provided by Schering Agrochemicals Ltd. along with 
U-[14C] phenyl labelled prochloraz and U-[14C] benzyl labelled compound n . Methanol, 
ethylacetate and toluene were purchased from Janssen Chimica (Beerse, Belgium); glucose 
and n-hexane from Lamers & Pleuger BV. (s'Hertogenbosch, The Netherlands); rifampi-
cine from Sigma (Deisenhofen, Germany); dichloromethane, acetic acid and all other 
chemicals from Merck (Darmstadt, Germany). 
Culture methods and preparation of mycelial suspensions. B. cinerea, C. 
cucumerinum, G. cingulata, P. herpotrichoides and R. solani were maintained on potato 
dextrose agar (PDA). F. culmorwn, F. oxysporum f.sp. lycopersici, U. maydis, P. 
italicum and P. digitatum were maintained on malt extract agar (MA). 
Mycelium of all filamentous fungi tested was grown in liquid medium containing 2% 
malt extract (Difco) and 1% mycological peptone (Oxoid L40). Flasks (300 ml) with 
medium (100 ml) were inoculated with 1 ml of a conidial suspension (final numbers of 
conidia ml"1 for P. italicum and C. cucumerinum 107 and for F. culmorwn 2x10s) and 
incubated in an orbital shaker at 25°C and 180 rpm for 10.5, 12 and 10.5 h, respectively. 
For R. solani, 50 to 100 mycelial plugs (0.25 cm2) were incubated at 25°C and 180 rpm 
for 60 h. Sporidia of U. maydis (8x10s ml1) were grown at 30°C and 180 rpm in a liquid 
medium described previously.30 P. herpotrichoides (5x10s conidia ml"1) was grown at 
22°C and 100 rpm for 64 h. Conidia of P. herpotrichoides were obtained by growing 
mycelial plugs (5 plugs per plate) on water agar amended with rifampicine (3 jxg ml1) for 
12 days at 16°C under constant near UV light. The plates were flooded with 1.5 ml 
sterile distilled water and the conidia were removed by scraping the agar surface with a 
glass rod. Conidial suspension (1 ml) was spread onto PDA and incubated under near UV 
light for 7 days at 16°C. This produces a mass of conidia (R.J. Birchmore, personal 
communication). 
Standard mycelial suspensions of all filamentous fungi were made by passing the 
suspension through a 0.21 mm pore sieve to remove clusters of mycelium and then 
collecting mycelium on a 0.02 mm pore sieve. Mycelium collected was washed once with 
tap water and twice with potassium phosphate buffer pH 6, containing 0.1 mM CaCl2 and 
50 mM glucose. Before sieving, mycelium of R. solani was partially fragmented for 10 s 
in a Polytron homogenizer (Kinematica, Kriens-Luzern, Switzerland). Sporidia of U. 
maydis were harvested by centrifugation at 2000g for 5 min and washed twice with 
potassium phosphate buffer. Standard biomass suspensions (average dry weight of about 3 
mg ml"1) of most test fungi were made by resuspending washed mycelium or sporidia (1 g 
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wet weight) in 50 ml of potassium phosphate buffer pH 6 as described previously.13,14 
Standard biomass suspensions of P. herpotrichoides were made by resuspending 1 g wet 
weight of mycelium in 100 ml buffer. 
Toxicity assay. Toxicities of prochloraz and II to radial fungal growth were determined 
in Petri dishes containing PDA amended with these fungicides at various concentrations 
(from 1000-fold stock solutions in methanol). For U. maydis, MA was used. Inverted 5-
mm agar discs with young mycelium or sporidia were placed on the agar surface (in 
duplicate, 3 discs per plate). All fungi but P. herpotrichoides (20°C) and U. maydis 
(30°C) were incubated at 25°C. 
Accumulation studies. The amount of radioactive fungicides associated with the 
mycelium was determined as described below. Standard biomass suspensions (50-80 ml) 
of F. culmorum, P. herpotrichoides, P. italicum and R. solani were preincubated in a 
reciprocal water bath shaker at 25°C for 30 min. Standard biomass suspensions of C. 
cucumerinum and U. maydis were incubated under similar conditions at 22 and 30°C, 
respectively. Experiments were started by adding [14C]prochloraz (spec, activity 1.3 MBq 
mmol"1) and [14C]compound II (spec, activity 1.2 MBq mmol"1) from 100-fold stock 
solutions in methanol to final concentrations of 90 jiM. At time intervals samples (5 ml) 
were taken, processed and radio-assayed as described previously.1314 
Metabolism studies. Metabolism of prochloraz and II was studied with standard 
biomass suspensions (20 ml) made from 16 h old liquid cultures by resuspending 1 g wet 
weight of biomass in 50 ml of fresh media. The metabolism experiments were initiated by 
adding [14C]prochloraz (spec, activity 1.3 MBq mmol"1) and [14C]compound II (1.2 MBq 
mmol1) to final concentrations of 0.3 and 90 f/M, respectively. Samples (10 ml) were 
taken after an additional 16 h incubation period and filtered on Whatman glass filter 
papers using a Millipore sampling manifold apparatus. [14C]Label was extracted from 
mycelium or sporidia with dichloromethane (20 ml) by grinding in a Potter-type 
homogenizer. Label in culture filtrates was extracted twice with dichloromethane (10 ml). 
Extracts were dried under reduced pressure, resuspended in dichloromethane (0.5 ml) and 
spotted on silica gel TLC-plates (Merck, 60 F254). The plates were developed immediately 
with ethylacetate/toluene (3:2) or ethylacetate/hexane/acetic acid (8:2:0.1) as solvent 
systems. Radioactive metabolites and fungicides were located by autoradiography using 
diagnostic films (Kodak, X-OMAT™ AR). The TLC plates were also bioassayed for 
fungicidal activity by spraying with a conidial suspension of P. italicum W5 in 1% 
KH2P04, 0.43% Na2HP04.2H20, 0.57% KN03, 0.14% MgS04.7H20 and 4.3% glucose. 
Growth was assessed after 3 days of incubation in glass trays at 100% R.H. and 25°C. 
Radioactivity in mycelial or sporidial extract, culture filtrate extract, mycelial or sporidial 
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(solid) residue and extracted culture filtrate (aqueous phase) was determined in a liquid 
scintillation system as described previously.13,14 
Results 
Toxicity assay. EC50 values of prochloraz to radial growth of the fungi tested ranged 
from 0.01 to 4.0 /*M. C. cucumerinum, F. culmorum and P. italicum W5 were the most 
sensitive species, while R. solani and U. maydis were the least sensitive ones (Table 1). 
Table 1: Toxicity of prochloraz and II to various fungal pathogens in radial growth assays on 
agar. 
Fungus 
B. cinerea 
C. cucumerinum 
F. culmorum 
F. oxysporum f.sp. 
lycopersici 
G. cingulata 
P. digitatum W 
P. digitatum 5 
P. digitatum FMC 
P. italicum 
P. italicum A10-9 
P. italicum E300-3 
P. italicumHn 
P. herpotrichoides 
P. herpotrichoides 
P. oryzae 
R. solani 
U. maydis 
Incubation 
period 
(days) 
2 
7 
2 
2 
3 
3 
3 
3 
3 
3 
3 
3 
wh 10 
ry 14 
4 
2 
9 
.11L50 
Prochloraz 
0.07 
0.01 
0.01 
0.03 
0.05 
0.02 (l)1 
0.10 (5) 
0.12 (6) 
0.01 (1) 
0.06 (6) 
0.13 (13) 
1.12 (112) 
0.09 
0.09 
0.03 
3.7 
4.0 
(]M) 
II 
0.61 
0.09 
40.5 
4.5 
0.59 
0.67 (l)1 
517 (772) 
461 (688) 
7.8 (1) 
154 (20) 
501 (64) 
531 (68) 
0.33 
19.6 
5.0 
5.0 
1.2 
1
 (): resistance factor defined as ratio between EC*, of prochloraz or II for resistant and wild-type 
isolate. 
Except for U. maydis all fungi tested were much less sensitive to II than to prochloraz 
(Table 1). EC50 values of II varied from 0.09 to 531 fiM. C. cucumerinum appeared to be 
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the most sensitive fungus, while P. italicum isolate H17 had the lowest sensitivity. The 
DMI-resistant P. italicum isolates A10-9, E300-3 and H17 exhibited positively correlated 
cross-resistance to prochloraz and II (Table 1). The levels of resistance in isolates A 10-9 
and E300-3 to prochloraz were lower than to n . In contrast, isolate H17 was more 
resistant to prochloraz than to n . Positively correlated cross-resistance to both azoles was 
also observed in imazalil-resistant isolates of P. digitatum. Both isolates showed a similar 
level of resistance, but were much more resistant to II than to prochloraz (Table 1). 
Since C. cucumerinum, F. culmorwn, P. herpotrichoides wheat- and rye-type, P. 
italicum isolates W5, E300-3 and H17, R. solani and U. maydis exhibited marked dif-
ferences in sensitivity to prochloraz and n , these fungi were selected for accumulation 
and (except for F. culmorwn and P. italicum E300-3) metabolism studies. The mechanism 
of DMI-resistance in P. digitatum is studied by Janssen Pharmaceutica (Vanden Bossche, 
pers. commun.) 
Short term accumulation studies. Time course studies of the accumulation of the two 
compounds by the fungi investigated are shown in Figures 2-4 and the maximum levels 
accumulated are given in Table 2. All the fungi investigated accumulated prochloraz to a 
higher, maximum level than they accumulated II (Table 2). Maximum accumulation of 
prochloraz and II by the fungi tested ranged from 2.3 to 12.9 and 0.4 to 8.6 nmol mg"1 
dry weight of biomass, respectively. Both types of P. herpotrichoides accumulated 
O 10 20 30 40 50 6 0 70 
Incubation time (min) 
1.5 
1.0 
0.5 
— X 
„ •—-•—•—— * ! " y 
B 
_^ _-« 
10 20 30 40 50 6 0 70 
Incubation time (min) 
Fig. 2. Accumulation of (A) [14C]prochloraz and (B) [14C]compound II by wild-type W5 (A) and 
DMI-resistant isolates E300-3 (•) and H17 (T) of Penicillium italicum. Initial external DMI 
concentration 90 /iM. 
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0 . 5 
0 . 0 
0 15 3 0 45 6 0 75 
Incubation time (min) 
Fig. 3. Accumulation of (A) [14C]prochloraz and (B) [14C]compound II by Cladosporiian 
cucumerinum (•), Rhizoctonia solani (T) and Ustilago maydis (A). Initial external DMI 
concentration 90 /iM. 
O 10 2 0 30 40 5 0 6 0 70 
Incubation time (min) 
0 10 20 3 0 40 50 60 70 
Incubation time (mini 
Fig. 4. Accumulation of (A) [14C]prochloraz and (B) [MC]compound II by Fusarium culmorum, 
(•), Pseudocercosporella herpotrichoides wheat- (A) and rye-type (•). Initial external DMI 
concentration 90 /*M. 
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Table 2. Maximum accumulation of [14C]prochloraz and [14C] compound II by various fungal 
species. Initial external DMI concentration was 90 pM. 
Fungus Maximum1 accumulation (nmol mg1 dry weight) 
Prochloraz II 
C. cucumerinum 
F.culmorum 
P. herpotrichoides 
P. herpotrichoides 
P. italicum W5 
P. italicum E300-3 
P. italicum H17 
R. solani 
U. maydis 
wheat 
rye 
6.6 
6.5 
12.0 
12.9 
5.2 
2.3 
2.5 
5.1 
2.7 
1.8 
1.8 
2.7 
8.6 
1.5 
0.5 
0.4 
1.8 
0.7 
1
 Maximum levels of compound associated with the mycelium, taken from Figs. 2-4. 
prochloraz to the greatest level, as compared with the other fungi. P. herpotrichoides rye-
type also accumulated II to a higher level, as compared with the other fungal species. In 
contrast to the situation for prochloraz, where both types of P. herpotrichoides accumu-
lated similar levels, the wheat-type accumulated much less II than did the rye-type. 
U. maydis and the two resistant isolates of P. italicum accumulated the lowest amounts of 
both compounds, although 3-4 times more prochloraz than II was accumulated in all three 
cases. 
P. italicum W5 showed a transient accumulation of prochloraz and n , while uptake by 
resistant isolates E300-3 and H17 was constantly low during the time course of the 
experiment (Fig. 2). Accumulation of prochloraz by both resistant isolates was similar. 
The same was true for n . U. maydis also showed transient accumulation of both com-
pounds, but the accumulation levels were about 2 times lower than observed for P. 
italicum W5 (Fig. 3). R. solani and C. cucumerinum showed less pronounced transient 
accumulation curves (Fig. 3). Azole accumulation by F. culmorum and P. herpotrichoides 
(wheat- and rye-type) was relatively constant with time (Fig. 4). 
Metabolism studies. Total recoveries of radioactivity from the fungi incubated with 
labelled prochloraz and II varied from 64 to 89% and 77 to 100%, respectively (Table 3 
and 4). Total recovery of label in P. herpotrichoides wheat- and rye-type incubated with 
[14C]prochloraz was low compared with the values obtained from other fungi, but this was 
not investigated further. After 16 h incubation with prochloraz radioactivity in mycelium 
of R. solani was relatively low compared with the other fungi tested (Table 3). 
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Table 3: Recovery (%) of added radioactivity from fungal cultures incubated with 
[14C]prochloraz (0.3 jiM) for 16 h. 
Fungus 
C. cucumerinum 
P. italicwn W5 
P. italicum E M ^ 
P. herpotrichoides 
P. herpotrichoides 
R. solani 
U. maydis 
wheat 
rye 
Repli-
cate 
1 
3 
3 
2 
2 
2 
2 
Mycelium 
Extract residue 
50 
44 
37 
34 
26 
20 
35 
16 
3 
4 
9 
8 
12 
10 
Culture filtrate 
Organic Aqueous 
phase 
17 
41 
40 
20 
32 
38 
35 
phase 
14 
1 
Total 
84 
89 
82 
64 
67 
84 
81 
Table 4: recovery (%) of added radioactivity from fungal cultures incubated with II (90 /*M) for 
16 h. 
Fungus Repli- Mycelium Culture filtrate Total 
cate Extract residue Organic Aqueous 
phase phase 
C. cucumerinum 
P. italicum W5 
P. italicum E ^ j 
P. herpotrichoides wheat 
P. herpotrichoides rye 
7?. solani 
U. maydis 
1 
3 
3 
2 
2 
2 
2 
34 
14 
12 
14 
16 
16 
54 
6 
1 
1 
6 
4 
4 
8 
40 
75 
73 
60 
56 
78 
31 
1 
2 
3 
1 
1 
1 
1 
81 
92 
89 
81 
77 
100 
94 
TLC of mycelial and culture filtrate extracts of all fungi incubated with [14C]compound II 
for 16 h and developed with two different solvent systems did not demonstrate any 
metabolite of this triazole (data not shown). Similar results were obtained with prochloraz 
(data not shown), with the exception of R. solani. TLC of mycelial and culture filtrate 
extracts of this fungus indicated the production of one metabolite after 16 h incubation 
with prochloraz (Fig. 5). Bioassays of the TLC-plates by incubating them with a conidial 
suspension of P. italicum W5 demonstrated that the metabolite was non-fungitoxic (data 
not shown). It was also tested whether extracellular enzymes were responsible for the 
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metabolic degradation of prochloraz. For this purpose culture filtrate of R. solani was 
incubated for another 16 h with [14C]prochloraz and extracted. TLC of this extract did not 
reveal any metabolites (data not shown). 
A 
Metabolite 
Rf: 0.72 Prochloraz 
R,: 0.27 
B 
rjM) 
Metabolite 
Rf: 0.67 
VJ 
Prochloraz 
R,: 0.26 
Origin 
Fig. 5: Radioactivity TLC patterns from (A) an extract of the culture filtrate and (B) a mycelial 
extract of Rhizoctonia solani incubated with "C-prochloraz for 16 h at 25°C. Solvent system was 
ethylacetatertoluene, 3:2. 
Discussion 
Investigation of the fungitoxicity of prochloraz and II to a number of fungi in in vitro 
radial growth assays showed a range of sensitivities. Prochloraz was extremely toxic to all 
the fungi tested, except for U. maydis and R. solani (Table 1). In contrast, n showed 
much more variation in toxicity and was less active than prochloraz in all cases except 
against U. maydis. The difference in senstivity between both types of P. herpotrichoides 
to II is in line with data obtained with other triazoles.12 As was expected, the DMI-
resistant isolates of P. italicum and P. digitatum were less sensitive to the two compounds 
as compared with the wild type strains. However, the resistance factors of individual 
strains to the two compounds did differ markedly in most cases, indicating that the 
resistance mechanisms were not always equally effective in preventing the toxicity of the 
compounds. 
From the initial toxicity studies, 9 fungi that exhibited marked differences in then-
responses to the two compounds were selected for further study to determine whether 
differences in uptake or metabolism could account for the observed differences in 
sensitivity. 
33 
The accumulation studies showed that there was no overall correlation between 
senstivity and the maximum amount of compound accumulated by the wild type fungi 
investigated for either prochloraz or n (Table 2). For example II was accumulated to a 
similar level by sensitive (C. cucumerinum and P. herpotrichoides wheat-type) and 
insensitive {F. culmorwn, P. italicum and R. solani) species. U. maydis accumulated the 
lowest levels of II despite being of intermediate sensitivity. The highest levels of II were 
accumulated by the relatively insensitive P. herpotrichoides rye-type. Hence, a negative 
correlation exists between sensitivity and accumulation of II in wheat- and rye-types of P. 
herpotrichoides (Table 1 and 2). No obvious explanation for this can be given, but it 
might be that in the rye-type the availability of II at the target site is reduced by 
deposition in other cell compartments. For prochloraz, the three most senstitive fungi (P. 
italicum, C. cucumerinum and F. culmorum) accumulated a similar level of prochloraz as 
did the relatively insensitive R. solani. The two types of P. herpotrichoides, which were 
about 9 times more insensitive than the three most sensitive species, accumulated some 2 
times more prochloraz than did the sensitive fungi. However, it is noted that the 
accumulation studies with P. herpotrichoides were undertaken with approximately half the 
biomass density than used for the other fungi and this may have resulted in a relatively 
higher level of accumulation. 
Despite the lack of any overall correlation between sensitivity and maximum 
accumulation, it is noted that U. maydis, which was the most prochloraz insensitive 
species, did show a rapid transient and low accumulation of prochloraz (Fig. 3A). The 
low accumulation in this fungus may contribute to, but cannot fully explain, its more than 
300-fold lower prochloraz sensitivity as compared with the other fungi. 
Investigation of the accumulation of the two compounds by laboratory-generated 
mutants of P. italicum also showed reduced maximum accumulation of both compounds in 
the resistant isolates as compared with the wild-type isolate (Fig. 2). As has been 
described for other DMIs15, accumulation of the compounds by the wild-type isolate 
showed an initial high accumulation followed by efflux. In contrast, the resistant isolates 
showed consistently low accumulation during the course of the experiment. Reduced 
initial accumulation may therefore be a major reason for the resistance of isolates E300-3 
to both compounds and of H17 to n . However, isolate H17 showed similar accumulation 
of prochloraz to that of isolate E300-3, despite being some 10 times more resistant. In 
this case, the resistance of isolate H17 to prochloraz must involve an additional, as yet 
unknown, mechanism. These findings agree with those of Ney16, who demonstrated that 
reduced accumulation alone could not account for the differential, laboratory-generated 
triazole-resistance in M. fructicola. 
Similar, transient accumulation curves to that of wild-type P. italicum were also evident 
for C. cucumerinum, R. solani and U. maydis (Fig. 3). This might indicate that these 
fungi also possess an inducible, energy-dependent efflux mechanism, but this still remains 
to be confirmed. Transient accumulation did not, however, correlate with sensitivity as 
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both the sensitive C. cucumerinwn and the relatively insensitive R. solani exhibited 
transient accumulation curves. F. culmorum and P. herpotrichoides wheat- and rye-type 
(Fig. 4) did not show transient accumulation which might indicate that these fungi possess 
constitutive efflux systems similar to those of P. italicum isolates E300-3 and H17. 
However, appearance of transient accumulation also depends on the initial external 
concentration and the nature of the DMI added. With respect to the latter aspect it is 
interesting to note that F. culmorum did, but U. maydis did not exhibit transient 
accumulation when incubated with 30 piM fenarimol (De Waard, unpublished results) in 
contrast to the present results. Furthermore, membrane or cell wall characteristics of 
these fungi might also account for the absence of transient accumulations. In this respect, 
it is noted that P. herpotrichoides produces a layer of mucilage around the hyphae.31 This 
might have hindered or masked azole efflux by high non-specific binding of the 
compounds. 
Comparison of the selective fungitoxicity of prochloraz and II showed that prochloraz 
was accumulated to a greater maximum level than was II in all cases (Table 2). However, 
the greater accumulation of prochloraz is not considered to provide a general explanation 
for the greater toxicity of this compound as compared with n . While the greater 
accumulation of prochloraz by C. cucumerinum, P. herpotrichoides wheat-type and R. 
solani might partially explain the observed 3 to 5 fold differences in sensitivity, it does 
not seem plausible that the same differences in uptake for P. italicum wild-type and F. 
culmorum can account for the up to 3000-fold differences in toxicity of the compounds. It 
is also noted that U. maydis was less sensitive to prochloraz than to n , despite 
accumulating more prochloraz. 
Investigation of the metabolism of the two compounds demonstrated no evidence of 
metabolism of either compound over a 16 hour incubation period for most of the fungi 
tested. Therefore, differential sensitivity of the fungi to the two compounds is not 
generally due to metabolism. The only exception to this was for R. solani which did 
significantly metabolise prochloraz, but not compound n , to a non-fungitoxic compound 
(unpublished result). In this case, metabolism may account for the low sensitivity of this 
species to prochloraz. The metabolite was detected in both the mycelial and culture 
filtrate extracts but was not formed by incubation of prochloraz with the isolated culture 
filtrate for 16 hours (unpublished result). The metabolite is therefore probably produced 
in the mycelium and excreted into the medium. This assumption is supported by the fact 
that, after 16 h incubation with prochloraz, the amount of radiolabel in mycelium of R. 
solani was lower than in the other fungi tested (Table 2). 
The present work has demonstrated that the selective fungitoxicity of prochloraz and II 
to a number of fungal species is not generally due to differential accumulation or 
metabolism. Consequently, other factors must also be involved in the observed selective 
fungitoxicity, for example differential affinity of the cytochrome-P450 to these DMIs, 
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altered sterol composition, removal of the toxic sterol precursors etc. Some of these 
mechanisms have been investigated in other studies.32 
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CHAPTER 4 
CHARACTERISATION OF ENERGY-DEPENDENT EFFLUX OF 
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Abstract 
Differential accumulation of [14C]imazalil and [14C]fenarimol by germlings of wild-type 
and DMI-resistant isolates of Penicillium italicum was studied at various pH values. At 
pH 7 and 8 the low resistant isolate £300.3 accumulated 22% and 35% less imazalil than 
the wild-type isolate W5, respectively. Imazalil accumulation at pH 5 and 6 was similar. 
Isolate £300.3 also accumulated less fenarimol as compared with the wild-type isolate. This 
difference was much more obvious than for imazalil and was observed at all pH values 
tested. Differences in accumulation of both imazalil and fenarimol between low (12300.3), 
medium (H17) and high resistant (I33) isolates were not observed. These results suggest 
that decreased accumulation of DMIs is responsible for a low level of resistance only and 
that additional mechanisms of resistance might operate in isolates with a medium and high 
degree of resistance. With all isolates fenarimol accumulation was energy-dependent. This 
was not obvious for imazalil. 
The wild-type and DMI-resistant isolates had a similar plasma membrane potential as 
determined with the probe [14C]tetraphenylphosphonium bromide ([14C]TPP+). Various 
test compounds among which ATPase inhibitors, ionophoric antibiotics, calmodulin 
antagonists affected the accumulation of [14C]TPP+, [14C]imazalil and [14C]fenarimol. No 
obvious correlation between the effects of the test compounds on accumulation levels of 
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the fungicides and [14C]TPP+ could be observed. These results indicate that the plasma 
membrane potential does not mediate the efflux of DMI fungicides by P. italicum. 
Introduction 
Sterol biosynthesis inhibitors (SBIs) are systemic fungicides used in agriculture for the 
control of plant diseases. The primary mode of action of most SBIs (e.g. derivatives of 
imidazoles, triazoles and pyrimidines) is based on inhibition of cytochrome P450-
dependent sterol Ma-demethylation.1 Therefore, these SBIs are referred to as demethyla-
tion inhibitors (DMIs). 
Resistance to DMIs has been reported for a number of fungi in both laboratory and 
field.2'3 Studies with various fungi suggested that a large number of potential mechanisms 
of resistance can be involved.4"12 A well documented mechanism is energy-dependent 
efflux of DMI-fungicides from mycelium of Aspergillus nidulans and Penicillium italicum. 
Increased efflux from fenarimol-resistant mutants of these fungi leads to secretion of 
DMIs into the external medium and hence prevents intracellular accumulation. 
Consequently, the target enzyme becomes less readily inhibited and the mutants less 
sensitive.13"16 The ATPase inhibitor AT,iV-dicyclohexylcarbodiimide (DCCD) and the 
plasma membrane ATPase inhibitor sodium orthovanadate were found to inhibit efflux 
causing accumulation of all DMIs tested.15 This might be a consequence of dissepation of 
the electrochemical proton gradient (ApH+) maintained by plasma membrane ATPase 
across plasma membranes.15 The A/ZH+ is composed of a proton gradient (AH+) and a 
plasma membrane potential (A^) and is known to drive transport processes of various 
xenobiotics such as benzoic and sorbic acid17 and aminoglycoside antibiotics,18 respecti-
vely. Accumulation of the aminoglycoside antibiotic gentamycin by Staphylococcus aureus 
was also found to be enhanced by DCCD.19 DMI-resistant isolates of A. nidulans showed 
cross-resistance to the aminoglycoside antibiotic neomycin.20 These results suggest that a 
similar mechanism may mediate the accumulation of DMIs and aminoglycosides. In 
addition, resistance to aminoglycoside antibiotics in Saccharomyces cerevisiae and 
Escherichia coli was found to correlate with decreased intracellular accumulation and was 
ascribed to a defect A\p.21'22 Therefore, we investigated the A^ of wild-type and DMI-
resistant isolates of P. italicum using [14C]tetraphenylphosphonium bromide ([14C]TPP+), 
a lipophilic cation, as a probe. 
Accumulation of fenarimol and other DMIs, and of imazalil by a wild-type and a 
fenarimol-resistant isolate of P. italicum with a low degree of resistance to imazalil, 
differed in various aspects.16 The main difference was that the differential accumulation 
by low-resistant isolates was obvious for fenarimol but absent for imazalil. Therefore, in 
the present study fenarimol and imazalil were selected as test compounds. The study 
compares the accumulation of these fungicides in isolates of P. italicum with a low, 
medium and high degree of resistance at different pH values. In addition, the effect of 
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compounds with known membrane-interfering properties on accumulation of [14C]TPP+ 
was compared with their effect on accumulation of both fungicides. 
Materials and methods 
Fungal isolates. P. italicum wild-type isolate W5 and DMI-resistant isolates E300-3, H17 
and I33 with a low, medium and high degree of resistance, respectively, were used. The 
isolates have been described previously.23,24 The fungus was maintained on malt-extract 
agar medium. 
Culture methods and preparation of germling suspensions. Germlings were grown in 
liquid malt-extract medium.14 Flasks (300 ml) with medium (100 ml) were inoculated with 
1 ml of spore suspension (109 conidia per ml) collected from 7 to 10 days old agar plates. 
The flasks were incubated at 26°C on an orbital shaker at 200 rpm for 11 h. Germlings 
were harvested on a sieve (0.21 mm pores) and collected on a second sieve (0.02 mm 
pores) by intensive washing with tap water. Germlings were washed once again with 25 
mM potassium phosphate buffer pH 7.0, containing 0.1 mM calcium chloride and 1% 
(w/v) glucose. Standard suspensions of germlings with an average dry weight of about 2 
mg ml1 were prepared by resuspending 1 g wet weight of germlings in 50 ml of the same 
buffer. 
Fungicides and chemicals. [14C]imazalil and imazalil sulphate (imazalil) were gifts 
from Janssen Pharmaceutica (Beerse, Belgium); [14C]fenarimol from Lilly Research 
Center Ltd. (Erl Wood Manor, England). [14C]tetraphenylphosphonium bromide 
([14C]TPP+) was purchased from Amersham, (UK), TPP+ from ICN Pharmaceuticals Inc. 
(New York, USA); calmidazolium, carbonyl cyanide 3-chlorophenylhydrazone (CCCP), 
chlorpromazine, diethylstilbestrol (DES), gramicidine-S, nigericine and triflupromazine 
(TFP) from Sigma (Deisenhofen, Germany). Sodium orthovanadate (vanadate) and 
valinomycine and from Janssen Chimica (Beerse, Belgium). Fungicides and chemicals 
were prepared as 100-fold concentrated solution in methanol. 
Determination of plasma membrane potential. Standard germling susensions (70 ml) in 
flasks (300 ml) were incubated on a reciprocal shaker at 26°C for 30 min. [14C]TPP+ (sp. 
act. 17.3 MBq mmol"1), a commonly used probe for assessing the A\j/,2S was added to a 
final concentration of 10 /*M. At time intervals, samples (5 ml) were taken and filtered on 
a Whatman GF/A glass filter using a Millipore sampling manifold apparatus. Pellets of 
germlings were washed 3 times with 1 mM MgS04 (5 ml) in 10 sec. This washing step 
reduces aspecific binding of [14C]TPP+ to anionic groups at the cell wall surface of the 
germlings.25 A correction of [14C]TPP+ accumulation for internal, aspecific probe binding 
was made by subtracting the amount of probe bound under deenergized conditions from 
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the total amount of accumulated probe under energized conditions.2527 In preliminary 
experiments, remaining background adsorption of [14C]TPP+ by deenergized germlings 
was studied after various treatments: incubation with 0.2 M KC1 for 50 min, incubation 
without carbon source in the presence of 0.2 or 1.0 M KC1 for 6 h, heating at 100°C for 
5 min, and incubation with 1% (v/v) toluene at 37°C or 50°C for 1 h according to 
Lolkema et al.71 Germling-associated radioactivity was extracted with scintillation liquid 
(Aqua luma plus) overnight and counted in a liquid scintillation spectrometer. After 
correction of [14C]TPP+ accumulation for aspecific probe binding the A^ was estimated 
with the Nernst equation.25 The intracellular volume of P. italicum was taken to be 2.3 /tl 
mg"1 dry weight of germlings.16 Effects of test compounds on accumulation of [14C]TPP+ 
were studied by addition from 500-fold concentrated stock solutions in methanol, 50 min 
after the addition of [14C]TPP+. Accumulation of [14C]TPP+ was determined in samples (5 
ml) taken 5 and 15 min after addition of the test chemicals. The correspondent amount of 
methanol was added to the controls. In these experiments [14C]TPP+ accumulation in the 
presence of test compounds was expressed as nmol mg"1 dry weight. The corresponding 
A^ values were not calculated since the effect of the test compounds on aspecific probe 
binding was not determined. 
Accumulation of ^CJimazalil and ^CJfenarimol. Experiments were carried out 
according to the method previously described.14 Standard germling suspensions were 
shaken on a reciprocal shaker at 26°C for 30 min. Concentrations of [14C]imazalil (sp. 
act. 11.1 MBq mmol"1) and [14C]fenarimol (sp. act. 5.6 MBq mmol"1) in the germling 
suspensions were 10 and 90 pM, respectively. The final methanol concentration in the 
suspension was below 1 %. Accumulation of DMIs was determined in germlings collected 
from 5-ml samples and washed 5 times with buffer (5ml) in 30 s. Further reduction of 
background adsorption of the DMIs failed since experimental conditions or chemicals 
tested which led to deenergization of the germlings gave a significant increase in 
accumulation of the DMIs. Test chemicals were added to the germling suspension after 40 
min of incubation with [14C]imazalil and [14C]fenarimol. Effects of the test compounds on 
fungicide accumulation were determined 10 min after their addition to the suspension. 
Results 
Determination of plasma membrane potential. Accumulation of [14C]TPP+ by 
germlings was relatively fast in the initial 10 min and reached a stationary phase in about 
50 min. The total amount of [14C]TPP+ accumulated in the stationary phase was similar 
for isolates W5, Ej^j and H17 (Fig. 1). In preliminary experiments background adsorption 
of [14C]TPP+ to germlings was determined according to various methods. Heat treatment 
of germlings slightly increased [14C]TPP+ accumulation (Table 1). Germlings treated with 
toluene at 37°C accumulated approximately 4-fold more [14C]TPP+ than untreated 
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Fig. 1. Accumulation of [14C]TPP+ (10 /*M) by wild-type isolate W5 (+) and DMI-resistant 
isolates £300.3 (A) and H17 (o) of Penicillium italicwn in 23.4 mM potassium phosphate buffer pH 
7, containing 0.1 mM calcium chloride and 1 % (w/v) glucose. 
Table 1. Relative effect of various treatments of germlings on accumulation of [14C]TPP+ (10 /tM) 
by Penicillium italicum isolates W5, Ejo^ and H17 
Treatment 
Heating (100°C, 5 min) 
Toluene (1% (v/v), 37 °C, 1 h) 4.4 
Toluene (1% (v/v), 50°C, 1 h) 0.7 
KC1 (0.2 M, 50 min) 
Starvation4 and KC1 (0.2 M) 
Starvation and KC1 (1.0 M) 
Relativ e effect of treatment 
on accumulation level1,2 
W5 
1.0 
4.4 
0.8 
0.6 
0.3 
E300-3 
1.3 
4.2 
0.7 
0.8 
0.6 
0.3 
H17 
1.3 
_3 
0.8 
0.8 
0.6 
0.3 
1
 Average accumulation levels of [l4]TPP+ in untreated germlings of isolates W5, E^^ and H17 
were 0.25±0.04, 0.27+0.04 and 0.29±0.06 nmol mg1 dry weight, respectively (n=6). 
2
 Ratio between accumulation level in treated and untreated germlings. 
3
 Not tested. 
4
 Incubation without glucose in orbital shaker at 180 rpm for 6 h. 
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germlings. In contrast, treatment of germlings with toluene at 50°C slightly reduced 
accumulation of the probe, as did the incubation of germlings with 0.2 M KC1 for 50 min 
(Table 1). Germlings which were deenergized by starvation for 6 h in the presence of 1.0 
M KC1 showed the lowest level of [14C]TPP+ accumulation suggesting a background 
adsorption of about 30% (Table 1). This percentage was used to correct A\p for internal, 
aspecific probe binding. The A^ values under equilibrium conditions were calculated to 
be 55.9±4.3, 58.1 ±4.3 and 59.8+6.7 mV (n=6) for isolates W5, E ^ and H17, 
respectively. 
Accumulation of ^*C]imazalU and ^*C]fenarimol. Accumulation of [14C]imazalil by 
germlings of the wild-type isolate W5 was pH-dependent, gradually reached a stable level 
in about 30 min and increased with pH, except for pH 8 (Fig. 2). At pH 5 and 6 
[14C]imazalil accumulation by W5 and the low-resistant isolate E30O_3 was similar, but at 
pH 7 and 8 accumulation by isolate E ^ j was 22 and 35 % less compared to the wild-type 
isolate (Fig. 2). No differential accumulation of [14C]imazalil among isolates EJ^J , H17 
and I33 was found (Fig. 3). 
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Fig. 2. Effect of external pH on accumulation level of [14C]imazalil (10/xM) by wild-type isolate 
W5 (—) and DMI-resistant isolate E ^ (—) of Penicillium italicwn in 23.4 mM potassium 
phosphate, containing 0.1 mM calcium chloride and 1% (w/v) glucose at pH 5 (+), 6 (A), 7 (o) 
and 8 (v). 
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Fig. 3. Accumulation of [14C]imazalil (10 /zM) by wild-type isolate W3 (+) and DMI-resistant 
isolates F^.., (A), H17 (o)and I33 (v) of Penicillium italicum in 23.4 mM potassium phosphate 
buffer pH 7, containing 0.1 mM calcium chloride and 1 % (w/v) glucose. 
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Fig. 4. Accumulation of [14C]fenarimol (90 fiM) by wild-type isolate W3 (+) and DMI-resistant 
isolates F ^ , (A), H17 (O) and I33 (v) of Penicillium italicum in 23.4 mM potassium phosphate 
buffer pH 7, containing 0.1 mM calcium chloride and 1% (w/v) glucose. 
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The accumulation pattern of [14C]fenarimol by wild-type isolate W5 at pH 7 (Fig. 4) was 
similar to the typical transient accumulation curve of [14C]fenarimol demonstrated 
previously by De Waard and Van Nistelrooy14 who used 16-h-old mycelium. A minor 
difference was that in the present experiments equilibrium in accumulation was obtained 
less readily. Accumulation of [14C]fenarimol was not significantly affected by changes of 
extracellular pH (results not shown). The accumulation of [14C]fenarimol by resistant 
isolate E300.3 was much lower than for wild-type isolate W5 (Fig. 4). No differential 
accumulation of [14C]fenarimol among isolates £300.3, H n and I33 was perceived. For all 
following experiments pH 7 was selected as a standard pH. 
Effects of chemicals on accumulation of f*C]TPP*, f*C]imazalil and ^CJfenarimol. 
Differential accumulation of [14C]imazalil and [14C]fenarimol was observed between wild-
type W5 and low-resistant isolate E30O_3 only. Therefore, these two isolates were selected 
for experiments in which the effects of chemicals with known membrane-interfering 
properties on accumulation of [14C]TPP+ and both [14C]DMIs were studied. The chemi-
cals selected were the protonophoric uncoupler CCCP, the membrane ATPase inhibitors 
DES and vanadate, the calmodulin anatagonists chlorpromazine and TFP, and the 
ionophoric antibiotics gramicidine-S, nigericine and valinomycine. CCCP, DES, 
gramicidine-S and vanadate caused a slight increase in accumulation of [14C]TPP+ in both 
isolates (Table 2 and 3). The effect of TFP was more pronounced, but became weaker in 
time. Chlorpromazine slightly inhibited accumulation of [14C]TPP+ while nigericine and 
valinomycine hardly showed any effect. 
On the other hand, all test compounds used strongly enhanced accumulation of 
[14C]fenarimol in both isolates (Table 2 and 3). The relative effect of most compounds on 
accumulation by isolate E^o^ was higher than by isolate W5. The effect of the test 
compounds on accumulation of [14C]imazalil was generally much weaker and not 
comparable with that of [14C]fenarimol. Only CCCP and DES caused a small increase in 
accumulation whereas all other compounds tested led to a slightly lower accumulation 
level (Table 2 and 3). 
Discussion 
Energy-dependent efflux of a number of DMIs from DMI-resistant isolates of A. 
nidulans and P. italicum has been well documented.13"16 The increased efflux of DMIs in 
resistant isolate E300.3, which is high-resistant to fenarimol and low-resistant to imazalil, is 
probably responsible for a lower level of accumulation at which the DMIs do not readily 
saturate the target enzyme in sterol biosynthesis. Imazalil was the only exception among 
DMIs since no differential accumulation between 16-h-old mycelium of sensitive and 
resistant isolates could be observed.16 However, the present study indicates that a 
significant difference in accumulation could be observed if 11-h-old germlings were used 
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and the pH of the external medium was 7.0 or higher (Fig. 1). Mycelium (16-h-old) 
probably accumulates more aspecifically bound imazalil than germlings and may, 
therefore, mask small differences in accumulation. In this respect, it is noted that the 
toxicity of imazalil to 11-h-old germlings of P. italicum in liquid medium is relatively 
Table 2. Effect of various test compounds on accumulation of [14C]imazalil (10 /*M), 
[14C]fenarimol (90 /tM) and [14C]TPP+ (10 /iM) by germlings of Penicillium italicum isolate W5 at 
pH 7.0. 
Compound Concentra- Relative effect of chemicals on 
tion (pM) on accumulation1 
Imazalil Fenarimol TPP3 
t=5 t=15 
Calmidazolium 
>) 
CCCP 
>> 
Chlorpromazine 
j » 
5> 
DES 
)> 
>> 
TFP 
>> 
»» 
Gramicidine-S 
»» 
Nigericine 
Valinomycine 
Vanadate 
10 
25 
50 
100 
10 
50 
100 
10 
50 
100 
10 
50 
100 
50 
100 
100 
100 
100 
0.82 
0.8 
1.8 
1.2 
0.5 
0.7 
0.6 
0.9 
1.3 
1.4 
-
0.7 
0.8 
-
-
-
-
-
2.72 
3.2 
4.5 
5.2 
1.4 
3.9 
2.9 
2.2 
4.7 
3.0 
1.8 
5.0 
2.9 
-
1.3 
2.7 
2.0 
2.0 
4 
-
1.2 
1.6 
-
-
0.9 
-
1.0 
1.3 
-
1.7 
2.2 
1.5 
1.6 
-
-
1.1 
-
-
1.5 
1.7 
-
-
0.9 
-
1.3 
1.7 
-
1.4 
1.9 
1.2 
1.5 
1.0 
1.0 
1.2 
1
 Average accumulation levels of [14C]imazalil, [14C]fenarimol and [14C]TPP+ in untreated mycelium 50 min 
after adding the radiolabeled compounds were 0.58±0.05, 1.10±0.07 and 0.26±0.04 nmol mg'1 dry 
weight of germlings, respectively. 
2
 Ratio between accumulation level in treatments and controls determined 10 min after addition of the test 
compounds. 
3
 Relative effect measured 5 and 15 min after addition of the test compounds. 
4
 Not tested. 
5
 Abbreviations used: DES (diethylstilbestrol), CCCP (carbonyl cyanide 3-chlorophenylhydrazone), TFP 
(triflupromazine), TPP+ (tetraphenylphosphonium bromide). 
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high as compared to its toxicity to 16-h-old mycelium in liquid cultures, but comparable 
to its toxicity determined in radial growth experiments.28 In addition, imazalil has a pK„ 
value of 6.5. Hence, at pH 7.0 it is mainly in a neutral form and accumulation may not 
be affected by the presence of its protonated form as compared with pH 6.0 used in 
previous studies.16 
Table 3. Effect of various test compounds on accumulation of [14C]imazalil (10 /JM), 
[14C]fenarimol (90 /*M) and [14C]TPP+ (10 /iM) by germlings of Penicillium italicum isolate E^, 
at pH 7.0. 
Compound Concentra- Relative effect of chemicals on 
tion (jiM) on accumulation1,2 
Calmidazolium 
M 
CCCP 
>) 
Chlorpromazine 
99 
»> 
DES 
>> 
>> 
TFP 
99 
>> 
Gramicidine-S 
99 
Nigericine 
Valinomycine 
Vanadate 
10 
25 
50 
100 
10 
50 
100 
10 
50 
100 
10 
50 
100 
50 
100 
100 
100 
100 
Imazalil 
0.8 
0.8 
1.7 
1.5 
0.7 
0.9 
0.5 
1.0 
1.2 
1.3 
-
0.7 
0.6 
-
-
-
-
-
Fenarimol 
4.6 
6.5 
7.9 
-
3.0 
7.8 
1.1 
1.1 
7.7 
7.1 
4.8 
12.7 
9.2 
-
3.8 
14.6 
5.7 
1.6 
TPP3 
t=5 
-
-
1.2 
1.5 
-
-
0.6 
-
1.2 
1.3 
-
1.0 
1.5 
1.3 
1.4 
-
-
1.2 
t=15 
-
-
1.5 
1.7 
-
-
0.6 
-
1.5 
1.8 
-
0.8 
1.1 
1.3 
1.3 
0.9 
0.9 
1.2 
1
 Average accumulation levels of [14C]imazalil, [14C]fenarimol and [14C]TPP+ in untreated mycelium 50 min 
after adding the radiolabeled compounds were 0.40±0.05, 0.42±0.04 and 0.28±0.05 nmol mg"1 dry 
weight of germlings, respectively. 
2
 Ratio between accumulation level in treatments and controls determined 10 min after additionof the test 
compounds. 
3
 Relative effect measured 5 and 15 min after addition of the test compounds. 
4
 Not tested. 
3
 Abbreviations used: DES (diethylstilbestrol), CCCP (carbonyl cyanide 3-chlorophenylhydrazone), TFP 
(triflupromazine), TPP+ (tetraphenylphosphonium bromide). 
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Fenarimol is in a neutral form at all pH values tested. This probably explains why the 
external pH does not affect accumulation of this fungicide. 
Increase in [14C]fenarimol accumulation by the protonophoric uncoupler CCCP, the 
membrane ATPase inhibitors DES and vanadate, the calmodulin antagonists chlorpromazi-
ne and TFP, and the ionophoric antibiotics gramicidine-S, nigericine and valinomycine 
(Table 2), confirms previous results that a mechanism of energy-dependent efflux is 
probably involved in accumulation of fenarimol and other DMIs.15,16 In contrast to 
fenarimol, accumulation of imazalil only slightly increased upon incubation with CCCP 
and DES while all other test chemicals decreased imazalil uptake (Table 2). P. itaJicum 
wild-type W5 also did not exhibit transient accumulation of imazalil in time (Fig. 2) as 
demonstrated for fenarimol and other DMIs.16,29 These results suggest that imazalil 
accumulation is not or only slightly mediated by a mechanism of energy-dependent efflux. 
It might be that the energy-dependent efflux of imazalil is hampered by intracellular 
protonation of the fungicide. 
Isolates E30Q.3, H17 and I33 with a low, medium and high degree of resistance to DMIs, 
respectively, did not show differential accumulation of fenarimol and imazalil (Fig. 2 and 
3). An explanation is that increased resistance in isolates H17 and I33 is based on other 
mechanisms such as decreased affinity of the target site for the toxicant. Alternatively, it 
might also be that the relatively high background adsorption of the fungicides masks any 
further decrease in accumulation in medium- and high-resistant isolates. 
The lipophilic cation TPP+ is a commonly used probe for measuring A^.25 Preliminary 
experiments showed that various methods to determine the background adsorption of the 
probe by deenergized germlings did not provide comparable results (Table 1). This 
finding is in agreement with data from Lolkema et al.71 It is noted that toluene treatment 
of the germlings at 37°C, a method used by them to determine the background adsorption 
of [14C]TPP+ to bacterial cells, was not useful (Table 1). Apparently, different methods 
have to be used for different organisms. In our tests starvation of germlings in the 
presence of 1 M KC1 for 6 h led to the lowest accumulation levels of the probe. With this 
method about 30% of the accumulated probe remained associated with the deenergized 
germlings (Table 1). This value was arbitrarily chosen to correct the amount of [14C]TPP+ 
accumulated for aspecific probe binding. The A^ values were calculated to be 55.9+4.3, 
58.1+4.3 and 59.8+6.7 mV for isolates W5, F^QJ and H17, respectively. These results 
indicate that the isolates do not differ in A\p. 
The relative effects of various compounds on the accumulation of [14C]TPP+ by P. 
italicum isolates W5 and E^^ were also studied. The effects observed were marginal 
(Table 2 and 3). For example, CCCP, DES, gramicidine-S and vanadate only enhanced 
accumulation of [14C]TPP+ with a factor below 2.0, while nigericine and valinomycine 
hardly had any effect (Table 2 and 3). There is no obvious explanation for the fact that 
addition of CCCP and DES resulted in an increased accumulation of [14C]TPP+ which 
was unexpected from their known effects on membrane processes. No correlation between 
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the effects of compounds on accumulation of [UC]TPP+ and both fungicides could be 
observed. For example, accumulation of [14C]fenarimol could be significantly enhanced 
by test compounds, such as nigericine and valinomycine, which hardly influenced 
accumulation of [WC]TPP+ (Table 2 and 3). Therefore, results suggest that the A^ is not 
involved in accumulation of fenarimol and imazalil by germlings of wild-type and DMI-
resistant isolates of P. italicum. 
Energy-dependent efflux of DMI fungicides (except for imazalil) in fungi resembles in 
several aspects multi-drug resistance (MDR) in mammalian cancer cells.30 Firstly, these 
mammalian MDR cells are cross resistant to structurally non-related drugs. DMI-resistant 
isolates of A. nidulans, Botrytis cinerea and Ustilago avenae also show cross-resistance to 
unrelated fungitoxicants and antibiotics such as cycloheximide, acriflavine, neomycin, 8-
azaguanidine, thiourea and nikkomycin.20'3133 In this respect, it is worthwile to investigate 
whether the DMI-resistant isolates of P. italicum are also cross-resistant to unrelated 
fungitoxic xenobiotics. Secondly, in both type of organisms resistance is based on reduced 
accumulation of compounds mediated by energy-dependent efflux. Thirdly, the 
accumulation of both anticancer drugs and DMI fungicides can be reversed by calmodulin 
antagonists such as TFP, chlorpromazine and calmidazolium (Table 2 and 3).M In 
addition, cycloheximide which reversed drug accumulation in MDR cells35 also increased 
accumulation of fenarimol in A. nidulans (De Waard, unpublished results). These lines of 
similarity suggest that DMI-resistance in fungi may be based on a similar mechanism as 
present in MDR mammalian cancer cells. This topic will be the subject of future studies. 
Acknowledgement. 
The critical reading of the manuscript by Prof. Dr. J. Dekker is acknowledged. 
References 
1. Kato, T., In Chemistry of Plant Protection, Vol. 1, ed. G. Haug & H. Hoffmann, Springer- Verlag, 
Berlin, 1986, p. 1-24. 
2. Roller, W. & Scheinpflug, H., PI. Disease 171 (1987) 1066-1074. 
3. Brent, K.J. & Hollomon, D.W., In Sterol Biosynthesis Inhibitors, Pharmaceutical and Agrochemical 
Aspects, ed. D. Berg & M. Plempel. Ellis Horwood Ltd., Chichester, 1988, p.332-346. 
4. Deas, A.H.B., Pestic. Sci. 17 (1986) 69-70. 
5. Hitchcock, C.A., Barrett-Bee, K.J. & Russell, N.J., / . Med. Vet. Mycol. 25 (1986) 29-37. 
6. Portillo, F. & Gancedo, C , Mol. Gen. Genet. 199 (1985) 493-499. 
7. Smith, F.D. & Koller, W., Phytopathol. 80 (1990) 584-590. 
8. Taylor, F.R., Rodrigues, R.J. & Parks, L.W., J. Bacteriol. 155 (1983) 64-68. 
9. Vanden Bossche, H., Marichal, P., Correas, J., Bellens, D., Moereels, H. & Janssen, P.A.J. 
Biochem. Soc. Trans. 1818 (1990) 56-59. 
50 
10. Walsh, R.L. & Sisler, H.D., Pestic. Biochem. Physiol. 18 (1982) 122-131. 
11. Watson, P.F. , Rose. M.E. & Kelly, S.L., J. Med. Vet. Mycol. 26 (1988) 153-162. 
12. Weete, J .D., Abstracts 6th Internal. Congr. on Pestic. Chem., IUPAC, Ottawa, Canada, 1986, 3C-06. 
13. De Waard, M.A. & Van Nistelrooy, J.G.M., Pestic. Biochem. Physiol. 10 (1979) 210-229. 
14. De Waard, M.A. & Van Nistelrooy, J.G.M., Neth. J. PI. Pathol. 90 (1984) 143-153. 
15. De Waard, M.A. & Van Nistelrooy, J.G.M., Exp. Mycol. 11 (1987) 1-10. 
16. De Waard, M.A. & Van Nistelrooy, J.G.M., Pestic. Sci. 22 (1988) 371-382. 
17. Warth, A.D., J. Appl. Bacteriol. 43 (1977) 215-230. 
18. Eisenberg, E.S., Mandel, L.J., Kaback, H.R. & Miller, M.H., J. Bacteriol. 157 (1984) 863-867. 
19. Gilman, S. & Saunders, V.A., J. Antimicrob. Chemother. 17 (1986) 37-44. 
20. Van Tuyl, J .M., Mededelingen Landbouwhogeschool, Wageningen, The Netherlands, (1977) 77-2. 
21 . Perlin, D.S., Brown, G.L. and Hafer, J.E., J. Biol. Chem. 263 (1988) 18118-18122. 
22. Damper, P.D. & Epstein, W., Antimicrob. Agents Chemother. 20 (1981) 803-808. 
23. De Waard, M.A., Groeneweg, H. & Van Nistelrooy, J.G.M., Neth. J. PI. Pathol. 88 (1982) 99-112. 
24. De Waard, M.A. & Van Nistelrooy, J.G.M., Neth. J. PI. Pathol. 96 (1990) 321-329. 
25. Kashket, E.R., Ann. Rev. Microbiol. 39 (1985) 219-242. 
26. Lolkema, J.S., Hellingwerf, K.J. & Konings, W.N., Biochim. Biophys. Acta 681 (1982) 85-94. 
27. Lolkema, J.S., Abbing, A., Hellingwerf, K.J. & Konings, W.N., Eur. J. Biochem 130 (1983) 287-
292. 
28. Guan, J. Kerkenaar, A. & De Waard, M.A., Neth. J. PI. Pathol. 95 (Supplement 1) (1989) 73-86. 
29. Kapteyn, J.C., Pillmoor, J.B. & De Waard, M.A. Pestic. Sci. (in press). 
30. Bradley, G., Juranka, P.F. & Ling, V., Biochim. Biophys. Acta 948 (1988) 87-128. 
31. Leroux, P. , Gredt M. & Fritz, R., Phytiatrie-Phytopharmacie 25 (1976) 317-334. 
32. De Waard, M.A. & Gieskes, S.A., Neth. J. PI. Pathol. 83 (1977) 177-188. 
33. Kramer, W., Berg, D. & Koller, W., In Combating Resistance to Xenobiotics - Biological and 
Chemical Approaches, ed. M.G. Ford, D.W. Hollomon, B.P.S. Khambay & R.M. Sawicki. Ellis 
HorwoodLtd., Chichester, 1987, p . 291-305. 
34. Endicott, J.A. & Ling, L., Ann. Rev. Biochem. 58 (1989) 137-171. 
35. Gottesman, M. & Pastan, I., J. Biol. Chem. 263 (1988) 12163-12166. 
5 1 
CHAPTER 5 
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Abstract 
A procedure for the isolation of microsomes containing cytochrome- P450 isozymes 
from Vstilago maydis is described. Yields of P450 amount to approximately 19±6 pmol 
mg1 of microsomal protein. The wavelength of maximum absorbance of the reduced 
carbon monoxide difference spectrum is 448-449 nm. The azole fungicides prochloraz, 
etaconazole, imazalil, triadimefon and 3-(2,4-dichlorophenyl)-2-(lfl-l,2,4 triazol-1-yl)-
4(3H)-quinazolinone, which differ markedly in toxicity to U. maydis, all induce type II 
binding difference spectra at extremely low concentrations (10~9-10~8 M). The DMI 
concentrations which cause half saturation of type II binding difference spectra (IC50) do 
not correlate with the fungicidal activities of the azoles. Binding of carbon monoxide to 
ferrous cytochrome-P450 was only slightly inhibited to different degrees by the DMIs 
tested. However, the inhibition of CO binding also does not correlate with fungitoxicity 
of the DMIs. The results of this paper suggest that the spectrophotometric studies with 
this preparation are not useful for evaluating selective toxicity of DMIs to intact sporidia 
of U. maydis. 
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Introduction 
Sterol demethylation inhibitors (DMIs) are antifungal agents which inhibit the 
biosynthesis of ergosterol by binding to cytochrome-P450 dependent sterol 14a-
demethylase (P450DM).1 Derivatives of imidazole, triazole, pyrimidine and pyridine belong 
to this group of fungicides. 
Relatively little is known about the mechanisms of DMI selectivity. A possible 
mechanism for selective toxicity may be differential affinity of fungal P450DM for the 
DMIs. In this respect, Vanden Bossche et alP demonstrated that microsomal P450 
isozymes isolated from Candida albicans and Saccharomyces cerevisiae show much 
greater affinity to azole fungicides than those from plants or mammals. This finding 
correlated with the observation that the azoles inhibited sterol biosynthesis to a greater 
extent in yeasts than in plant or mammalian systems. In addition, azole-resistant isolates 
of C. albicans contained P450 isozymes with lower affinity to various DMIs than azole-
sensitive strains.3,4 Yoshida and Aoyama5"7 and Yoshida et al} studied the interaction of 
DMIs, including a number of stereo-isomers, with P450DM purified from S. cerevisiae 
microsomes. They suggested that the inhibitory effect of azole antifungals on P450,jM was 
predominantly determined by the N! substituent of the azole moieties regulating the 
mobility of the molecules in the haem crevice of P450DM. Similar results were obtained 
using microsomal preparations of C. albicans.9'11 
The isolation of P450DM is a prerequisite to studying the differential affinity of the 
target site to various DMIs. In contrast to the isolation of yeast P450 isozymes, it is 
difficult to isolate these enzymes from filamentous fungi. This is probably because of the 
instability and low content of the enzymes. Therefore, few papers deal with P450 in these 
organisms, but two papers on the isolation of P450 from filamentous fungi have recently 
been published. Marichal et al.12 developed a method to isolate microsomes from the 
filamentous fungus Aspergillus fumigatus which contained relatively stable P450 
isozymes. With this method, microsomal preparations with a P450 content of 45 to 50 
pmol mg"1 protein were obtained. Ballard et al.13 also succeeded in isolating P450-
containing microsomes from A. fumigatus. They used a slightly different method which 
resulted in a P450 content of about 19 pmol mg"1 protein. 
In this paper a novel procedure is described for isolating P450 from the 
phytopathogenic fungus Ustilago maydis. The sporidia of this fungus multiply in a yeast-
like fashion by budding, but the fungus has no physiological or systematic relation to 
yeasts. The interactions of the DMIs prochloraz, etaconazole, imazalil, triadimefon and 
experimental fungicide 3-(2,4-dichlorophenyl)-2-(lff-l,2,4 triazol-l-yl)-4(3fl)-quinazolino-
ne (Fig. 1) with the P450 isozymes of this fungus are discussed. 
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Fig. 1. Structural formulae of (I) prochloraz, (II) etaconazole, (III) imazalil, (IV) triadimefon and 
(V) 3-(2,4-dichlorophenyl)-2-(lZM,2,4 triazol-l-yl)-4(3fl)-quinazolinone 
Materials and Methods 
Chemicals. 3-(2,4-dichlorophenyl)-2-(lff-l,2,4 triazol-l-yl)-4(3.ff)-quinazolinone (Com-
pound V) and prochloraz were obtained from Schering Agrochemicals Ltd. (Saffron 
Walden, UK). Imazalil sulphate (imazalil) was a gift from Janssen Pharmaceutica (Beerse, 
Belgium). Etaconazole and triadimefon were acquired from Ciba-Geigy (Basel, 
Switzerland) and Bayer (Leverkusen, Germany), respectively. Novozym™234 was 
purchased from Novo Bio Labs (Bagsvaerd, Denmark); ethylenediaminetetraacetic acid 
(EDTA), B-mercaptoethanol (MCE), sodium dithionite and dithiothreitol (DTT) from 
Sigma (Deisenhofen, Germany); toluenesulfonyl fluoride (TSF) from Janssen Chimica 
(Beerse, Belgium). TSF was used as solution in acetone (2 M). 
Culture methods. Sporidia of U. maydis were grown in liquid medium described by 
Coursen and Sisler14 at 30°C for 20 or 38 h in an orbital shaker (180 rpm). Inoculum was 
106 sporidia ml"1 medium. 
Toxicity assay. Sensitivity of U. maydis to prochloraz, etaconazole, imazalil, 
triadimefon and compound V was assessed in liquid medium. Sporidial suspensions (10 
ml; 104 sporidia ml"1) in conical flasks (25 ml) were incubated with different fungicide 
concentrations (from 100-fold stock solutions in DMSO) at 30°C for 38 h in an orbital 
shaker (180 rpm). After incubation, dry weight of sporidia was determined by harvesting 
on a Biichner funnel and drying in an oven at 50°C for 20 h. 
Isolation procedure for P450 isozymes. Sporidia grown for 20 h (9 to 12 g wet weight 
of sporidia) were harvested by centrifugation at 2000g for 10 min and washed twice with 
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incubation medium consisting of 100 mM potassium phosphate buffer pH 5.8 and 0.5 M 
ammonium sulphate; the second washing also contained 14 mM MCE. Standard sporidial 
suspensions were made by resuspending 1 g wet weight of sporidia into 25 ml incubation 
medium containing Novozym™234 (1 mg ml"1) and 1 mM TSF. After incubating the 
sporidial suspension (200-300 ml) at 28°C for 15 min, sphaeroplasts and/or 'plasticised' 
cells were harvested by centrifugation (10 min; lOOOg) and washed with cold incubation 
medium (100 ml). The pellets were carefully resuspended with a teflon pestle in cold 10 
mM potassium phosphate buffer pH 7.0 containing 2.0 M sorbitol (150 ml) and 
recentrifuged at 1000g for 15 min. All subsequent procedures were carried out at 4°C and 
the buffers used were modified media described previously by Marichal et al.n 
Sphaeroplasts were resuspended in 10 mM potassium phosphate buffer pH 7.0 containing 
14 mM MCE, 0.25 M sorbitol, 1.0 mM TSF, 0.1 mM DTT and 0.1 mM EDTA (75 ml). 
The sphaeroplasts were collapsed by gentle disruption in a Braun Potter-type homogenizer 
(Salm and Kipp, Breukelen, The Netherlands) using a loosely-fitting Potter-tube to avoid 
generating a vacuum. Homogenization was achieved by moving the rotating pestle (100 
rpm) slowly 10 times up and down. Glycerol (12% (v/v)) was added and the suspension 
was homogenized by another 10 strokes. The concentration of glycerol was increased to 
22% (v/v) and a further 10 strokes were applied. Cell wall fragments and uncollapsed 
cells were removed by centrifugation at 2500g for 10 min. The resulting supernatant was 
centrifuged for 20 min at 25000g to sediment mitochondria, filtered through glass wool to 
remove the floating lipid layer and centrifuged at 120000g for 80 min. After removing the 
supernatant by aspiration, the solid microsomal pellet was carefully separated from a 
putative glycogen pellet with a spatula and transferred to a washing medium (15 ml) 
consisting of 100 mM potassium phosphate buffer pH 7.4, 14 mM MCE, 10 mM EDTA, 
0.1 mM DTT and 20% (v/v) glycerol. The microsomal pellets were recentrifuged at 
120000g for 1 h and resuspended in 100 mM potassium phosphate buffer pH 7.4, 
containing 20% (v/v) glycerol (5ml). Microsomal samples (0.7 ml) were stored in 
Eppendorf centrifuge tubes at -70 °C until use. 
Spectrophotometric analysis. Spectrophotometric analysis of the microsomal samples 
was conducted with an Aminco DW-2C UV-VIS spectrophotometer. The P450 isozyme 
content of the microsomal fractions was determined according to Omura and Sato15 by 
measuring the reduced carbon monoxide difference spectrum. A microsomal sample (0.7 
ml) was thawed, diluted with 100 mM potassium phosphate buffer pH 7.4 containing 20% 
(v/v) glycerol (0.7 ml) and centrifuged at 2000g for 1 min to remove denatured protein. 
The microsomal sample (1.4 ml) was reduced with sodium dithionite (17 mg ml1) and 
divided between the reference and sample cuvettes. The cuvette-holder was kept at 20°C. 
After establishing the baseline manually the sample cuvette was saturated with carbon 
monoxide (approx. 20 bubbles; 30 s) and tightly closed. The reduced CO difference 
56 
spectrum was recorded 1 min later and at various time intervals up to 15 min. The 
absorbance difference between 448 and 490 nm (OD(44W90 „„,)) after 15 min incubation 
with CO was used for calculation of the P450 isozyme content. 
The interaction of DMIs with P450 isozymes was studied by measuring type II binding 
difference spectra with standard microsomal preparations of 100 nM P450. The 
microsomal preparation (1.4 ml) was divided between both cuvettes, and after establishing 
the baseline manually, the DMIs were added to the sample cuvette with increments of 0.7 
id from lOOOx concentrated stock solutions in DMSO. The maximum amount of DMSO 
(15 /il) added to the sample cuvette caused no change in the spectrum over the region 
scanned. 
Effects of DMIs on formation of the CO-complex (ODmtA90mi)) were studied with 
standard microsomal samples of 100 nM P450. In these studies a microsomal sample (1.4 
ml) was pre-incubated with DMIs (1.4 /il from lOOOx concentrated stock solutions in 
DMSO) for 2 min prior to reduction. After bubbling the sample cuvette with CO (approx. 
20 bubbles; 30 s) the reduced CO difference spectrum was recorded at various time 
intervals. 
Protein content. Protein content of microsomal preparations was determined by the 
Bio-Rad protein assay (Bio-Rad Laboratories B.V., Veenendaal, The Netherlands). 
Results 
Toxicity assay. The EC50 values of various DMIs to growth of U. maydis in liquid 
culture ranged from 0.01 to 35 /xM (Table 1). Imazalil had the highest inhibitory effect on 
growth of U. maydis, followed by etaconazole, prochloraz, Compound V and triadimefon. 
Isolation procedures for P450 isozymes. The standard isolation procedure described 
under 'Materials and Methods' yielded microsomal preparations which showed a reduced 
CO difference spectrum (Fig. 2). The wavelength of maximum absorbance varied from 
448 to 449 nm between experiments. The small shoulder at approximately 424 nm 
indicates that denaturation of P450 isozymes to P420 hardly occurred during isolation of 
microsomes. However, after 9 min the peak at 424 nm did increase a little suggesting that 
a small amount of P450 isozymes was converted to P420 during this time. The specific 
content of P450 isozymes isolated in the standard procedure amounted to 19 ±6 pmol mg"1 
protein and 106±29 pmol g1 wet weight of sporidia (mean ± SEM of 13 isolations). 
Microsomal preparations which had been stored at -70°C in 100 mM phosphate buffer pH 
7.4 containing 20% (v/v) glycerol for one month did not show any decline in P450 
isozyme content. 
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Table 1. Toxicity of DMIs to growth of Ustilago maydis in synthetic liquid medium according to 
Coursen and Sisler14. 
DMI EC*, (M)* 
Imazalil 
Etaconazole 
Prochloraz 
V 
Triadimefon 
l.lxlO"8 
1.7xl0"7 
8.5x10-* 
1.6xl0-5 
3.5xl0"5 
" Concentration of DMI which caused 50% growth inhibition. 
b
 ECJO values are based on duplicate experiments. 
£90nm 
£50 
Wavelength (nm) 
500 
Fig. 2. Reduced carbon monoxide difference spectrum of P450 isozymes in microsomal 
preparation from Ustilago maydis obtained after homogenizing sporidial sphaeroplasts with a 
Potter-type homogenizer. Baseline (a); Spectra recorded 1 (b) and 9 (c) minutes after addition of 
CO. 
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It was observed that several factors were important for successful isolation of 
microsomal P450 isozymes. Preliminary experiments showed that the age of sporidial 
cultures of U. maydis was a critical factor. Yield of P450 isozymes was maximal when 20 
h old sporidial cultures of U. maydis were used for isolation (data not shown). At this 
stage cultures of U. maydis were in the late log phase. The method of disrupting the 
sporidia was also crucial. Mechanical breakage using a French press or Braun homogeni-
zer led to the isolation of P420 isozymes and to contamination of the samples by cyto-
chrome oxidase (data not shown). Disruption of sporidial sphaero-plasts by sonication (20 
KHz, 10 s) in 10 mM potassium phosphate buffer pH 7.0, consisting of 14 mM MCE, 
0.1 mM DTT, 0.1 mM EDTA, 0.25 M sorbitol and 1 mM TSF before addition of 20% 
(v/v) glycerol also was not as successful as the standard disruption method. Sonication led 
to very dense proteinaceous microsomal preparations (2.5 to 4 mg protein ml"1) containing 
P450 isozymes, but also small amounts of P420 and traces of cytochrome oxidase (data 
not shown). 
Reduction of the microsomal samples with sodium dithionite was a critical step in the 
assay procedure to determine the content of P450 isozymes accurately. Optimal reducing 
effect was attained at a concentration of about 17 mg dithionite ml"1 microsomal 
suspension (data not shown). This concentration of dithionite was used in all the following 
experiments. 
Type II difference spectra. Type II difference spectra of microsomal P450 isozymes 
(100 nM) from U. maydis were recorded after stepwise addition of various DMIs. Typical 
examples for prochloraz and compound V are shown in Fig. 3. The type II spectra were 
characterized by an absorbance maximum at approximately 428 nm and a minimum at 
approximately 410 nm. The increase in OD(42MIO nm) in relation to azole concentration 
yielded saturation curves (Fig. 4). Saturation of type II spectral response was attained at 
concentrations ranging from 10"5 and 5X10"4 M for most fungicides, but was not fully 
achieved for triadimefon and compound V. Therefore the concentrations of triadimefon 
and compound V which caused 50% of maximum type II spectral response (IC50) should 
be regarded as minimum values and amounted approximately 10"5 and 10"6 M (Table 2). 
The other azoles had lower IC50 values in the order of 10"7 M. 
CO displacement tests. The relative affinities of prochloraz, imazalil, etaconazole and 
compound V for U. maydis microsomal P450 isozymes were also studied by determining 
their inhibitory effects on binding of CO to the P450 isozymes. It appeared to be a 
consistent trend that imazalil, prochloraz and compound V (10"6 M) inhibited binding of 
CO to P450 (10~7 M) to about a similar extent (Table 3). Etaconazole was the most 
effective compound of all DMIs tested, but still only caused 25% inhibition of CO 
binding. Except for imazalil, the extent of inhibition of CO/P450 complex formation by 
the DMIs tested varied significantly between experiments. 
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428nm (B) 
£28nm 
380 £80 £30 £80 380 £30 
Wavelength(nm) Wavelength (nm) 
Fig. 3. Type II binding difference spectra of (A) prochloraz and (B) compound V obtained after 
stepwise addition of DMIs to microsomal preparations of Ustilago maydis containing P450 
isozymes (100 nM). Baseline (a); Final DMI concentration in sample cuvette ranged from 10"9 (b) 
to 10"5M (c). 
Table 2. Maximum absorbance difference of type II spectra (OD(42g^10 ^ ^^ upon saturation with 
DMIs and concentrations of DMIs which induce half saturation response in type II difference 
spectra of microsomal P450 isozymes obtained from Ustilago maydis (ICJO). 
DMIs OD, (428-410 nm)max (10-3) IC» (M) 
Imazalil 
Etaconazole 
Prochloraz 
Compound V 
Triad imefon 
7.9+3.3 (4)a 
6.5 + 1.7(4) 
5.4+1.6(3) 
4.3 + 1.6(3) 
8.8+2.5 (3) 
6.3+4.1xl0"7 
4.4± 1.4x1a7 
7.0±4.1xl0"8 
1.3+0.6X10"6 
2.9+2.1xl0"5 
a
 ( ) : number of replicates 
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Concentration of DMI(M) 
ig.4. Type II spectral response (OD(42&410 ^ of microsomal P450 isozymes (100 nM) from 
Jstilago maydis induced by stepwise addition of prochloraz (V), etaconazole (O), imazalil (>), 
riadimefon ( • ) and compound V (x). 
'able 3. Inhibitory effects of various DMIs on binding of carbon monoxide to microsomal P450 
iozymes from Ustilago maydis. Concentration of P450 isozymes and DMIs were 10"7 and 106 M, 
espectively. At each time of spectrophotometric measurement binding of CO in the control 
reatment (DMSO) was taken as 100%. 
'ime after CO- Binding of CO in treated samples as percentage of control 
reatment (min) of the specific treatments 
1 
3 
6 
10 
15 
Imazalil (3)b 
81.9±3.8C 
84.5 + 1.3 
87.1+0.8 
89.2+0.2 
80.0+0.9 
Prochloraz 
88.0±7.6 
92.1±5.8 
95.8+6.5 
96.1+6.5 
100.9+7.0 
Compound V 
87.8 + 10.5 
82.2+17.7 
86.4+11.9 
84.8+13.5 
92.3 + 16.3 
Etaconazole 
72.4+10.9 
73.8+09.3 
75.3+08.8 
74.7+08.0 
77.1 + 11.2 
Average OD(448_490 ma) (xlO3) values of all controls at t = l , 3, 6, 10 and 15 min after CO addition were 
8.3+0.9, 9.1 + 1.2, 9.5+1.2, 9.7 + 1.4 and 9.4+1.0, respectively. 
( ) : number of replicates of the specific treatments. 
Percentage values correspond to the controls of the specific treatments. 
61 
Discussion 
This study demonstrates that microsomes containing stable P450 isozymes can be 
isolated from U. maydis. Yields amounted to approximately 19 pmol mg"1 of microsomal 
protein, which corresponds well with results of Hitchcock et al.16 and Ballard et al.n, 
who isolated comparable quantities of microsomal P450 isozymes from C. albicans and 
A. fiunigatus, respectively. The maximum absorbance of the reduced CO difference 
spectrum was at 448-449 nm. All the azole fungicides investigated induced type II binding 
difference spectra at extremely low concentrations (10~9-10"8 M) (Fig. 3). This indicates 
that the nitrogen atom at position three and four of the imidazole and triazole rings, 
respectively, interacted with the ferric iron at the haem centre of P450. The artefactual 
peaks at approximately 430 nm recorded in the base lines (Fig. 3) were due to the high 
protein content of the microsomal preparations which exceeded the protein concentration 
limit that can be tolerated by the optical system.17 
The DMI-concentrations which induced half saturation of the response in type II spectra 
(IC50) demonstrated that the microsomal P450 preparation from U. maydis had different 
affinities for the antifungal azoles tested (Table 2). The apparent IC50 values, however, 
did not correlate with the fungicidal activity of the DMIs tested. For example, prochloraz, 
poorly active against U. maydis, exhibited an IC50 value of similar order (10"7 M) as 
etaconazole and imazalil, which were more toxic by several orders of magnitude (Table 1 
and 2). The IC50 values may also be over-estimated since, due to the high protein content 
of the microsomal preparations, maximal type II difference response may not be propor-
tional to protein concentration.17 It was not possible to work with less microsomal protein, 
because then the concentration of P450 isozymes would have been lower than 100 nM, 
which was regarded as the minimal concentration for accurate spectrophotometric 
analysis. 
The maximum type II spectral response also did not correlate with the toxicity of DMIs 
to U. maydis. However, these values changed considerably between experiments for 
reasons unknown (Table 2). Wiggins and Baldwin18 used microsomes of S. cerevisiae and 
partially purified yeast P450 preparations. They concluded that in both cases the final 
saturation value did relate to fungicidal activity. Hence, in order to demonstrate such a 
correlation with U. maydis it may also be necessary to purify the P450DM from the 
microsomal preparations. The concentrations at which type II spectral responses were 
saturated were similar for all DMIs tested and ranged from 10"5 to 5x10^ M (Fig. 4), 
which is far higher than the actual concentration of P450 used (10~7 M). It is known that 
azole fungicides bind with P450UM with one-to-one stoichiometry.6'71019 The fact that 
stoichiometric interaction was not observed in the present study might be explained by 
partitioning of the lipophilic azoles in the microsomal membranes, thus making the DMIs 
unavailable to the P450DM at low concentrations. In addition, the microsomes isolated 
from U. maydis almost certainly contain a variety of P450 isozymes which could differ in 
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affinity for DMIs and mask the specific P450DM. This view is supported by work of 
Henry and Sisler20 who demonstrated that U. maydis, grown under identical conditions to 
those used in the present experiments, was able to demethylate p-chloro-N-methylaniline 
(PMCA), a classical model P450 type substrate. The N-demethylation of PCMA by intact 
sporidia appeared to be constitutive and far less sensitive to DMIs than sterol biosynthesis 
or growth of U. maydis. 
It has been suggested that the CO-displacement studies may be useful to evaluate DMI 
fungicides.5"1121 This suggestion was based on studies with purified P450DM from S. 
cerevisiae and microsomal P450 isozymes from C. albicans. These studies have shown 
that the differences in inhibition of sterol 14c*-demethylation by a number of DMIs, inclu-
ding stereoisomers of triadimenol and diniconazole, correlated with their ability to impair 
binding of CO to the ferrous cytochrome(s).5"11 The present study revealed that the inhibi-
tory effects of prochloraz, imazalil, compound V and etaconazole on CO/P450 complex 
formation were small and, except for imazalil, variable (Table 3). This might be due to 
fact that P450DM, highly sensitive to DMIs, forms only a minor and variable proportion of 
the total amount of microsomal P450 isozymes from U. maydis. The relatively low 
variability observed with imazalil may relate to its higher water solubility as compared 
with the other azoles tested. Despite this low level of inhibition and high variability, the 
CO displacement studies demonstrated that the azoles did differ in their affinity for the 
P450 isozymes (Table 3). However, the affinity did not correlate with fungicidal activity. 
For example, imazalil was more readily displaced by CO than etaconazole despite the fact 
that etaconazole was about 10 times less toxic to U. maydis than imazalil. This lack of 
correlation implies that the CO displacement studies with microsomal preparations are not 
useful for evaluating selective toxicity of DMIs to whole cells of U. maydis. These 
conclusions are in line with results from Marichal et al.n and Ballard et al.13, who 
studied the interaction of microsomal P450 isozymes obtained from A. fumigatus with 
fluconazole, ketoconazole and itraconazole. Fungitoxicity of DMIs could also, therefore, 
be determined by other parameters like accumulation, metabolism of the fungicide or 
disposition in lipid compartments in the cells. However, it may also be that the current 
CO displacement tests with microsomal preparations are not suitable for determination of 
the specific inhibition of P450DM by azoles. Firstly, this may be due to the crude nature of 
these preparations containing multiple forms of P450, which may mask the specific 
interaction of the DMIs with P450DM. Secondly, the CO concentration in the sample 
cuvette is far above the DMI concentration thus preventing the DMIs from effectively 
competing for the P450 isozymes. Thirdly, as suggested by Yoshida21, interference of the 
azoles with CO binding or oxygen activation may not be essential for their inhibition of 
P450DM activity. This view is mainly based on the observation that buthiobate, 
triadimefon and triadimenol, which have relatively small substituents at N\ of the azole 
group, exhibit practically no interference with CO, while these azole fungicides inhibit 
reconstituted lanosterol 14a-demethylase activity from S.cerevisiae.5,6'21,22 Furthermore, 
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Hitchcock et al.19 found that the ability of the triazole-related compound ICI 153066 to 
inhibit reconstituted P450DM activity from C. albicans also did not relate to its ability to 
interfere with the binding of CO to the ferrous P450DM. Consequently, interaction of the 
azole moiety of DMIs with the haem iron may be of minor importance with respect to 
their ability to inhibit the biochemical activity of the P450,jM. Therefore, affinity to 
P450DM may be mainly determined by binding of the Nj substituent of DMIs, possibly to 
the substrate binding site of the cytochrome. This is especially relevant for antimycotics 
with large N! substituents like ketoconazole and itraconazole which may tightly bind to 
the substrate binding site in the haem crevice of P450DM and in consequence impair 
binding of CO to the haem iron. These compounds thus inhibit both substrate binding and 
oxygen activation.5'6,21 
Results of the present study demonstrate that spectroscopic analysis of U. maydis 
microsomes does not give clear information about the affinity of the azole fungicides to 
P450DM from this fungus. Purification of P450DM and/or using reconstituted P450DM assay 
systems may resolve this question. To test the intrinsic toxicity of DMIs to P450DM 
activity it may be easier and more valuable to test the sensitivity of enzyme activity in 
cell-free systems. 
Using the techniques described it would be interesting to compare the P450 content of 
the wild-type strain used in the present study to that of the mutant deficient in 14a-sterol 
demethylation described by Walsh and Sisler.23 
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Abstract 
The interaction of various sterol demethylation inhibitors (DMIs) and experimental 
compounds with cytochrome-P450 dependent sterol 14a-demethylase (P45014DM) from 
Penicillium italicum was studied by difference spectroscopy using a preparation of 
microsomal P450 isozymes and assays with cell-free extracts capable of synthesizing 
ergosterol from [14C]mevalonate. The EC50 values (concentrations of compounds which 
inhibit radial growth of P. italicum by 50%) of the compounds ranged from 3xlO"8 M to 
levels higher than 10"3 M. All the compounds investigated gave type II difference spectra 
and interfered with the binding of carbon monoxide (CO) to microsomal P450 isozymes. 
However, the differences in the IC50 values (concentrations of compounds which cause 
50% of maximal type II spectral change) between compounds and their inhibition of CO 
binding did not correlate with the fungicidal activity of the compounds. Hence, neither 
type II difference spectra nor CO-displacement tests with microsomal preparations from 
this fungus can be used for studying the selective fungitoxicity of azoles. Data obtained 
using the cell-free sterol 14a-demethylase assay revealed larger differences between the 
compounds in their inhibition of sterol 14a-demethylation. The I50 values (concentrations 
of compounds which inhibit cell-free sterol biosynthesis by 50%) varied from 4.3xlfr9 to 
4.4xl0"5 M. This assay was able to rank the compounds in order of fungitoxicity, but the 
I50 values did not quantitatively reflect the differences in toxicity. Consequently, the 
observed differential inhibition of P45014DM activity between the compounds can not fully 
explain their selective fungitoxicity. Additional mechanisms must be involved. The 
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present study supports the general opinion that the affinity of azoles for P45014DM depends 
on the nature of their N, substituent. However, it was demonstrated that the nature of the 
azole moiety was also of importance in determining the affinity of DMIs for P45014DM. 
Introduction 
Sterol demethylation inhibitors (DMIs) are antifungal agents used in agriculture and 
medicine. Their primary mode of action is inhibition of sterol biosynthesis due to binding 
to cytochrome-P450 dependent sterol 14a-demethylase (P450UDM).1 Derivatives of 
imidazole and triazole constitute the most important group of DMIs. 
Great differences in both potency and selectivity have been found for various DMIs.2 
The biochemical basis of selective fungitoxicity of DMIs, however, has not yet been 
elucidated. Previous work has demonstrated that the selective fungitoxicity of prochloraz 
and an experimental triazole fungicide to a number of fungi is not generally due to 
differential fungal accumulation or metabolism.3 Another possible mechanism for 
selectivity may be differential affinity of DMIs for the P45014DM. The binding affinity of 
DMIs for P45014DM can be studied in several ways: For example spectrophotometrically 
by determining the ability of carbon monoxide (CO) to displace DMIs from reduced 
P45014DM, or by measuring the ability of DMIs to induce type II difference spectra.4"18 It 
can also be studied enzymatically by measuring the inhibitory effect of DMIs on 
ergosterol biosynthesis in fungal cell-free extracts6,911,19"23 or reconstituted systems.4"7,911'23 
Such studies with P45014DM purified from Saccharomyces cerevisiae and with microsomal 
P450 isozymes from Candida albicans indicated that the interaction of azole DMIs is 
twofold: first, the N3 and N4 of the imidazole and triazole rings, respectively, bind to the 
ferric iron at the haem centre of P45014DM and second, the Nj substituent of the azoles 
interacts with the apoprotein of the enzyme, presumably within the substrate binding site. 
The degree of inhibitory action of DMIs on P45014DM activity has been suggested to be 
predominantly determined by the second interaction.4"12 This view was mainly based on 
CO-displacement studies which showed that replacement of the imidazole ring of 
ketoconazole by a triazole moiety did not affect the affinity to microsomal P450 from C 
albicans}112 Similar results were obtained when the triazole ring of itraconazole was 
replaced by an imidazole ring.11,12 Comparison of ketoconazole with deacylated 
ketoconazole (nor-ketoconazole) showed that minor structural changes in the Nx 
substituent did affect the interaction with P450 isozymes from C. albicans." Further 
evidence for the importance of the N, substituent of azoles in fungicidal activity was also 
deduced from the differences in affinity of yeast P45014DM for the different isomers of 
triadimenol, diniconazole, diclobutrazol and paclobutrazol.6'7,13,19,20 Moreover, the two 
isomers of diclobutrazol differentially inhibited CO binding to microsomal P450 isozymes 
from Ustilago maydis which correlated with their differences in fungitoxicity.14 Since the 
inhibition of in vitro and in vivo sterol 14a-demethylation by various DMIs correlated 
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with their ability to impair the formation of CO-P45014DM complexes, the 
spectrophotometric analysis of the interaction of DMIs with P450J4DM has been proposed 
to be an effective method for evaluating their in vitro fungicidal action.4"12,14 However, 
more recently, spectrophotometric studies with microsomal P450 isozymes from 
Aspergillus fumigatus, Penicillium italicum and U. maydis demonstrated that the ability of 
CO to displace DMIs from such complexes did not always correlate with their in vitro 
toxicity.15"18 In contrast, the inhibitory effects of DMIs on ergosterol biosynthesis by cell-
free preparations of A. fumigatus and P. italicum did reflect to some degree their in vitro 
fungitoxic action.21'22 Furthermore, the potency of the triazole, ICI 153066, in inhibiting 
cell-free and reconstituted P45014DM activity from C. albicans also did not relate to its 
ability to impair binding of CO to purified P45014DM.23 
In the present paper the interaction of prochloraz (compound I), prochloraz analogues 
(compounds II to IX), the structurally unrelated compound X, and racemic mixtures of 
etaconazole, imazalil, triadimenol and triadimefon (compounds XI to XIV) (Fig. 1) with 
microsomal P450 isozymes from P. italicum was measured spectrophotometrically. The 
interaction was also studied by measuring the inhibitory effect of the compounds on 
ergosterol biosynthesis in cell-free extracts of P. italicum. The results of both analytical 
methods were compared and discussed in relation to the toxicity of the compounds to P. 
italicum. 
Materials & methods 
Chemicals. Imazalil sulphate (imazalil) was a gift from Janssen Pharmaceutica (Beerse, 
Belgium). Etaconazole was obtained from Ciba-Geigy (Basel, Switzerland). Triadimefon 
and triadimenol were provided by Bayer (Leverkusen, Germany). Prochloraz and 
experimental compounds (II-X) were from Schering Agrochemicals Ltd. Dimethyl 
sulfoxide (DMSO) and sodium dithionite were purchased from Merck (Darmstadt, 
Germany). DL[2-14C]mevalonate was from Du Pont De Nemours (s'Hertogenbosch, The 
Netherlands). All test compounds were dissolved in DMSO. 
Culture methods, toxicity assays. P. italicum wild-type was maintained on malt extract 
agar. Liquid mycelial cultures were prepared as described previously.18,22 Toxicity of 
DMIs and related compounds to radial growth of P. italicum on potato dextrose agar 
(PDA) was determined according to Kapteyn et al.3 
Isolation and spectrophotometric analysis of microsomes. Microsomes containing 
stable P450 isozymes were isolated and analysed spectrophotometrically as described 
previously.17'18 
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Preparation of cell-free extracts and sterol biosynthesis assays. A cell-free extract of 
P. italicum was prepared by mechanical disruption of 32 ml mycelial paste (80 mg fresh 
weight of mycelium in 1 ml 100 mM potassium phosphate buffer pH 7.5) using a Bead-
Beater 
Cl 
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Fig. 1 : Structural formulae of prochloraz (I), prochloraz analogues (II-IX), the unrelated 
compound X and reference DMIs etaconazole (XI), imazalil (XII), triadimenol (XIII) and 
triadimefon (XIV). Reference DMIs were used as racemic mixtures. 
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(Biospec Products, Bartlesville, Oklahoma, USA) as described previously.22 The sterol 
biosynthesis assay was also carried out according to Guan et al.22 The test compounds 
were added from 1000-fold stock concentrations in DMSO. Radiolabeled non-saponifiable 
C44-dimethylated, Q-monomethylated and C4-desmethylated sterols produced in the assay 
were separated by thin layer chromatography (TLC). Radioactive zones were located by 
autoradiography, cut from the plate and the radioactivity present was determined by liquid 
scintillation counting. 
Results 
Toxicity assay. Prochloraz had the lowest EC50 value (3.1xl08 M) of all the 
compounds tested. EC50s of the prochloraz analogues ranged from 4.2xl0"8 M to levels 
higher than 10~3 M (Table 1). EC50s for analogues VIII, IX and compound X could not be 
determined accurately, since they did not show any inhibitory effect at a concentration of 
10"3 M. The EC50 values of the reference DMIs tested ranged from 2.4xlO"7 to 2.1xlO"3 M 
(Table 1). 
Table 1: Toxicity of prochloraz, experimental compounds and various reference DMIs to radial 
growth of Penicillium italicum on PDA. 
Compounds EC*, (M)1,2 
Prochloraz series: 
I (Prochloraz) 3.1x10s 
II 4.2X10"8 
m 4.0xl0-7 
IV 4.9xl0"7 
V 6.9x10* 
VI 3.8xl0"5 
VII 7.6X10"4 
VIII > 103 
IX > 10"3 
X > 10"3 
Reference DMIs: 
XI (Etaconazole) 2.4xl0-7 
XII (Tmazalil) 3.3xl0"7 
XIII (Triadimenol) 1.6X10"4 
XIV (Triadimefon) 2.1xl0"3 
Concentration of compounds which caused 50% inhibition of radial growth of P. italicum on PDA. 
2
 ECs, values based on two replicate experiments. 
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Due to changes in experimental conditions imazalil had an approximately 20 times lower 
EC5() value than reported before.22 
Type II binding difference spectra. Type II difference spectra of microsomal P450 
isozymes (100 nM) from P. italicum could be recorded for all compounds tested including 
the non-azoles VI and X, the latter of which is unrelated to prochloraz (data not shown). 
Compounds HI, V and IX were not tested. A typical type II spectrum of prochloraz is 
presented in Fig. 2. The type II spectral changes induced by all azole agents were 
characterized by an absorbance maximum at approximately 428-429 nm and minima 
varying from 387 to 403 nm (Table 2). In contrast, the non-azole VI and the unrelated 
compound X gave rise to absorbance maxima at about 434 nm. For most compounds 
429 nm 
380 430 
WAVELENGTH (nm) 
480 
Fig. 2 : Type II difference spectra of prochloraz recorded after stepwise addition to microsomal 
preparations of Penicillium italicum containing P450 isozymes (l(r7 M). Final prochloraz 
concentrations in sample cuvette: 0 (a), 5xl0"9 M (b), 5xl0"8 M (c), 6.2X10"6 M (d) and 1.6xl(r5 
M(e). 
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Table 2: Characteristics of type II difference spectra of microsomal P450 isozymes (10~7 M) 
induced by prochloraz, experimental compounds and reference DMIs and their inhibition of CO 
binding to these enzymes. 
Compounds 
Prochloraz series: 
I (Prochloraz) 
II 
IV 
VI 
VII 
VIII 
X 
Reference DMIs: 
XI (Etaconazole) 
XII (Imazalil) 
XIII (Triadimenol) 
XIV (Triadimefon) 
Type II spectrum (nm) 
minimum 
390-392 
390-392 
390-392 
396-399 
398-402 
398-403 
390-398 
390-394 
390-394 
388-390 
387-390 
maximum 
428-429 
428-429 
428^29 
434-435 
429-430 
429-430 
432-434 
428-429 
428-429 
428-429 
427-429 
IC* (M)1 
3.2 + 3.9xl0"8 (5)3 
4.1 + 1.8xl0"8 (3) 
1.0+0.5xl0"8 (3) 
5.4±7.3xl0"8 (3) 
9.5xl0"8 (2) 
1.5+2.5xl0-6(3) 
3.3xl0"9 (2) 
1.3±0.7xl0"8 (5) 
2.0±1.0xl0-9(5) 
5.4±1.4xl0"8(5) 
4.3±4.1xl0"8(6) 
CO-binding (%f 
49.1 + 10.3(5) 
47.8+04.5 (3) 
93.1 + 13.6(3) 
17.6+04.4 (4) 
81.6+04.8 (3) 
98.1+04.9(3) 
84.3+13.4(4) 
72.2±0.00 (2) 
43.5+0.00 (2) 
73.5+13.7(3) 
100.8±13.3 (3) 
1
 Concentration of compounds which induced half saturation response in type II difference spectra. 
2
 Binding of CO in DMI-treated samples (10"6 M) as percentage of the control treatments measured 6 min 
after CO addition. Figures calculated from values presented in Fig. 4. Average OD(448.490nm) values of all 
controls at t=6 min after CO addition was 8.4 + 0.9 xlO3 (n=ll) . 
3
 ( ): number of replicates. 
tested satuaration response in the type II spectra was attained at almost equimolar 
concentrations (10~7 M) of P450 isozymes and antifungal compounds (data not shown). A 
satuaration response for compounds VI, VII, Vm and X was found at concentrations of 
about 10"*, 10"6, 10"5 and 2xl0"8 M, respectively. Most compounds examined showed IC50 
values in the order of 108 M (Table 2). Imazalil and X exhibited relatively low IC50 
values of 2.0xl0~9 and 3.3xl0~9 M, respectively, whereas Vin showed an exceptionally 
high IC50 of 1.5x10"* M. Dissociation constants (Kd values) of the P450 isozymes and test 
compounds were not determined due to technical difficulties. 
Spearman's ranking correlation coefficients (r,) between the EC50 (Table 1) and IC50 
values for the prochloraz analogues, for the reference DMIs and for all the compounds 
tested amounted to 0.70, 0.80 and 0.53, respectively. In all three cases there was no 
correlation between the EC50 and IC50 values (P=0.05). 
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CO displacement tests. Reduced CO difference spectra with a maximum absorbance at 
449 nm recorded at various time intervals after addition of CO are shown in Fig. 3A. The 
relative affinity of DMIs and related chemicals for the ferrous P450 isozymes was studied 
by determining their inhibitory effects on CO-P450 complex formation. Except for 
triadimefon and Vm, all chemicals tested were able to interfere with the binding of CO, 
but to significantly different degrees (Fig. 4 and Table 2). The isonitrile analogue (VI) 
was the most potent inhibitor of CO-P450 complex formation, while IV, VIH and 
triadimefon (XIV) hardly interfered with CO binding (Fig. 4). VI was also the only 
compound which induced the formation of a maximum at 420 nm in addition to the one at 
449 nm (Fig. 3B), indicating that it caused denaturation of the P450 isozymes. 
Spearman's r, coefficients between the EC50s and the inhibitory effects of the prochloraz 
analogues, of the reference DMIs and of all compounds tested on CO binding to the 
microsomal P450 isozymes were 0.10, 0.70 and 0.45, respectively. In all three cases 
there was no correlation (P=0.05). 
g 0.012 
< 
CD 
DC 
O 
co 
m 
•* 0.008 
0.004 
0.000 
-0.004 
§ 0.012 
< 
CO 
rr 
O 
co 
CO 
** 0.008 
0.004 
0.000 
-0.004 L 
B 
410 450 
WAVELENGTH (nm) 
l 
490 410 450 
WAVELENGTH (nm) 
490 
Fig. 3 : Reduced CO difference spectra of microsomal P450 isozymes (10"7 M) from Penicillium 
italicum preincubated with 0.1% DMSO (A) and 10"6 M VI (B) recorded before (a) and 1 (b), 3 
(c), 10 (d) and 15 min (e) after CO-treatment. 
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Cell-free sterol biosynthesis assay. Total incorporation of label into non-saponifiable 
lipids varied between experiments from 18 to 24% of the total radioactivity added. On 
average the percentage of radioactivity incorporated into ergosterol amounted to 16% of 
the non-saponifiable lipids. Fig. 5 (control treatment) shows an autoradiogram of a TLC 
separation of non-saponifiable lipids produced from [2-14C]mevalonate by a cell-free 
extract of P. italicum. Based on TLC and radio-HPLC analysis by Guan et al.72 bands 1 
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Fig. 4 : Displacement of (A) prochloraz (I; T), imazalil (XII; •) and triadimefon (XTV; A); (B) 
etaconazole (XI; •) and triadimenol (XIII; A); (C) II (•), IV (*) and VII (•); (D) VI (•), VDI 
(A) and X (•) from microsomal P450 isozymes (10-7 M) of Penicillium italicum after reduction 
with dithionite and CO treatment. Binding of CO as percentage of control (DMSO) plotted against 
time after CO treatment. Concentration of all test compounds 10"6 M. 
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ORIGIN 
Control 3x10"9 6x10"9 10-8 2x10"8 
PROCHLORAZ (M) 
Fig. 5 : Autoradiogram of a TLC separation of non-saponifiable lipids synthesized from [2-
wC]mevalonate by a cell-free preparation of Peniciltium italicum in the presence of increasing 
concentrations of prochloraz. Bands 1, 2, 3 and 4 contained C4-desmethyl sterols, C4-monomethyl 
sterols, C44-dimethyl sterols and squalene, respectively. All other bands were not identified. 
and 2 are assigned to ergosterol and Q-monomethyl sterols, respectively. Band 3 contains 
the C4i4-dimethyl sterols, lanosterol and 24-methylenedihydrolanosterol (eburicol). 
Radioactivity in band 4 is most probably squalene while the other bands are not yet 
identified. Prochloraz inhibited incorporation of radiolabel into Q-desmethyl sterols at 
very low concentrations (Fig. 5); it had an I50 value (concentration which inhibits 
incorporation of label into C4-desmethylsterols by 50%) of 8.0xl0"9 M (Table 3). All 
other compounds tested also had inhibitory effects, but over a wide range of I50 values 
(Table 3). Prochloraz analogue II was the most potent inhibitor tested (I50 4.3xl0"9 M). 
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Table 3: Inhibitory effects of prochloraz, experimental compounds and reference DMIs on cell-
free 14a-demethylase activity from Penicilliwn italicum. 
Compounds I50 (M)1 
Prochloraz series: 
I (Prochloraz) 
II 
HI 
IV 
V 
VI 
VII 
VIII 
IX 
X 
Reference DMIs: 
XI (Etaconazole) 
XII (Imazalil) 
XIII (Triadimenol) 
XIV (Triadimefon) 
8.0+1.0xl0-9(3)2 
4.3 ±1.0x10-' (4) 
1.4±0.2xl0-8 (3) 
1.8 ±0.1x10-* (3) 
1.0±0.2xl0"7 (3) 
9.2±2.7xl0"7 (3) 
3.5±l.lxl0"7(3) 
9.0±0.5xl0"7 (3) 
6.5±l.lxl0"7(3) 
4.4±1.0xl0-3(3) 
8.7+1.lxlO'9 (4) 
9.0±1.0xl0-9(4) 
4.2±1.8xl0-8(3) 
7.2±1.0xl0-8(3) 
1
 Concentration which inhibits incorporation of [2-14C]mevalonate into C4-desmethyl sterols by 50%. 
2
 ( ): number of replicates. 
Prochloraz, etaconazole, imazalil, HI and IV all had comparable I50s of approximately 
10"8 M. Triadimenol and triadimefon were slightly less effective, but still exhibited ^0 
values at 4.2xl0-8 and 7.2xl0-8 M, respectively. All other chemicals showed higher I50 
values ranging from approximately 10"7 to 10"* M. Compound X was the weakest inhibitor 
of cell-free sterol 14a-demethylation found (I50 4.4xl0"5 M). It is noted that DMSO (0.1% 
(v/v)) did not have any inhibitory effect on cell-free sterol 14a-demethylation. With 
respect to prochloraz and experimental compounds II-X Spearman's rs coefficient was 
0.96. This value decreased to 0.86 when the reference DMIs were included, while rs was 
1.0 for the reference DMIs alone (Table 3). In all three cases there was a ranking 
correlation between the EC50 and I50 values (P=0.05). 
Discussion 
The present study demonstrates that a number of related azoles is capable of inducing 
type II difference spectra with microsomal preparations of P450 isozymes from P. 
11 
italicum (Table 2). This indicated that the ferric haem iron of P450 was occupied by the 
N3 and N4 of the imidazole and triazole rings, respectively. However, the non-azole VI 
and the unrelated compound X also induced type II difference spectra, suggesting that the 
isonitrile carbon of analogue VI must also interact with the haem iron. It is unknown 
which functional group of compound X is responsible for the induction of the type II 
spectrum. These findings confirm literature data that type II spectra are not only induced 
by compounds with nitrogenous heterocyclic rings, but generally by all kinds of amines 
and isonitriles.24'25 Comparison of the spectral characteristics showed differences in the 
absorbance maxima in type II spectra of azole and non-azole compounds. Maxima of type 
II spectra induced by the azoles ranged from 427 to 430 nm, whereas those of the non-
azole compounds VI and X were at approximately 434 nm. Apparently, the type II 
spectral characteristics induced are determined by the chemical nature of the interacting 
moiety. This observation corresponds to data obtained by others.24 Irrespective of their 
toxicity to P. italicum, the concentration of most DMIs which induced a half saturation 
response of type II spectra (IC50) was in the order of 10"8 M (Table 2). For reasons 
unknown imazalil had an exceptionally low ICS0, as did the unrelated compound X. The 
relatively high IC50 of compound VIII can be explained by the fact that the amino group 
at C2 of the heterocyclic ring hampers the interaction of N3 with the sixth ligand of the 
cytochrome ferric haem iron. The observed absence of a correlation between the ability of 
azoles to induce type II spectra and their fungitoxicity is in line with most recent 
literature data.8'12'17'18 
The CO-displacement test has previously been reported as being suitable for assessing 
the in vitro fungicidal activity of DMIs,4"12 but more recently, this has been 
contradicted.1518 In the present paper the compounds interfered differentially with the 
binding of CO to the ferrous cytochrome(s) (Fig. 4; Table 2), but the differential 
inhibition of CO-P450 complex formation did not correlate with their toxicity to P. 
italicum (Table 1 and 2). For instance, compound IV, which is almost as toxic as 
etaconazole, was readily displaced by CO, while the isonitrile VI, which is relatively non-
toxic, was the most potent inhibitor of CO-P450 complex formation. This may relate to 
the fact that isonitriles have a very high affinity for (haem) iron atoms.26 However, the 
denaturing effect of this compound on P450 (Fig. 3B) may also explain the relatively 
strong inhibition of CO binding. The low biological activity of VI could be due to the fact 
that this compound is likely to be susceptible to metabolic degradation. It was therefore 
concluded that CO-displacement tests could not be used here for structure-activity 
correlation studies. The lack of correlation between fungitoxicity and inhibition of CO-
P450 complex formation is in agreement with results from comparable studies with A. 
fumigatus, P. italicum and U. maydis.isn Most probably this is due to the crude nature of 
the microsomal preparations consisting of multiple P450 isozymes, which may mask the 
specific interaction of the compounds with P45014DM. Another explanation is, as Yoshida 
suggested, that impairment of CO binding or oxygen activation by azoles may not be 
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essential for their ability to inhibit sterol 14a-demethylase activity.27 This view was based 
on the finding that various DMIs, that hardly interfered with CO binding, did inhibit 
reconstituted lanosterol 14a-demethylase activity from S. cerevisiae. Hitchcock et al.23 
also demonstrated in a comparison of two azoles that the inhibition of cell-free sterol 
biosynthesis did not relate to their inhibitory effect on CO binding to the purified ferrous 
P450i4DM from C. albicans. The present study is also supportive of this view. 
The correlation between fungitoxicity of the compounds examined and their ability to 
inhibit cell-free sterol 14a-demethylation was much better, especially within the group of 
prochloraz analogues (Table 1 and 3). It is emphasized, however, that although the cell-
free bioassay was suitable for ranking the analogues in order of fungitoxicity, the I50 
values obtained did not quantitatively reflect the differences in fungitoxicity. For example, 
the relatively large differences in toxicity between compounds V and VII could not be 
explained by their small differences in inhibitory effects on cell-free sterol 14a-
demethylation. The same tendency was found for the racemic mixtures of the reference 
DMIs (Table 1 and 3). For instance, triadimenol and triadimefon, which were relatively 
inactive against P. italicum, still showed relatively low I50 values. Consequently, the 
differential toxicity of prochloraz, the related structures and reference DMIs is not 
determined only by differential affinity for the P45014DM. Additional mechanisms, such as 
metabolism, uptake and disposition, will also determine their fungitoxicity. Similar results 
were found by Guan et al.22 Considering the fact that triadimefon needs to be converted 
to triadimenol to exert its fungitoxicity,28 it was surprising to notice that triadimefon was 
only a slightly weaker inhibitor of cell-free P450MDM activity than triadimenol (Table 3). 
This might be explained by the fact that the cell-free extract of P. italicum is able to 
reduce triadimefon to triadimenol. This phenomenon has also been observed with cell-free 
extracts of Cladosporium cucumerinum.29 The interpretation of these results is hampered 
by the possibility that the composition of the racemic mixture of triadimenol is different 
from the stereoisomer composition present after the putative conversion of triadimefon by 
the cell-free extract. It is well documented that the four triadimenol stereoisomers differ 
in their ability to bind with P45014DM.6 The inhibitory potency of the single stereoisomers 
of the reference DMIs on cell-free P45014DM activity will be studied in future research. 
The isonitrile compound VI and unrelated compound X, to which P. italicum was 
relatively insensitive, belonged to the least effective inhibitors of sterol 14a-demethylase 
activity having I50s in the order of 10"* and 10"5 M, respectively. Interestingly, compound 
VI denatured P450 to P420 (Fig. 3B), but was still a weak inhibitor of cell-free sterol 
biosynthesis. The low activity of VI in the cell-free assay might, however, be related to 
its relatively high susceptibility to metabolic degradation. 
The present study supports the general view that the affinity of azole antifungals for 
P450i4DM is influenced by the Nt substituent of the azole moiety,4"12 since structural 
changes in the N! substituent of prochloraz affected the inhibition of P45014DM activity 
from P. italium (Table 3). For instance, replacement of the propyl chain in the Nt 
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substituent of prochloraz by an isopropyl group (V) caused an approximately 12-fold loss 
of activity in the cell-free assay. This finding agrees with that described by Baillie.30 
However, the affinity of azoles to P45014DM is not exclusively determined by their Nj 
substituents, since replacing the imidazole ring of prochloraz by a triazole moiety (IX) 
abolished its toxicity to P. italicum and decreased its inhibitory effect on cell-free 
ergosterol synthesis nearly 100-fold (Table 1 and 3). Baillie30 also found that prochloraz 
analogues in which the imidazole group was replaced by a triazole ring were much less 
active against for example Erysiphe graminis. It is possible that the triazole group of 
compound IX, due to the electron-withdrawing effect of the carbonyl group, may not be a 
good enough ligand to bind to the haem iron, or the compound may be too hydrolytically 
unstable (C.G. Earnshaw, pers. commun.). This implicates that the Ni substituent of 
prochloraz also has an effect on the interaction of the azole moiety with the haem iron. 
The antifungal activity of imidazole-1-carboxylates, to which prochloraz is related in 
terms of structure and biological activity, was also lost when the imidazole ring was 
replaced by a triazole moiety.31 The same phenomenon was observed for ketoconazole and 
its triazole analogue interacting with microsomal P450 from piglet testis.11 Addition of an 
amino group at C2 of the imidazole ring (VIII) led to a 100-fold reduction of the 
inhibitory effect on cell-free sterol biosynthesis. These observations agree with findings 
that substitutions in the 2, 4, and 5 positions of the imidazole, or 1, and 3 positions of the 
triazole diminish the potency of azoles against yeast P45014DM activity.25'32 Consequently, 
the affinity of this group of compounds for P45014DM is dependent on both the azole part 
and the Ni substituent of the molecule. 
Acknowledgements 
The authors would like to thank Drs. J.B. Pillmoor and C.G. Earnshaw for their critical 
comments. J.C. Kapteyn acknowledges the financial support of Schering Agrochemicals 
Ltd, Saffron Walden, UK. 
References 
1. Kato, T., In Chemistry of Plant Protection, ed. G. Haug and H. Hoffmann. Springer Verlag, Berlin, 
1986, pp. 1-24. 
2. Scheinpflug, H. & Kuck, K.H., In Modern Selective Fungicides - Properties, Applications, 
Mechanisms of Action, ed. H. Lyr. VEB Gustav Fischer Verlag, Jena, 1987, pp. 173-204. 
3. Kapteyn, J .C, Pillmoor, J.B. & De Waard, M.A., Pestic. Sci., (in press). 
4. Yoshida, Y. & Aoyama, Y., In In-vitro and In-vivo Evaluation of Antifungal Agents, ed. K. Iwata & 
H. Vanden Bossche. Elsevier Science Publishers BV., Amsterdam, 1986, pp. 123-134. 
5. Yoshida, Y. & Aoyama, Y., Biochem. Pharmacol, 36 (1987) 229-235. 
6. Yoshida, Y. & Aoyama, Y., Chirality, 2 (1990) 10-15. 
80 
7. Yoshida, Y., Aoyama, Y., Takano, H. & Kato, T., Biochem. Biophys. Res. Cotnmun., 137 (1986) 
513-519. 
8. Vanden Bossche, H., Bellens, D., Cools, W., Gorrens, J., Marichal, P., Verhoeven, H., Willemsens, 
G., De Coster, R., Beerens, D., Haelterman, C , Coene, M-C, Lauwers, W. & Le Jeune, L., Drug 
Dev., 8 (1986) 287-298. 
9. Vanden Bossche, H., In Sterol Biosynthesis Inhibitors, Pharmaceutical and Agrochemical Aspects, 
ed. D. Berg & M. Plempel. Ellis Horwood, Chichester, 1988, pp. 79-119. 
10. Vanden Bossche, H., In Recent Trends in the Discovery, Development and Evaluation of Antifungal 
Agents, ed. R.A. Fromtling. J.R. Proust Science Publishers S.A., Barcelona, 1987, pp. 207-21. 
11. Vanden Bossche, H., Marichal, P., Gorrens, J., Coene, M-C, Willemsens, G., Bellens, D., Roels, 
I., Moereels, H. & Janssen, P.A.J., Mycoses, 32 (Suppl. 1) (1989) 35-52. 
12. Vanden Bossche, H., Marichal, P., Gorrens, J., Geerts, H. & Janssen, P.A.J., Ann. N.Y. Acad. Sci., 
544 (1988) 191-207. 
13. Wiggins, T.E. & Baldwin, B.C., Pestic. Sci., 15 (1984) 206-209. 
14. Carelli, A., Farina, G., Gozzo, F., Merlini, L. & Kelly, S.L., Pestic. Sci., 35 (1992) 167-170. 
15. Marichal, P., Vanden Bossche, H., Gorrens, J., Bellens, D. & Janssen, P.A.J., In Cytochrome P-
450: Biochemistry and Biophysics, Proc. 6th Int. Conf. Biochemistry and Biophysics of Cytochrome P-
450, Vienna, 1988, ed. I. Schuster. Taylor & Francis, London-New York-Philadelphia, 1989, pp. 
177-180. 
16. Ballard, S.A., Kelly, S.L., Ellis, S.W. & Troke, P.F., J. Med. Vet. Mycol, 28 (1990) 327-334. 
17. Kapteyn, J.C., Pillmoor, J.B. & De Waard, M.A., Pestic. Sci., 34 (1992) 37-43. 
18. Guan, J., Braks, H.M.J., Kerkenaar, A. & De Waard, M.A., Pestic. Biochem. Physiol, 42 (1992) 
24-32. 
19. Baldwin, B.C. & Wiggins, T.E., Pestic. Sci., 15 (1984) 156-166. 
20. Gadher, P., Mercer, E.I., Baldwin, B.C. & Wiggins, T.E., Pestic. Biochem. Physiol, 19 (1983) 1-
10. 
21. Ballard, S.A., Ellis, S.W., Kelly, S.L. & Troke, P.F., J. Med. Vet. Mycol, 28 (1990) 335-344. 
22. Guan, J., Stehmann, C , Ellis, S.W., Kerkenaar, A. & De Waard, M.A., Pestic. Biochem. Physiol., 
42 (1992) 262-270. 
23. Hitchcock, C.A., Dickinson, K., Brown, S.B., Evans, E.G.V. & Adams, D.J., Biochem. J., 266 
(1990) 475-480. 
24. Schenkman, J.B., Sligar, S.G. & Cinti, D.L., Pharmacol. Ther., U (1981) 43-71. 
25. Janssen, P.A.J. & Vanden Bossche, H., Arch. Pharm. Chem. Sci. Ed., 15 (1987) 24-40. 
26. Malatesta, L., In Progress in Inorganic Chemistry, ed. F.A. Codon. Interscience, New York, 1959, 
pp. 233-379. 
27. Yoshida, Y., In Current Topics in Medical Mycology, ed M.R. McGinnis, Springer-Verlag, New 
York, 1988, vol.2, pp. 388-418. 
28. Deas, A.H.B., Carter, G.A., Clark, T., Clifford, D.R. & James, C.S., Pestic. Biochem. Physiol, 26 
(1986) 10-21. 
29. Gasztonyi, M. & Josepovits, G., Pestic. Sci. 15 (1984) 48-55. 
30. Baillie, A.C., In Synthesis and Chemistry of Agrochemicals, ed. D.R. Baker, J.G. Fenyes, W.K. 
Moberg & B. Cross. ACS Symposium Series 355 (1987) 328-339. 
31. Imai, T., Takao, H., Yamaguchi, K., Uchida, T., Goto, T. & Umetsu, N., Pestic. Sci., 34 (1992) 
119-125. 
32. Hitchcock, C.A., Biochem. Soc. Trans., 19 (1991) 782-787. 
81 
CHAPTER 7 
DEVELOPMENT OF A CELL-FREE ASSAY OF BOTRYTIS CINEREA 
TO BIOCHEMICALLY SCREEN FOR 
STEROL BIOSYNTHESIS INHIBITORS 
Christiane Stehmann, Johan C. Kapteyn and Maarten A. De Waard 
Department of Phytopathology, Wageningen Agricultural University, P.O. Box 8025, 
6700 EE Wageningen, the Netherlands. 
(To be submitted to Pesticide Science) 
Abstract 
An assay for measuring ergosterol biosynthesis in cell-free extracts of the filamentous 
plant pathogen Botrytis cinerea is described. The extracts capable of synthesizing C4-
desmethyl sterols from [2-14C]mevalonate were prepared by mechanical disruption of 
young conidial germlings in a Bead-Beater apparatus. The C4-desmethyl sterol fraction 
consisted of three distinct compounds and totalled 39% of the non-saponifiable lipids 
formed. Ergosterol accounted for 63 % of the Q-desmethyl sterols. Only little amounts of 
C4-monomethyl sterols were synthesized, while C44-dimethyl sterols made up 29% of the 
non-saponifiable lipids. The latter fraction mainly consisted of lanosterol (54%) and 
eburicol (28%). The cell-free system had a narrow pH optimum (pH 7.3-7.4) for 
synthesis of C4-desmethyl sterols. Cell-free synthesis of C4-desmethyl sterols was 
inhibited by the imidazole fungicide imazalil, concomitant with an accumulation of 
eburicol. The IC50 value (concentration of fungicide which inhibits cell-free synthesis of 
C4-desmethyl sterols by 50%) was 9.1xl0"9 M. This indicates that imazalil is a potent 
inhibitor of the cytochrome-P450 dependent sterol 14a-demethylase of B. cinerea. The 
method described may be used to biochemically screen compounds for inhibition of sterol 
biosynthesis in an agriculturally important plant pathogen. 
Introduction 
In the last two decades the development of resistance to benzimidazole and 
dicarboximide fungicides has severely hampered chemical control of Botrytis cinerea. 
During this period, fungicides which inhibit sterol biosynthesis (SBIs) were developed. 
Sterol demethylation inhibitors (DMIs) constitute the largest group of SBIs. The primary 
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target of these antifungals is the cytochrome-P450 dependent sterol 14a-demethylase 
(P450i4DM)-1,z Although DMIs have a broad antifungal spectrum only few of them show 
substantial biological activity against the economically important plant pathogen B. 
cinerea.3'6 Registration of more DMIs for the control of B. cinerea is therefore desirable. 
A cell-free sterol biosynthesis assay from this filamentous fungus would be useful to study 
the quantitative structure activity relationships of potential DMI-fungicides so that the 
toxicity of DMIs to B. cinerea could be optimized. The information would aid in the 
understanding of the selectivity of DMIs for different pathogens and could be used to 
screen for SBIs which inhibit sterol synthesis at sites other than the P45014DM. 
Cell-free extracts capable of synthesizing ergosterol from the sterol precursor [2-
14C]mevalonate have been largely confined to Saccharomyces cerevisiae,1* and the yeast 
form of Candida albicans.911 These assays have often been used to optimize the 
fungitoxicity of candidate fungicides. This is not an ideal situation, since the sensitivities 
of P45014DM activity of different fungi to a specific DMI are not necessarily the same. For 
a long time attempts to develop comparable assays from plant pathogenic filamentous 
fungi have been unsuccessful.12 This might have been due to instability of the membrane-
bound P450MDM during preparation of the cell-free extract or to a relatively low 
concentration of the enzyme in filamentous fungi. A difference in the sterol biosynthetic 
pathway (transmethylation of lanosterol instead of zymosterol, probably in mitochondria) 
might be an additional explanation.1314 However, the development of sterol 14a-
demethylase assays has recently been reported for the filamentous fungi Aspergillus 
fumigatusis and Penicillium italicum.16 Nevertheless, a similar assay for an important 
plant pathogen is still not available. 
In this paper a method is described to obtain a cell-free extract of the filamentous plant 
pathogen B. cinerea capable of synthesizing C4-desmethyl sterols. To evaluate the validity 
of this assay, the inhibitory action of the imidazole DMI-fungicide imazalil on P45014DM 
activity was studied. 
Materials & methods 
Chemicals. [2-14C]mevalonate, dibenzethylenediamine salt in ethanol (specific activity 
1.9 GBq mmol"1), was purchased from Amersham International pic (Amersham, UK). 
NAD+, NADP+, NADPH, ATP, glucose-6-phosphate, L-methionine, dimethyl sulfoxide 
(DMSO), oxytetracycline, dithiothreitol (DTT) and mercaptoethanol (MCE) were 
purchased from Sigma (St. Louis, Mo., USA). Reduced glutathione and N-acetyl cysteine 
were from Boehringer (Mannheim, Germany). Nicotinic acid amide was from Hoffmann-
La Roche (Basle, Switzerland). Imazalil (sulphate salt) was kindly supplied by Janssen 
Pharmaceutica (Beerse, Belgium). 
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Fungus and culture conditions. The monoascospore isolate of B. cinerea SAS-56,17 a 
gift from Dr. F. Faretra (Bari, Italy), was maintained on PDA slants. Conidia of B. 
cinerea were obtained from PDA cultures (30 ml) in Petri dishes (diameter 9 cm) 
incubated at 20°C for 24 hours in the dark and for 14 to 20 days under near UV light. 
Subcultures were made every three to four days by transferring agar plugs with young 
sporulating mycelium to the centre of agar plates. Flasks (2 1) with liquid synthetic media 
(1 1) prepared according to Fritz et a/.19 were inoculated with washed conidia collected 
from these plates (initial density 2x10* conidia ml"1). The cultures were incubated in a 
rotary shaker (200 rpm) in the dark at 20°C for 14 h. By then, germination percentages 
of conidia exceeded 90%. Germinated conidia had one to three (usually two) germ tubes. 
The average germ tube length of the longest germ tube was 1.40+0.06 pm. 
Preparation of cell-free extract. Cell-free extracts were prepared according to a 
modified method described by Guan et al.16 A standard germling suspension of B. cinerea 
was made by passing 14-hour-old cultures (harvest amounted to about 3 g wet weight f1 
medium) through a 0.2 mm pore sieve to remove clusters of mycelium and collecting the 
germlings on a 0.05 mm pore stainless steel sieve. Germlings collected were washed 
extensively with running cold tap water and twice with 100 mM ice-cold potassium 
phosphate buffer, pH 7.5 (250 ml). Washed germlings were resuspended in the buffer to 
give a ratio of 100 mg wet weight (27 mg dry weight) ml"1 buffer. Subsequent steps were 
carried out at 0-4°C. A 32 ml Bead-Beater vessel (Biospec Products, Bartlesville, Okl., 
USA) containing 15 g glass beads (0.5 mm diameter) was completely filled with germling 
suspension. Remaining air was removed by evacuation at -1 bar for 5 min. The vessel 
was again completely filled with germling suspension. Fungal cells were disrupted four 
times for 30 sec with 30 sec intervals, while the outer jacket of the vessel was filled with 
ice-water. The disrupter was driven at 100 V. The resulting homogenate was filtered 
through two layers of gauze (Klinion, Medical Care, Untermohlen, Utrecht, The 
Netherlands) presoaked in buffer. Glycerol was immediately added to the filtrate (22% 
(v/v) final concentration), gently mixed and centrifuged twice at 3000g for 10 min to 
sediment cell debris. The resulting supernatant was used immediately for sterol 
biosynthesis assays. The protein concentration in cell-free preparations was determined 
using a Bio-Rad Protein Assay (Bio-Rad Laboratories, Veenendaal, The Netherlands) with 
bovine-7-globulin as a standard. The absence of any intact cells was verified by 
microscopic observation and streak tests on PDA. 
Sterol biosynthesis assay. Standard sterol synthesis assays were carried out according 
to a modified method of Ballard et al.15 Incubation mixtures (1 ml) consisted of cell-free 
extract (924 yX), cofactor solution (50 jttl; containing 1 /*mol NADPH, 1 /tmol NADP+, 1 
/tmol NAD+, 3 /tmol glucose-6-phosphate, 5 /imol ATP, 1 /*mol reduced glutathione in 
distilled water adjusted to pH 7.2 with 1 M KOH), L-methionine (5 jtl; 2 /*mol) and 
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divalent cation solutions (10 /xl of 0.5 M MgCl2 and 5 fi\ of 0.4 M MnCl2, both adjusted 
to pH 7.0 with 1 M KOH). The combined incubation mixtures (20 ml) were adjusted to 
pH 7.4 with 5 M K2HP04 (which never exceeded 1 % of the total volume) and samples of 
994 pi were divided into screw-capped tubes. DMSO (control treatments) or DMSO-
solutions of imazalil (1 /*1) were added to the incubation mixtures. Sterol biosynthesis was 
started by adding [2-14C]mevalonate (5 jtl; 18.5 kBq). Mixtures were incubated in a 
reciprocal water bath shaker (80 strokes min1) at 20°C in the dark for 3 h. Reaction was 
stopped by adding 1.5 ml of freshly prepared 20% KOH (w/v) in ethanol (90%, v/v). 
Effects of pH on cell-free sterol biosynthesis were studied by adjusting incubation 
mixtures with KH2P04 (3 M) or K2HP04 (5 M) to the pH values tested. The pH of 
mixtures was measured again after incubation. 
Saponification, sterol extraction and analysis. Saponification of incubation mixtures, 
extraction and analysis of the non-saponifiable lipids (NSLs) by thin layer chromatograp-
hy (TLC) and radio-HPLC were carried out as described previously.17 In order to identify 
components of the C4-desmethyl, C4-monomethyl and C44-dimethyl sterol fractions 
separated on TLC plates, zones containing sterol fractions were cut out of the plates, 
extracted with chloroform and re-chromatographed on TLC-plates pretreated with AgNOs 
as described by Kerkenaar et a/.19 Ergosterol, lanosterol and eburicol (24-methylene 
dihydrolanosterol) were identified by co-chromatography with authentic standards. 
Inhibitory effects of imazalil on sterol biosynthesis. Effects of imazalil on sterol 
biosynthesis were investigated by incubating cell-free extracts with the inhibitor at various 
concentrations. Incorporation of radiolabel into C4-desmethyl sterols was calculated as a 
percentage of total incorporation into NSLs.8 Subsequently, corresponding incorporation 
rates of fungicide treatments were calculated as percentages of control treatments (100%). 
Using the soft-ware program Lotus 1-2-3 percentages were plotted against fungicide 
concentration on a logarithmic scale, regression analysis of these inhibitor-response data 
was performed and the imazalil concentration which inhibited synthesis of C4-desmethyl 
sterols by 50% (IC50) was calculated. The experiment was repeated four times. 
Results 
Characterization of cell-free sterol biosynthesis. Incorporation of [2-14C]mevalonate 
into NSLs accounted for 27.0±4.6% (n=10) of the total radiolabel added. Separation of 
these NSLs by TLC resulted in a typical separation pattern as illustrated by the 
autoradiogram presented in Fig. 1 (control lane). Upon co-chromatography with authentic 
samples of ergosterol and lanosterol and by comparison with literature data811,15 bands 2, 
3 and 4 were tentatively identified as C4-desmethyl sterols, C4-monomethyl sterols and 
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C4>4-dimethyl sterols, respectively. Similarly, band 7 was identified as squalene. Literature 
data suggest that band 6 is probably 2,3-oxido-squalene.8,20 The identities of bands 1 and 
5, composed of several zones, are unknown. Q-desmethyl sterols represented the major 
component of the sterols formed (39.0+4.4% of the NSLs); C44-dimethyl sterols 
accounted for 28.0+2.9%, while only minor amounts (3.2+1.1%) of C4-monomethyl 
sterols were synthesized (n=10). 
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Fig. 1: Autoradiogram of a TLC separation of non-saponifiable lipids synthesized from [2-
14C]mevalonate in cell-free assays of Botrytis cinerea in the absence and presence of imazalil at 
pH 7.4. Bands 2, 3, 4, 6 and 7 contained C4-desmethyl sterols, C4-monomethyl sterols, C4>4-
dimethyl sterols, 2,3-oxidosqualene (tentative) and squalene, respectively. The identities of bands 
1 and 5, which contained several sterols, are unknown. 
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Results of a typical time-course experiment (Fig. 2) show that incorporation of [2-
14C]mevalonate into NSLs was approximately linear with time up to 2 h. This was also 
true for synthesis of C4-desmethyl sterols. Formation of C44-dimethyl sterols decreased 
after 1 h. The amount of radiolabel incorporated into C4-monomethyl sterols was low and 
decreased after 1 h. 
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Fig. 2: Time course of synthesis of non-saponifiable lipids (•), C^-dimethyl sterols (A), C4-
monomethyl sterols (o) and C4-desmethyl sterols ( • ) in a cell-free preparation of Botrytis cinerea. 
Left ordinate: radioactivity in sterol fractions as percentage of radioactivity in non-saponifiable 
lipids. Right ordinate: radioactivity in non-saponifiable lipids as percentage of total radioactivity 
added. 
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Half or double the standard [2-14C]mevalonate concentration (8.5 nmol ml1 incubation 
mixture) resulted in similar incorporation percentages of the radiolabel into NSLs and C4-
desmethyl sterol fractions (results not shown), indicating that sterol biosynthesis was 
linear with the substrate concentration. The intermediate concentration was chosen in all 
other studies. In a further experiment cell-free sterol biosynthesis was investigated in 
extracts diluted with potassium phosphate buffer to cover a range of protein 
concentrations from 1.1 to 9.1 mg ml1. Synthesis of NSLs and Q-desmethyl sterols 
proved to be more or less proportional to the protein content and hence the amount of 
enzyme present in cell extracts, except for the lowest concentration tested (Fig. 3). The 
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Fig. 3: Effect of protein concentration of cell-free extracts on synthesis of non-saponifiable lipids 
(•), C4-desmethyl sterols (•) , C„-monomethyl sterols (o), C44-dimethyl sterols (A) and squalene 
(O). Left ordinate: radioactivity in sterol fractions as desintegrations min"1. Right ordinate : 
radioactivity in non-saponifiable lipids as percentage of total radioactivity added. 
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highest protein concentration investigated led to the highest amount of C4-desmethyl 
sterols and the highest ratio between C4-desmethyl sterols and total NSLs synthesized. 
Therefore, this concentration was used throughout the experiments. 
Stability of sterol biosynthetic activity did not siginificantly decrease upon storage at -
18°C for 8 days (data not shown). Cell-free extracts were not contaminated with mycelial 
fragments, since no cells could be detected microscopically after the second centrifugation 
of the cell-free extract and PDA-plates inoculated with droplets of extract did not show 
any fungal growth, although some bacterial colonies were noticed. Addition of 
oxytetracycline (10 mg ml"1) to incubation mixtures had no significant effect on cell-free 
sterol biosynthesis but did inhibit bacterial growth on PDA plates. Cell-free extracts 
heated at 80°C for 1 min incorporated only 0.2% of [2-14C]mevalonate added into NSLs. 
Omission of either the cofactor solution or the divalent cations in the incubation mixture 
yielded only 0.2 and 1.0% of incorporation of the radiolabel into NSLs, respectively. 
Essential factors for biosynthesis of Cfdesmethyl sterols. The intensity of disruption 
of the germlings was a crucial point. Microscopical examination showed that the standard 
procedure disrupted more than 90% of the cells (Fig. 4a and b). Protein concentrations of 
the resulting cell-free extracts were in the range of 9.0±1.1 mg ml"1 (n=10). Lower 
disruption speeds of the Bead-Beater, shorter disruption periods or the use of smaller 
glass beads resulted in less severe disruption of conidial germlings and yielded cell-free 
Fig. 4: Conidial germlings before (A) and after (B) the standard disruption procedure. Magnifica-
tion: 200x. 
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extracts with lower protein concentrations. Similarly, higher disruption speeds, longer 
disruption periods and the use of larger glass beads increased protein concentrations of 
cell-free extracts and then germlings were more severely disrupted than in the standard 
assay. Incorporation of [2-14C]mevalonate into C4-desmethyl sterols by these extracts was 
poor, although C44-dimethyl sterols were formed (results not shown). Similar results were 
obtained when glycerol was not added to the cell-free extract immediately after filtration 
of the germling homogenate (Table 1). Evacuation of the disruption vessel was also 
essential for synthesis of C4-desmethyl sterols (data not shown). 
Activity of the cell-free assay was strongly affected by the pH of the incubation 
mixture, which in itself did not change significantly during incubation. Incorporation of 
radiolabel into NSLs and C4-desmethyl sterols had narrow pH optima between pH 7.4-7.6 
and pH 7.3-7.4, respectively. Incorporation into C4-desmethyl sterols at pH 7.1 and 7.7 
Table 1: Effect of composition of the disruption buffer on sterol biosynthesis in cell-free extracts 
of Botrytis cinerea 
Standard 
composition1 
NSLs2 Sterol ratio3 
Eburicol lanosterol C„-desmethyl 
sterols 
None 18.5 1.0 1.2 2.0 
+ MCE5 (14 mM) 09.3 
+ DTT (10 mM) 
1.0 8.7 n.d.4 
+ MCE (14 mM) 10.2 
+ DTT (10 mM) 
+ EDTA (10 mM) 
1.0 8.7 n.d. 
+ N-Ac (10 mM) 01.4 
+ NAA (10 mM) 
n.d. n.sd. n.d. 
glycerol (22%) 18.9 1.0 5.9 n.d. 
1
 K2HP04 - KH2PO„ buffer pH 7.5 supplied with 22% glycerol 
2
 NSLs synthesized as percentage of [2-l4C]mevalonate added 
3
 Ratio relative to eburicol; based on HPLC analysis 
4
 Not detected 
5
 MCE: mercaptoethanol; DTT: dithiothreitol; EDTA: ethylene diamine tetraacetic acid; N-AC: N-acetyl 
cysteine: NAA: nicotinic acid amide 
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was 39 and 45% lower than at pH 7.4, respectively (Fig. 5). Formation of C44-dimethyl 
and C4-monomethyl sterols did not show an obvious pH optimum. 
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Addition of L-methionine to the cofactor solution enhanced in vitro production of Q -
desmethyl sterols. Samples supplied with L-methionine incorporated on average compara-
ble amounts of radiolabel into NSLs as those incubated without L-methionine, but the 
presence of the compound caused an increase in C4-desmethyl sterols of about 30 to 40% 
of total NSLs. When L-methionine was replaced by the same molar amount of S-adenosyl 
methionine, C4-desmethyl sterols accounted for 52 to 59% of NSLs, but total 
incorporation of [2-14C]mevalonate into the sterol fraction was very low (only 5 to 6% of 
the radiolabel added). The addition of glucose-6-phosphate dehydrogenase did not 
improve cell-free synthesis of C4-desmethyl sterols. 
In preliminary experiments activity of cell-free extracts using different disruption 
buffers was investigated. Interestingly, replacement of the standard potassium buffer by a 
sodium potassium phosphate buffer significantly reduced synthesis of C4-desmethyl sterols 
and also resulted in accumulation of C4-monomethyl sterols (Table 2). Disruption of 
germlings in Tris-HCl-buffer, commonly used for A24 sterol: S-adenosyl methionine 
transferase assays,21"23 reduced synthesis of NSLs by 50% and resulted in a relatively high 
amount of eburicol (Table 2), indicating negative effects on P45014DM activity. In further 
experiments the effect of different supplements, often used in P45014DM assays of 
yeasts,711,24 were tested. MCE, DTT and EDTA reduced incorporation of [14C]mevalonate 
into NSLs by about 50% (Table 1). More interestingly, they blocked formation of C4-
desmethyl sterols concomitant with an accumulation of lanosterol, which indicates an 
inhibitory effect of these compounds on side chain alkylation of lanosterol. 
Table 2: Effect of different disruption buffers (100 mM) on sterol synthesis in cell-free extracts of 
Botrytis cinerea. 
Buffer pH 7.5 NSLs1 Sterol ratio2 
Eburicol lanosterol C„-monomethyl C„-desmethyl 
sterols sterols 
ICflPO,, - KH2P04 21.3 1.0 
Na2HP04 - KH2P04 18.3 1.0 
Tris-HCl 11.0 1.0 
3.3 
1.7 
0.1 
n.d.3 
2.5 
n.d. 
4.1 
2.6 
0.3 
1
 NSLs as percentage of [l4C]mevalonate added 
2
 Relative to eburicol; based on HPLC analysis 
3
 Not detected 
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Addition of N-acetyl cysteine and nicotinic acid amide to the disruption buffer severely 
impaired cell-free sterol synthesis (Table 1). Hence, the 100 mM potassium phosphate 
buffer (pH 7.5) was chosen in the standard assay. 
Inhibition studies. The imidazole fungicide imazalil inhibited radial growth of B. 
cinerea by 50% at 1.5X10"6 M. Imazalil inhibited cell-free incorporation of [2-
14C]mevalonate into Q-desmethyl sterols (Fig. 1). Inhibition coincided with an increase of 
radiolabelled C4 4-dimethyl sterols. Effects of imazalil on the formation of C4-monomethyl 
sterols could not be observed. Fig. 6 shows a dose-response curve of imazalil for 
inhibition of C4-desmethyl sterol biosynthesis obtained from four replicate experiments. 
The IC50 value was calculated to be 9.1±1.5xia9 M. DMSO (0.1%) in control treatments 
did not have any significant effects on sterol synthesis. 
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Fig. 6: Inhibition of incorporation of [2-14C]mevalonate into Q-desmethyl sterols in cell-free 
assays (n=4) of Botrytis cinerea at pH 7.4 by imazalil. Abscis: concentration of test compound. 
Ordinate: radioactivity in C4-desmethyl sterols as percentages of control treatment. 
Identification of radiolabelled sterols. NSLs were analyzed by radio-HPLC. In control 
samples, six major peaks with retention times of 4.9 (peak 1), 10.0 (peak 2), 12.8 (peak 
3), 16.6 (peak 4, consisting of two peaks), 22.8 (peak 5) and 25.1 min (peak 6) were 
observed (Fig. 7A). Peaks 4, 5 and 6 had retention times identical to those of authentic 
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ergosterol, lanosterol and eburicol, respectively, as demonstrated by UV-detection at 210 
and 280 nm. The identities of other sterols were not studied any further. 
Radioactivity [cpm] 
2.00x10-
1.00-
5.70x10 
2.85-
30 
Retention time [min] 
Fig. 7: Radio-HPLC separation of radiolabeled non-saponifiable lipids extracted from control (A) 
and imazalil-treated (3x10s M) (B) cell-free sterol biosynthesis assays of Botrytis cinerea at pH 
7.4. Peak 4 is composed of a mixture of ergosterol (4a) and another non-identified C4-desmethyl 
sterol (4b). The identities of peak 5 and 6 are lanosterol and eburicol, respectively. 
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In imazalil-treated samples (3x10* M) only two major peaks were observed (Fig. 7B): 
peak 5 (lanosterol) and 6 (eburicol). The size of the latter increased significantly. Sterols 
were further analyzed by separation on TLC plates pretreated with AgN03. The C4-
desmethyl sterol fraction proved to consist of three sterols with Rf-values of 0.02, 0.07 
and 0.21 which accounted for 12.6, 63.1 and 24.3% of the C4-desmethyl sterol fraction, 
respectively. The compound with a Rf-value of 0.07 cochromatographed with authentic 
ergosterol. The other two C4-desmethyl sterols were not identified. C44-dimethyl sterols 
separated into four distinct bands with Rf-values of 0.04, 0.31, 0.36 and 0.42. Com-
pounds with Rf-values of 0.36 and 0.42 co-chromatographed with authentic eburicol and 
lanosterol and accounted for 53.6 and 28.2% of the C44-dimethyl sterol fraction, 
respectively. No attempts were undertaken to identify the other sterols. 
Discussion 
Cell-free extracts of B. cinerea actively synthesized C4-desmethyl sterols and other 
sterols from [2-14C]mevalonate. The disruption procedure was relatively vigorous 
compared with those described for other filamentous pathogens,15'16 but this proved to be 
essential. The protein concentration of cell-free extracts in standard assays was 9.0+1.1 
mg ml1, which is comparable to those described for assays developed for yeasts7,8,11 and 
ten times higher than reported for cell-free systems of A. fitmigatus15 and P. italicum.16 
The necessity of a relatively strong method to disrupt the germlings may be explained by 
the fact that cells of B. cinerea are surrounded by a layer of mucilage. However, it may 
also be due to differences in quality and quantity of P45014DM in different fungi and 
P45014DM stability. Additional crucial points for the preparation of active cell-free extracts 
were the addition of glycerol to filtrates of cell-homogenates before centrifugation (Table 
1) and the pH of the incubation mixture (Fig. 5). The cell-free system had a narrow pH 
optimum for synthesis of C4-desmethyl sterols between pH 7.3 and 7.4. This result is 
different from that reported for the cell-free assay of P. italicum,16 but resembles data 
obtained for A. fiimigatus.15 
Under optimal conditions the average amount of radioactivity incorporated into C4-
desmethyl sterols was about 39.0% of total NSLs. In intact cells incorporation of 
radiolabel into C4-desmethyl sterols accounts for more than 90% of the NSLs formed.25 
The relatively low incorporation of label into C4-desmethyl sterols under cell-free 
conditions is probably not due to a feed-back inhibition by ergosterol, since addition to 
the incubation mixture of the polyene antibiotic nystatin (10'5 M), which forms complexes 
with C4-desmethyl sterols, did not influence cell-free synthesis of C4-desmethyl sterols 
(results not shown). However, increased synthesis of NSLs in extracts in the presence of 
imazalil (results not shown) is supportive of feed-back inhibition. 
96 
Incorporation of [2-14C]mevalonate by cell-free extracts of B. cinerea into Q-desmethyl 
sterols is higher than reported for cell-free preparations derived from other filamentous 
fungi15'16 and C. albicans.9 B. cinerea assays yielded relatively low amounts of lanosterol 
as compared with cell-free assays of A. fiunigatus15 and P. italicum.16 This is probably 
due to the addition of L-methionine to the incubation mixture, since its biologically 
activated form S-adenosyl methionine is used for the C24 side chain alkylation of 
lanosterol.21'26 Interestingly, the addition of S-adenosyl methionine itself resulted in a very 
high conversion of [2-14C]mevalonate to C4-desmethyl sterols, but in an extremely low 
formation of total sterols. We have no explanation for this phenomenon. 
Analysis of the C4-desmethyl sterol fraction with argentation TLC showed three distinct 
C4-desmethyl sterols. The C4-desmethyl sterol which co-chromatographed with authentic 
ergosterol accounted for 63.1% of the C4-desmethyl sterols synthesized. Radio-HPLC 
analysis of NSLs revealed three C4-desmethyl sterol peaks (peaks 3, 4a and 4b), which 
were absent upon imazalil-treatment of cell-free extracts (Fig 7). The identities of peak 1 
and 2 are most probably non-sterols and C4-monomethyl sterols, respectively. Peak 4a 
had a retention time identical to that of standard ergosterol. This indicates that ergosterol 
is the major C4-desmethyl sterol synthesized in cell-free extracts. The other two C4-
desmethyl sterols are not yet identified. According to literature data on sterol composition 
of intact cells of B. cinerea these sterols might be A5,8,22-ergostatrienol and episterol.27"29 
Only a minor amount (3.2± 1.1%) of C4-monomethyl sterols was synthesized under cell-
free conditions, which is in agreement with literature data on the sterol content of intact 
B. cinerea cells.25 The other sterols in the NSLs identified by co-chromatography on 
radio-HPLC and argentation TLC were lanosterol and eburicol. These data suggest that 
the cell-free sterol synthesis follows the same pathway as described for intact 
mycelium.28'29 
Treatment of cell-free extracts with imazalil led to accumulation of eburicol and 
depletion of C4-desmethyl sterols (Fig. 1 and 7). This suggests that sterol 14a-
demethylation is blocked by inhibition of P45014DM activity and that eburicol is the 
substrate for the P45014DM. The IC50 value of imazalil was extremely low (9.1±1.5xl0"9 
M) indicating a potent inhibition of P450i4DM activity of this fungus. The EC50 value of 
imazalil for radial growth is 1.5x10"* M. This difference may be explained by the 
accumulation, distribution and metabolism of the compound in fungal cells, the 
intracellular pH or some other unknown factors. These factors may be of relatively great 
importance for the fungicidal activity of DMIs against B. cinerea and may explain the 
present low number of DMIs which are used for control of this fungus 
The cell-free assay provides a simple method to screen biochemically for compounds 
which potentially inhibit sterol biosynthesis at C14-demethylation or, alternatively, at any 
other site in the sterol biosynthetic pathway between the precursor squalene and the end 
product ergosterol. 
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Abstract 
The sensitivity of cytochrome-P450 dependent sterol 14a-demethylase (P45014DM) to 
prochloraz and several prochloraz analogues was studied in a cell-free assay of Botrytis 
cinerea. The EC50 values (concentrations which inhibited radial growth of B. cinerea by 
50%) of the compounds tested ranged from 3.3xlO"8 to 1.7xl0"5 M. The IC50 values 
(concentrations which inhibited cell-free sterol synthesis by 50%) in cell-free assays of B. 
cinerea ranged from 2.6xl0"9 to 4.4xl0"7 M. The assay ranked the compounds in order of 
fungitoxicity, but the IC50 values did not quantitatively reflect the differences in toxicity. 
Therefore, the differential inhibition of cell-free P45014DM activity by these compounds 
can not fully account for their differences in toxicity to B. cinerea. Additional 
mechanisms must be involved. 
The compounds tested were generally more potent in the Botrytis assay than in similar 
assays developed for Penicillium italicum and, in particular, Saccharomyces cerevisiae. 
This correlated with the relatively higher toxicity of most test compounds to B. cinerea. 
Results suggest that the cell-free assay of B. cinerea is more useful to biochemically 
screen candidate fungicides as inhibitors of sterol 14a-demethylase activity than similar 
assays from model organisms. 
The present study confirms that the affinity of prochloraz analogues for P45014DM 
depends on the nature of their N! substituent and their azole moiety. It was also found 
that addition of an amino group at C2 of the imidazole moiety of prochloraz (VI) resulted 
in inhibition of C4-desmethyl sterol biosynthesis at a different site to P45014DM. This was 
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confirmed by the observation that laboratory-generated triadimenol-resistant isolates of B. 
cinerea did show reduced sensitivity to triadimenol and prochloraz, but not to compound 
VI. 
Introduction 
Control of grey mould caused by Botrytis cinerea, an economically important plant 
pathogen, is highly dependent on the application of fungicides. However, the number of 
fungicides which are available is limited due to resistance development to benzimidazoles 
and dicarboximides. Therefore, attention is focussed on other types of fungicides such as 
the sterol 14a-demethylation inhibitors (DMIs). However, only a few DMIs have been 
found to be effective,1"5 and other commercial DMIs possess only low or moderate 
efficacy.3 Availability of more DMIs for Botrytis control would be desirable. Sufficient 
knowledge on the biochemical mechanisms which are responsible for the observed 
selective toxicity of DMIs to B. cinerea is lacking. DMI fungicides inhibit sterol 
biosynthesis by binding to cytochrome-P450 dependent sterol 14a-demefhylase 
(P45014DM).6 The differences in toxicity of DMIs to Aspergillus fumigatus and Penicillium 
italicum were shown to be, at least in part, due to differential affinities for P45014DM in 
these fungi.79 The recent development of a cell-free sterol biosynthesis assay from B. 
cinerea10 makes it possible to investigate whether the observed differences in toxicity of 
DMIs to this fungus also result from different potencies of P45014DM inhibition. In 
addition, the cell-free assay opens the opportunity to optimize the inhibitory action of 
DMIs against fungal P45014DM activity and to search for other potential target sites in 
fungal sterol biosynthesis. These studies may eventually lead to the development of 
improved DMIs and of new types of sterol biosynthesis inhibitors (SBIs) active against B. 
cinerea. 
In this paper the inhibitory potencies of prochloraz, several prochloraz analogues and 
the experimental triazole fungicide 3-(2,4-dichlorophenyl)-2-(lZ/-l,2,4-triazol-l-yi)-4(3#)-
quinazolinone (Fig. 1) on the activity of P45014DM in cell-free extracts of B. cinerea are 
described. The results are discussed in relation to the fungitoxicities of the compounds to 
B. cinerea. The data from the assays are compared with those obtained with similar cell-
free assays developed for P. italicum1 and Saccharomyces cerevisiae. 
Materials & Methods 
Chemicals. Prochloraz (I), experimental triazole fungicide 3-(2,4-dichlorophenyl)-2-
(liy-l,2,4-triazol-l-yl)-4(3flr)-quinazolinone (H), and prochloraz analogues (III-VIII) 
were donated by Schering Agrochemicals Ltd. Dimethyl sulfoxide (DMSO) was 
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purchased from Merck (Darmstadt, Germany). DL[2-14C]mevalonate (spec, activity 1.9 
Gbq mmol"1) was from Du Pont De Nemours (s'Hertogenbosch, The Netherlands). All 
test compounds were dissolved in DMSO. 
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Fig. 1: Structural formulae of prochloraz (I), experimental triazole fungicide 3-(2,4-
dichlorophenyl)-2-(l//-l,2,4-triazol-l-yl)-4(3#)-quinazolinone (II) and various prochloraz 
analogues (III-VIII) 
Culture methods, radial growth inhibition tests. The monoascospore isolate of B. 
cinerea SAS-5611 was donated by Dr. F. Faretra (Bari, Italy). The laboratory-generated 
triadimenol-resistant isolates TN-150/6-6 and TN-25 of B. cinerea were obtained from Dr. 
B.N. Ziogas (Athens, Greece). Isolate SAS-56 was maintained on potato dextrose agar 
(PDA); the resistant isolates on PDA amended with triadimenol (10 jug ml1). Liquid 
germling cultures of SAS-56 were prepared as described by Stehmann et al.10 Toxicity of 
compounds to radial growth on PDA was determined according to Kapteyn et al.12 
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Preparation of cell-free extracts and sterol biosynthesis assays. Cell-free extracts of B. 
cinerea isolate SAS-56 were obtained by mechanical homogenization of germling 
suspension (100 mg fresh weight of germlings in 1 ml 100 mM potassium phosphate 
buffer pH 7.5) using a Bead-Beater (Biospec. Products, Bartlesville, Okl., USA).10 The 
average protein content was 9.0+1.0 mg ml"1 (n=10). Sterol synthesis in cell-free 
extracts of this fungus was assayed as described previously.10 The test compounds were 
added from 1000-fold concentrated stock solutions in DMSO. Radiolabeled C44-dimethyl, 
C4-monomethyl and C4-desmethyl sterols synthesized in the bioassay were separated by 
thin layer chromatography (TLC). Radioactive zones were located by autoradiography, 
cut from the plate and the radioactivity present was determined by liquid scintillation 
counting. The amount of radioactivity incorporated into different sterol fractions was 
expressed as a percentage of the radioactivity in total non-saponifiable lipids (NSLs) 
recovered from the bands on the TLC plates.7"9 NSLs were further analysed with radio-
HPLC as described previously.8"10 
With regard to S. cerevisiae, the preparation of cell-free extracts and the sterol 
biosynthesis assays were carried out according to Kato and Kawase.11 The average protein 
concentration used in the yeast cell-free assay was 29.5+2.0 mg ml"1 (n=4). Analysis of 
NSLs was performed by radio-HPLC using a 5 fim. Hypersil silica column (25 cm x 4.6 
mm) (Hichrom, Reading, U.K.). Mobile phase was heptane/isopropanol (98:2) at 1 ml 
min'1 flow rate. Cell-free sterol 14a-demethylation was calculated as radioactivity 
incorporated into C4-desmethylsterol sterols as a proportion of radioactivity in lanosterol 
and the C4-desmethyl sterols. 
Results 
Radial growth inhibition tests. Among the compounds tested prochloraz was the 
strongest inhibitor of radial growth of B. cinerea isolate SAS-56 with an EC50 of 3.3xlO"8 
M (Table 1). Experimental triazole fungicide II exhibited an EC50 of 2.0xl0"7 M. EC50s of 
the prochloraz analogues ranged from 1.4xl0"6 to 1.7xl0"5 M (Table 1). Compound VIH 
had the weakest fungitoxicity of all the compounds tested. Except for prochloraz, 
compounds i n and V, all test compounds were relatively more fungitoxic to Botrytis than 
to Penicilliwn. Prochloraz was equally toxic to both fungi (Table 1). Spearman's ranking 
correlation coefficient (rj between the EC50s for B. cinerea and those for P. italicum was 
0.26 indicating that these fungi differed markedly in sensitivity to most of the compounds 
tested (Table 2). 
As expected, isolates TN-150/6-6 and TN-25 were resistant to triadimenol exhibiting 
resistance levels of 9 and 10, respectively (Table 3). The triadimenol-resistant isolates 
were also resistant to prochloraz but as sensitive to VI as the wild-type isolate SAS-56 
(Table 3). 
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Table 2: Ranking correlation between the fungitoxic activities of various compounds to Botrytis 
cinerea and Penicillium italicum (EC.,,) and their inhibitory effects on sterol 14a-demethylation in 
cell-free extracts of B. cinerea and P. italicum (\CX values). 
h\*x 
EC50 (B. cinerea) 
ECJO (P. italicum) 
ICJQ (B. cinerea) 
ICso (P. italicum) 
B. cinerea 
X 
IC50 
P. italicum 
0.26* 
X 
B. cinerea 
0.76 
0.83 
X 
P. italicum 
0.81 
0.83 
0.88 
X 
* Spearman's correlation coefficient (r,) followed by an asterisk indicates the absence of a ranking 
correlation. 
Table 3: Toxicity of triadimenol, prochloraz and compound VI to radial growth of Botrytis 
cinerea wild-type isolate SAS-56 and triadimenol-resistant isolates TN-25 and TN-150/6-6. 
Isolate 
SAS-56 
TN-150/6-6 
TN-25 
Triadimenol 
ECX[MY Q2 
1.8xl06 
1.6xl0-5 
1.8xl0-5 
9 
10 
Prochloraz 
EC*, [M] Q 
2.0xl0"8 
1.3xl0"7 
l.lxlO"7 
Compound VI 
EC^ [M] Q 
6.6xl0"6 
3.8xl0"6 0.7 
7.4X10"6 1.1 
1
 Figures based on two replicates. 
2
 Q (resistance level): ratio between EC*) of resistant isolate and isolate SAS-56. 
Inhibition of cell-free sterol 14a-demethylation in B. cinerea SAS-56. The total 
incorporation of radioactivity into NSLs was on average 17.9+3.7% of radiolabel added 
(n=10). Fig. 2A shows an autoradiogram of a TLC plate on which labelled C44-dimethyl, 
C4-monomethyl and C4-desmethyl sterols, and other NSLs synthesized in control 
treatments were separated. TLC and radio-HPLC analyses by Stehmann et a/.10 indicated 
that band 1 contains ergosterol and another, yet unidentified C4-desmethyl sterol. Band 2 
represents C4-monomethyl sterols, while band 3 contains the C44-dimethyl sterols, 
lanosterol and 24-methylenedihydrolanosterol (eburicol). Band 5 was tentatively identified 
as 2,3-oxidosqualene12,13 whilst band 6 was most probably squalene. All other bands were 
not identified. Percentage of radioactivity incorporated into C4-desmethyl sterols was on 
average 38.3+8.6% of the NSLs recovered from TLC. Prochloraz inhibited incorporation 
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of radiolabel into C4-desmethyl sterols at extremely low concentrations concomitant with 
an accumulation of eburicol (Figs. 2A, 2B, 3A and 3B). It was the most potent inhibitor 
tested and had an IC50 of 2.6xl0"9 M (Table 1). All other compounds tested inhibited C4-
desmethyl sterol synthesis to lower degrees. The triazole analogue VII was the weakest 
inhibitor with an IC50 of 4.4xia7 M (Table 1). Except for compound VI (see 3.4), all test 
compounds impaired C4-desmethyl sterol synthesis due to inhibition of P45014DM activity. 
The Spearman's rs value between the EC50 values for radial growth and the IC50 values 
was 0.76 indicating that a ranking correlation existed between these values (Table 2). 
Fig. 2: Autoradiogram of a TLC separation of non-saponifiable lipids synthesized from [2-14C] 
mevalonate by a cell-free preparation of Botrytis cinerea in the presence of (A) DMSO (control), 
(B) 10"8 M prochloraz, (C) 5x10s M compound VI and (D) 105 M terbinafine. Bands 1, 2, 3, 5 
and 6 contained C4-desmethyl sterols, C4-monomethyl sterols, C4,„-dimethyl sterols, 2,3-
oxidosqualene (putative), and squalene, respectively. AH other bands were not identified. 
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Inhibition of cell-free sterol 14a-demethylation in S. cerevisiae. The cell-free system 
of S. cerevisiae was used to make preliminary comparisons of the inhibitory potencies of 
test compounds in similar assays from filamentous and yeast-like fungi. The most potent 
inhibitors in the yeast assay were prochloraz, compounds II and HI with IC50s of 2.2x10" 
1
, 2.9xl0~7 and 1.2xl0"7 M, respectively (Table 1). The weakest inhibitor was VII with an 
IC50 of l.lxlO"5M (Table 1). 
Inhibition of cell-free sterol synthesis at other sites. Incubation of the cell-free extract 
of B. cinerea with compound VI led to a depletion of C44-dimethyl and C4-desmethyl 
sterols, and an accumulation of bands 4 (putatively 2,3-oxidosqualene) and 5 (identity 
unknown) (Fig. 2C). HPLC-analysis of NSLs of compound Vl-treated assays yielded two 
new peaks (6 and 7) concomitant with a reduction in synthesis of lanosterol (4), eburicol 
(5) and C4-desmethyl sterols (2 and 3) (Fig. 3C). Squalene synthesis was not significantly 
affected. In contrast to prochloraz, compound VI (5xl0~8 M) did not significantly decrease 
the ratio between lanosterol and eburicol synthesized. (Fig. 3B, 3C). Terbinafine, a 
squalene epoxidase inhibitor, led to a decrease in synthesis of C4 4-dimethyl, C4-
monomethyl and C4-desmethyl sterols concomitant with an accumulation of squalene (Fig. 
2D). Radio-HPLC analysis of the NSLs formed upon incubation of yeast cell-free extract 
with compound VI showed no detectable C4-desmethyl sterols. Lanosterol synthesis was 
hardly influenced and no new peaks were observed (data not shown). 
Discussion 
The present study demonstrates that prochloraz and a number of prochloraz analogues 
inhibit cell-free P45014DM activity of B. cinerea to different degrees (Table 1). Prochloraz 
was the most active compound in the cell-free assay and also showed the highest toxicity 
to radial growth of this fungus. Although the most potent inhibitors in the cell-free assay 
tended to be the most toxic to radial growth of Botrytis (rs=0.76), the differences in IC50 
values did not fully reflect the observed differences in toxicity. For example, the 
relatively large difference in toxicity between prochloraz and III-Vin did not relate to the 
small difference in inhibition of P45014DM activity (Table 1). Consequently, this finding 
indicates that the toxicity of prochloraz and its analogues to B. cinerea is not only 
determined by their differential inhibition of P45014DM activity. Other mechanisms must 
also be involved, such as for instance differential accumulation or metabolism. The 
relatively low inhibition of radial growth and of P45014DM activity by compound VIH 
might be explained by its relatively high susceptibility to metabolic breakdown. These 
results are in agreement with those found for P. italicum.1'9 
B. cinerea and P. italicum differed greatly in sensitivity to most of the test compounds 
(Table 1). This was also demonstrated by the absence of a ranking correlation between 
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Fig. 3: Radio-HPLC separation of radiolabeled non-saponifiable lipids extracted from (A) control, 
(B) prochloraz-treated (108 M) and (C) compound VI-treated (5xl0"8 M) cell-free assays of 
Botrytis cinerea. The identities of peak 2, 4, and 5 are ergosterol, lanosterol and eburicol, 
respectively. All other peaks were not identified. 
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the EC50 values for both fungi (rs 0.26; Table 2). The cell-free assay of B. cinerea ranked 
the compounds in almost the same order of intrinsic potency as the cell-free system of P. 
italicum (rs=0.88) (Table 2). However, to some extent all the compounds tested were less 
potent in the cell-free assay from P. italicum than in the one from B. cinerea (Table 1) 
suggesting that the P45014DM from B. cinerea has a slightly higher affinity for the 
compounds tested than the demethylase from P. italicum. This was reflected in the 
generally higher toxicity of the test compounds to Botrytis (Table 1). However, for some 
test compounds this correlation was absent. For example, compound V was almost 
equally potent in both cell-free assays, but was less toxic to B. cinerea than to P. italicum 
(Table 1). An alternative explanation for the relatively high potency of test compounds in 
the cell-free assay of B. cinerea may be a relatively low P450MDM concentration in cell-
free extracts from this fungus. The validity of this hypothesis could not be tested, since 
the actual concentration of P45014DM in both cell-free extracts was too low to be 
determined by CO difference spectroscopy. 
Prochloraz and compounds II and HI were relatively potent inhibitors of yeast 
P45014DM activity while compounds VI and VII were relatively weak inhibitors (Table 1). 
This agrees with data from the Botrytis and Penicillium assays. Prochloraz was far less 
potent in the yeast cell-free assay than in those from B. cinerea and P. italicum (Table 1). 
This also applies for the other test compounds, except for compound VIII. Consequently, 
the yeast cell-free assay is less suitable as a biochemical screening test of candidate 
fungicides than the assays of both filamentous fungi. This observation may relate to the 
fact that both B. cinerea and P. italicum belong to the Euascomycetidae while S. 
cerevisiae is a member of the Hemiascomycetidae. 
Structural modifications in the Nx substituent of prochloraz significantly affected its 
inhibition of P450i4DM activity from B. cinerea (Table 1). For instance, when the propyl 
chain in the Nj substituent of prochloraz was replaced by an isopropyl group (IV), the 
activity in the cell-free assay was reduced by a factor 12. This is in agreement with 
literature data indicating that the affinity of azole fungicides for P45014DM is influenced by 
the Nj substituent of the azole moiety.71418 
Modifications in the azole moiety of prochloraz had relatively more impact on P45014DM 
activity, since substitution of the imidazole ring of prochloraz by a triazole moiety (VII) 
reduced its inhibitory effect on cell-free sterol synthesis and its fungicidal activity 169 and 
333-fold, respectively (Table 1). These results are consistent with data obtained from cell-
free assays of S. cerevisiae and P. italicum (Table 1) and data from other studies.19"21 It 
has been postulated that the triazole group of VII might not be a good enough ligand, due 
to the electron-withdrawing effect of the carbonyl group.7 Consequently, the present study 
confirms that the affinity of this group of compounds for P45014DM is dependent on both 
the azole part and the Nj substituent of the molecule. 
Addition of an amino group at C2 of the imidazole ring of prochloraz (VI) resulted in 
inhibition of C4-desmethyl sterol biosynthesis at a different site. Compound VI inhibited 
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both C44-dimethyl and Q-desmethyl sterol synthesis concomitant with the accumulation of 
2,3-oxidosqualene (putative) and another, as yet unidentified NSL (Figs. 2C and 3C). 
Similar inhibition patterns by VI were observed in cell-free assays of P. italicum 
(unpublished results). Since the ratio between the levels of lanosterol and eburicol 
synthesized in the B. cinerea assays did not increase upon treatment with compound VI 
(5xlO'8 M) (Fig. 3C), it was concluded that compound VI is not a potent inhibitor of 
P45014DM activity of B. cinerea. This is in agreement with previous observations that 
substitutions at C2 of the imidazole moiety decrease inhibition of P45014DM activity by 
imidazole compounds.22'23 Compound VI did not inhibit squalene epoxidase, since TLC 
patterns of NSLs synthesized upon incubation with VI did not resemble those obtained 
upon incubation with the squalene epoxidase inhibitor terbinafine (Fig. 2D). The results 
presented indicate that the primary site of action of compound VI in B. cinerea is located 
between 2,3-oxidosqualene and lanosterol, possibly 2,3-oxidosqualene lanosterol-cyclase. 
The unidentified NSL (Fig. 2C, band 4) might be 2,3;22,23-dioxidosqualene, a product 
which is not a normal intermediate in sterol synthesis but may accumulate upon 
incubation with inhibitors of 2,3-oxidosqualene lanosterol-cyclase.24"26 To date, most 
inhibitors of 2,3-oxidosqualene lanosterol-cyclase have been designed as amine analogues 
of the transient carbocationic high energy intermediate, occurring in the epoxide ring 
opening during the cyclization of 2,3-oxidosqualene.6,27'28 Amines such as N-(l-n-
dodecyl)-heterocycles, which are protonated at physiological pH, have been suggested to 
inhibit the cyclase due to binding of their positively charged nitrogen atom to the catalytic 
site of the enzyme.29 Therefore, it might be that protonation of the amino group of 
compound VI is responsible for inhibition of 2,3-oxidosqualene lanosterol-cyclase 
activity. 
Further evidence that prochloraz and compound VI have different modes of action was 
obtained from studies with the laboratory-generated triadimenol-resistant isolates of B. 
cinerea (TN-150/6-6 and TN-25). These isolates showed cross resistance to triadimenol and 
prochloraz but not to VI (Table 3). The mechanism of DMI-resistance in these isolates of 
B. cinerea is not known, but will be subject of further study. Like most compounds 
tested, compound VI was less potent in the assays from P. italicum and S. cerevisiae than 
in the one from B. cinerea (Table 1). Radio-HPLC analysis of the NSLs formed upon 
incubation of yeast cell-free extracts with compound VI (unpublished results) suggests that 
in yeast compound VI is an inhibitor of P45014DM and not earlier in the pathway. 
Results described in this paper underline the validity of biochemical screening tests and 
emphasize that such tests should preferentially be carried out with cell-free assays from 
the target pathogen of interest. 
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CHAPTER 9 
GENERAL DISCUSSION 
The term 'selective fungitoxicity' of fungicides comprises the phenomena of natural 
insensitivity and acquired (field or laboratory) resistance of fungi to these compounds. 
The molecular mechanisms of natural insensitivity of fungi to fungicides can be closely 
related to those responsible for acquired resistance. This also holds true for DMI-
fungicides.1 These compounds differ greatly in both potency and selectivity.2 However, 
the biochemical mechanisms which account for their selective fungitoxicity are not well 
documented. 
A potential mechanism of selective fungitoxicity is metabolism of these antifungal 
compounds. Fungal metabolism may either be a detoxification or an activation process.3 
So far, natural insensitivity to DMIs based on detoxification has only been found for 
Aspergillus niger, Colletotrichum atramentarium and Stemphylium radicinum.* These 
fungi were able to detoxify triforine. Fungitoxicity of triadimefon depends on fungal/plant 
activation of this compound to triadimenol and the fungal sensitivity to the triadimenol 
enantiomers produced.5 To date, acquired resistance based on metabolism has only been 
reported for triadimefon-resistant isolates of Cladosporium cucumerinum6 and Nectria 
haematococca.1 These resistant isolates failed to convert triadimefon to triadimenol. In the 
present study metabolism of prochloraz and an experimental triazole in selected plant 
pathogenic fungi which markedly differed in sensitivity to these DMIs was investigated 
(Chapter 3). The selective toxicity of these azoles did not obviously relate to metabolism. 
Only Rhizoctonia solani metabolised prochloraz to a non-fungitoxic compound. This 
might contribute to its low prochloraz sensitivity. This metabolite was most probably 
formed in the mycelium and excreted into the medium. 
Another potential mechanism of selective fungitoxicity studied was differential 
accumulation of DMIs (Chapter 3). To date, natural DMI-insensitivity based on low 
accumulation has only been described for Trichothecium roseum and R. solani.4. These 
insensitive fungi accumulated triforine to a relatively low level as compared with 
triforine-sensitive fungi. The present accumulation studies demonstrated no general 
correlation between fungal sensitivity to prochloraz and an experimental triazole, and 
accumulation of these fungicides (Chapter 3). However, DMI-resistant isolates of 
Penicilium italicum did show reduced accumulation of prochloraz, the experimental 
triazole, fenarimol and imazalil (Chapters 3 & 4). Reduced accumulation of prochloraz, 
the experimental triazole and fenarimol might be due to an increased energy-dependent 
efflux mechanism which has been described before for other DMIs.8 Imazalil 
accumulation, however, was not obviously mediated by an energy-dependent efflux 
(Chapter 4). An energy-dependent efflux mechanism has also been proposed to be 
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responsible for acquired DMI-resistance in Aspergillus nidulans, Monilinia fructicola and 
N. haematococca var. cucurbitae.9'11 Accumulation levels of DMIs tested by isolates of P. 
italicum with different degrees of resistance were similar. Hence, reduced accumulation is 
responsible for a low degree of resistance only. Additional mechanisms of resistance may 
be involved in isolates with relatively high levels of DMI-resistance (Chapters 3 & 4). 
This supposition is supported by results of Ney who found that the observed differential 
DMI-resistance in M. fructicola could also not be attributed to reduced accumulation 
only.10 However, slight differences in accumulation between the low- and high-resistant 
strains of P. italicum and M. fructicola might be masked by aspecific binding of DMIs to 
mycelium and may, therefore, not be detectable with the methods applied. Therefore, the 
possibility that the high degree of resistance to DMIs results from a further increase in 
efflux capacity can not fully be excluded. The observation that different mutations in N. 
haematococca var. cucurbitae show additive effects in decreasing fenarimol accumulation 
by mycelium is in support of this possibility.11 This is probably also true for A. nidulans 
since all laboratory-generated DMI-resistant mutants of this fungus exhibited reduced 
accumulation of fenarimol.12 
Since plasma membrane ATPase inhibitors and ionophoric antibiotics were found to 
inhibit efflux and to increase accumulation of DMIs, efflux has been suggested to be 
mediated by the electrochemical proton gradient maintained across the plasma membranes 
by plasma membrane ATPase.8,9 The electrochemical proton gradient consists of a proton 
gradient and a plasma membrane potential. However, no correlation between the 
accumulation of DMIs and TPP+, a probe commonly used for measuring plasma 
membrane potential, could be found (Chapter 4). Consequently, the plasma membrane 
potential does not play a role in mediating the energy-dependent efflux of DMIs by P. 
italicum. Hence, the mechanism beyond this efflux of fungicides remains unclear. 
However, there are some similarities between DMI-resistance in P. italicum and 
multidrug resistance (MDR) of mammalian cancer cells (Chapter 4). For instance, both 
phenotypes are under polygenetic control and show cross-resistance to chemically 
unrelated compounds (e.g. antibiotics). In addition, DMI and multidrug resistance are 
both ascribed to reduced accumulation caused by an ATP-dependent efflux of the 
compounds concerned. In mammalian cancer cells MDR is often related to overexpression 
of membrane-associated P-glycoproteins which act as relatively aspecific transport 
proteins for drugs.13 It might be that similar transport proteins are operative in P. italicum 
and account for the reduced accumulation of DMIs by the resistant isolates of P. italicum. 
The genetic background of pleiotropic drug resistance (PDR) in yeast, which is 
comparable with MDR in mammalian cells, has also been subject of extensive studies.14 
From these studies it has been suggested that a PDR1 encoded protein transcription 
regulator controls the expression of various target genes mediating PDR in yeast like for 
instance the genes which encode for plasma membrane ATPases and other putative 
transport proteins.14 Future research should elucidate whether similar genes are present in 
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the DMI-resistant isolates of P. italicum and/or A. nidulans. In this respect, DNA 
fragments from yeast which encode for these genes may be useful heterologous probes to 
detect whether similar genes are involved in filamentous fungi. 
The selective fungitoxicity of DMIs may also be explained by differences in affinity of 
these antifungals for their target enzyme, cytochrome-P450 dependent sterol 14a-
demethylase (P45014DM). Therefore, microsomal P450 isozymes were isolated from 
Ustilago maydis to study the affinity of several DMIs for the P45014DM from this fungus 
(Chapter 5). Gentle mechanical homogenization of sphaeroplasts and differential 
centrifugation of homogenates yielded microsomal preparations containing P450 isozymes 
with good quality and stability. Yields of P450 isozymes amounted to approximately 
19+6 pmol mg1 of microsomal protein. Next to P. italicum,15 this is the second report of 
a successful isolation of microsomal P450 isozymes from a phytopathogenic fungus. A 
similar procedure for the isolation of these enzymes from U. maydis has recently been 
published by Carelli et a/.16 The successful isolation procedures described made it 
possible to study spectrophotometrically the affinity of various DMIs, including 
prochloraz and prochloraz analogues, for the P450 isozymes from U. maydis and P. 
italicum (Chapters 5 and 6). All compounds tested induced type II binding difference 
spectra when added at extremely low concentrations (10"9-10"8 M) to the oxidized forms of 
the P450 isozymes from both fungi. This indicated that the heterocyclic nitrogen atom of 
the DMIs tested interacted with the oxidized haem iron atom of the cytochromes. The 
IC50 values (concentration of DMIs which causes a half saturation response in type II 
binding spectra) did not correlate with the fungitoxicity of the compounds. This finding 
agrees with data from Guan et a/.15 and supports the general assumption that the affinity 
of DMIs for P45014DM is not determined by their interaction with the haem iron. It is 
generally accepted that the affinity is largely dependent on the interaction of the N, 
substituent of the antifungals with the apoprotein of the enzyme (Chapter 2). It has been 
proposed that this interaction can be studied by measuring the ability of carbon monoxide 
(CO) to displace DMIs from the isozymes (Chapter 2). The present study showed that CO 
differentially displaced the DMIs tested, including prochloraz and its analogues, from the 
microsomal P450 isozymes of U. maydis and P. italicum (Chapters 5 & 6). However, the 
differences in inhibition of CO-P450 complex formation by DMIs tested did not correlate 
with their toxicity to U. maydis and P. italicum. It was concluded that the CO-
displacement tests with microsomal preparations from these fungal species do not give 
relevant information about the selective fungitoxic action of DMIs (Chapters 5 & 6). This 
conclusion agrees with recent literature data.15,17"19 
Another method for studying the affinity of DMIs for P45014DM is by measuring the 
inhibitory effects on ergosterol biosynthesis in cell-free extracts or reconstituted systems 
(Chapter 2). Such cell-free sterol synthesis assays have been reported for Saccharomyces 
cerevisiae, Candida spp., U. maydis, Aspergillus fumigatus and recently for P. italicum.1^ 
26
 Using the assay of P. italicum it was demonstrated that the DMIs tested differentially 
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inhibited cell-free sterol 14a-demethylase activity (Chapter 6). The cell-free assay was 
able to rank the compounds tested in order of fungitoxicity, but I50 values did not 
quantitatively reflect differences in toxicity. This implicates that differential toxicity of 
DMIs to P. italicum is partly determined by their differences in affinity for the P45014DM. 
Obviously, additional mechanisms which influence toxicity are involved. Similar results 
were obtained by Guan et al.26 
Results in Chapter 6 indicate that, in contrast to the spectrophotometric studies, the 
cell-free sterol biosynthesis assay of P. italicum is far more useful for evaluating the 
differences in inhibitory potency of DMIs on P45014DM activity of this fungus. Therefore, 
it was decided to develop a similar cell-free assay for Botrytis cinerea. Chapter 7 
describes the successful development of the assay, an improved version of the ones 
described for A. fumigatus and P. italicum.25,26 It is the first time that this is achieved for 
an economically important plant pathogenic fungus. Cell-free preparations of B. cinerea 
were capable of synthesizing a relatively high percentage of C4-desmethylsterols (39% of 
total non-saponifiable lipids). P45014DM activity was very sensitive to the azole fungicides 
imazalil (Chapter 7), prochloraz and several prochloraz analogues (Chapter 8). The 
potency of the compounds tested in inhibiting P45014DM activity of B. cinerea (IC5Q) 
ranked with the fungicidal activity to this fungus (EC50). However, as for P. italicum, I50 
values did not fully reflect differences in toxicity, suggesting that differential affinity of 
the DMIs for the enzyme is not the only factor accounting for their differences in 
toxicity. Comparison of the cell-free assays of B. cinerea and P. italicum showed that 
these systems ranked prochloraz and its analogues nearly in the same order of intrinsic 
potency (Chapter 8). However, all compounds tested were less potent in the cell-free 
assay from P. italicum than in the one from B. cinerea, suggesting that the P45014DM from 
B. cinerea has a generally higher affinity for the compounds tested. This suggestion could 
not be confirmed. Most compounds tested were far less potent in the cell-free assay from 
S. cerevisiae than in those from B. cinerea and P. italicum indicating that the cell-free 
sterol synthesis assay of S. cerevisiae is less suitable as a model system to biochemically 
screen azole compounds as potential DMIs with fungitoxicity to B. cinerea than the assays 
from both filamentous fungi (Chapter 8). This finding may be related to the fact that both 
filamentous fungi are members of the Euascomycetidae while S. cerevisiae belongs to the 
order of the Hemiascomycetidae. 
The present study confirms the general view that the affinity of azole antifungals for 
P45014DM is dependent on the Nx substituent of the azole ring since modifications in the 
structure of the Nt substituent of prochloraz affected the inhibition of P45014DM activity of 
P. italicum, B. cinerea and S. cerevisiae (Chapters 6 & 8). However, the nature of the 
azole moiety is also significant since substituting the imidazole ring of prochloraz by a 
triazole moiety reduced inhibition of P450UDM activity considerably (Chapter 6 & 8). It 
has been postulated that the triazole moiety in triazole analogues of the imidazole 
carboxylates is presumably not a good enough ligand to interact with the haem iron, due 
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to the electron-withdrawing effect of the carbonyl group. It might also be that the 
compound is too hydrolytically unstable (Chapter 6 & 8). 
Addition of an amino group at C2 of the imidazole ring of prochloraz reduced fungi-
toxicity and inhibition of cell-free P45014DM activity significantly (Chapters 6 & 8). Most 
probably, the amino substituent sterically hinders the interaction with the haem iron of the 
P45014DM. However, concomitant with the reduced potency to inhibit P45014DM activity this 
modification also led to a change in its mode of action. It was demonstrated that in cell-
free extracts of B. cinema and P. italicwn the analogue did not induce an accumulation of 
C44-dimethyl sterols but of two other, non-identified non-saponifiable lipids. One of these 
is probably 2,3-oxidosqualene. Therefore, the compound might be an inhibitor of 2,3-
oxidosqualene lanosterol-cyclase (Chapter 8). This hypothesis is supported by the fact that 
laboratory-generated triadimenol-resistant isolates of B. cinerea which were also resistant 
to prochloraz did not show resistance to the C2-amino-substituted analogue (Chapter 8). 
Like most compounds tested the analogue was less potent in the assays from P. italicwn 
and S. cerevisiae than in the one from Botrytis. In yeast, the analogue did not inhibit 2,3-
oxidosqualene lanosterol-cyclase activity, but only P45014DM activity. 
The results described (Chapter 8) suggest that biochemical screening tests should 
preferentially be carried out with cell-free assays from the target pathogen of interest. 
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SUMMARY 
Sterol demethylation inhibitors (DMIs) are antifungal agents which inhibit the 
biosynthesis of ergosterol by binding to cytochrome-P450-dependent sterol 14a-
demethylase (P45014DM). These compounds significantly differ in both toxicity and 
selectivity. This thesis presents results of studies on several potential mechanisms of 
selective fungitoxicity of DMIs. 
Chapter 2 gives a literature review on the mode of action of DMIs, their specific 
interaction with P45014DM and selective fungitoxicity. 
Chapter 3 describes the selective fungitoxic actions of two DMIs, prochloraz and an 
experimental triazole fungicide, to selected plant pathogenic fungi showing significant 
differences in sensitivity to these compounds. Results indicate that the relatively high 
toxicity of prochloraz to the fungi tested could not be explained by the slightly higher 
acccumulation of prochloraz. As for prochloraz, there was no general correlation between 
sensitivity of the fungi tested and fungicide accumulation. The same situation held true for 
the triazole compound. However, the low-DMI-resistant isolate of P. italicum, E300-3, did 
exhibit decreased accumulation of both DMIs, which may be responsible for the low level 
of acquired DMI-resistance in this isolate. Since the high-resistant isolate H17 did not 
show a further decrease in accumulation of both DMIs, additional mechanisms for 
resistance in this particular isolate may be involved. Results also show that under the 
experimental conditions used most fungi tested did not metabolise both DMIs. This 
implicates that fungal metabolism also does not play a major role in selective fungitoxicity 
of DMIs. Metabolism also does not generally explain the differences in toxicities of 
prochloraz and the triazole compound to each individual species. In this respect, 
Rhizoctonia solani behaved exceptionally, since this fungus metabolised prochloraz to a 
non-fungitoxic compound. This correlates with its low prochloraz sensitivity. 
In Chapter 4 the role of plasma membrane potential in mediating the observed reduced 
accumulation of two other DMIs, fenarimol and imazalil, by resistant isolates of P. 
italicum was studied. As found for prochloraz and the experimental triazole compound 
(Chapter 3), the results confirm that decreased accumulation of these DMIs is responsible 
for a low level of resistance only and that additional mechanisms may operate in isolates 
with a medium and high degree of resistance. With all isolates of P. italicum fenarimol 
accumulation was mediated by an energy-dependent efflux. This was not obviously the 
case for imazalil. Since no correlation between the accumulation of DMIs and tetraphenyl 
phosphonium bromide, a probe for measuring plasma membrane potential, could be 
found, it was concluded that the plasma membrane potential is not involved in 
accumulation of fenarimol and imazalil by P. italicum. Hence, the mechanism involved in 
the reduced fungicide accumulation remains unsolved. 
121 
Chapter 5 describes a procedure to isolate microsomal cytochrome P450 isozymes from 
Ustilago maydis. As demonstrated by difference spectroscopy (type II binding spectra) the 
the DMIs investigated bind with their heterocyclic nitrogen atom to the oxidized haem 
iron atom in the protoporphyrinic moiety of the isozymes. However, the DMI 
concentrations which cause half saturation of type II binding spectra (IC50-type II) did not 
correlate with the fungicidal activities of the azoles. In the carbon monoxide(CO)-
displacement tests binding of CO to ferrous cytochrome-P450 was only slightly inhibited 
to different degrees by the DMIs tested. The inhibition of CO binding did not correlate 
with fungitoxicity of these DMIs. It was, therefore, concluded that the spectrophotometric 
studies are not useful for evaluating toxicity of DMIs to U. maydis. 
In Chapter 6 the interaction of various DMIs and experimental compounds with 
P45014DM from P. italicum was studied by difference spectroscopy using microsomal P450 
isozymes and assays with cell-free extracts capable of synthesizing ergosterol from 
[14C]mevalonate. Similar to the results obtained with microsomal preparations of U. 
maydis (Chapter 5), neither type II binding spectra nor CO-displacement tests were useful 
to assess fungitoxicity of the test compounds. In contrast, the cell-free sterol 14a-
demethylase assay gave valuable information. I50 values (concentrations of compounds 
which inhibit cell-free sterol synthesis by 50%) varied from 4.3xl0"9 to 4.4xl0"5 M. The 
assay ranked the compounds tested in order of fungitoxicity. Results presented in Chapter 
6 support the general view that the inhibitory potency of azole fungicides against P45014DM 
activity is influenced by the N, substituent of the azole moiety, since structural changes in 
the Nt substituent of prochloraz clearly affected the inhibition of cell-free P450i4DM 
activity. However, the intrinsic inhibitory potency of azoles is not exclusively affected by 
their N, substituent. It was demonstrated that the nature of the azole moiety is also 
important. 
Chapter 7 presents the development of a sterol 14a-demethylase assay with cell-free 
extracts of the filamentous plant pathogen Botrytis cinerea. Extracts were obtained by 
mechanical disruption of young germlings in a Bead-Beater apparatus. The C4-desmethyl 
sterol fraction accounted for 39% of the non-saponifiable lipids formed and consisted of 
three distinct compounds. Ergosterol was the major one. The cell-free system had a pH 
optimum for synthesis of C4-desmethyl sterols at pH 7.3-7.4. Cell-free synthesis of C4-
desmethyl sterols was inhibited by the imidazole fungicide imazalil (IC50 9.1xl0"9 M). 
The Botrytis assay was used to screen prochloraz and several prochloraz analogues for 
their intrinsic inhibitory potency (Chapter 8). Their IC50 values ranged from 2.6xl0"9 to 
4.4xl0~7 M. The compounds were also tested in cell-free assays of Saccharomyces 
cerevisiae. The test compounds were less potent in the yeast assay than in the one of 
Botrytis. Therefore, it was concluded that the Botrytis assay is more suitable for screening 
compounds biochemically for their potency to inhibit P45014DM activity than the yeast 
assay. Results confirm that the inhibitory activity of prochloraz analogues on P45014DM 
activity depends on the nature of their Nj substituent and their azole moiety. 
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Unexpectedly, addition of an amino group at C2 in the imidazole moiety of prochloraz 
caused a change in its mode of action in sterol synthesis of P. italicum and B. cinerea 
(Chapter 8). This was supported by the fact that laboratory-generated triadimenol-resistant 
strains of B. cinerea exhibited cross resistance to triadimenol and prochloraz, but not to 
its amino-substituted analogue. Like most compounds, this analogue was less potent in the 
assays from P. italicum and S. cerevisiae than in the one from B. cinerea. In yeast, this 
compound did not inhibit sterol biosynthesis at another step in the pathway, but only 
P45014DM activity. These findings indicate that biochemical screening tests should 
preferentially be carried out with cell-free assays from the target pathogen of interest. 
It is concluded that the selective fungitoxicity of DMIs is in part determined by their 
potency to inhibit P45014DM activity. Further studies should elucidate which other 
mechanisms are involved in selective fungitoxicity. 
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SAMENVATTING 
Steroldemethyleringsremmers (DMIs) zijn fungitoxische middelen, die de biosynthese 
van ergosterol remmen door interactie met cytochroom P450-afhankelijk sterol 14a-
demethylase (P45014DM). Deze stoffen verschillen aanzienlijk in zowel toxiciteit als 
selectiviteit. Dit proefschrift geeft de resultaten weer van studies naar enkele potentiele 
mechanismen, die betrokken zijn bij de selectieve fungitoxiciteit van DMIs. 
Hoofdstuk 2 bevat een literatuuroverzicht over het werkingsmechanisme van DMIs, de 
specifieke interactie van deze middelen met P45014DM en hun selectieve fungitoxiciteit. 
Hoofdstuk 3 beschrijft de selectieve fungitoxische werking van twee DMIs, prochloraz 
en een experimenteel triazool-fungicide, tegen geselecteerde plant-pathogene schimmels, 
die significant verschillen in gevoeligheid voor deze stoffen. De resultaten tonen aan, dat 
de relatief hoge toxiciteit van prochloraz voor de schimmels niet verklaard kon worden 
door de iets hogere accumulatie van prochloraz. Er was geen correlatie tussen de 
gevoeligheid van de onderzochte schimmels voor prochloraz en accumulatie van dit 
fungicide. Hetzelfde gold voor het experimentele triazool-fungicide. Het P. italicum 
isolaat E j ^ , dat een lage graad van DMI-resistentie bezit, vertoonde echter wel een 
lagere accumulatie van beide DMIs, hetgeen de lage graad van verworven DMI-resistentie 
kan verklaren. Het feit, dat het hoog-resistente isolaat H n geen verdere verlaging in 
accumulatie van beide DMIs te zien gaf, kan betekenen dat er additionele resistentie-
mechanismen werkzaam zijn. De resultaten tonen ook aan, dat onder de toegepaste 
experimentele condities de meeste schimmels beide DMIs niet omzetten. Dit impliceert 
dat metabolisme door schimmels ook geen grote rol speelt in de selectieve fungitoxiciteit 
van DMIs. Metabolisme kan over het algemeen ook niet de verklaring vormen voor de 
verschillen in toxiciteit van prochloraz en het triazool-fungicide voor de verschillende 
schimmelsoorten. Alleen Rhizoctonia solani was in dit opzicht een uitzondering. Deze 
schimmel was namelijk in staat om prochloraz om te zetten tot een niet-fungitoxische stof. 
Dit correleert met de lage gevoeligheid van R. solani voor prochloraz. 
In hoofdstuk 4 wordt de rol bestudeerd van de plasmamembraanpotentiaal bij de 
verminderde accumulatie van twee andere DMIs, fenarimol en imazalil, door resistente 
isolaten van P. italicum. De verkregen resultaten bevestigen de bevindingen met 
prochloraz en het experimentele triazool-fungicide (Hoofdstuk 3), dat verminderde 
accumulatie verantwoordelijk is voor een lage graad van resistentie en dat additionele 
mechanismen wellicht werkzaam zijn in isolaten met hogere resistentie-niveau's. In alle 
isolaten van P. italicum werd de fenarimol-accumulatie bepaald door een energie-
afhankelijke efflux. Dit was niet duidelijk het geval voor imazalil. Er kon geen correlatie 
worden aangetoond tussen de accumulatie van de onderzochte DMIs en van tetrafenyl-
fosfonium bromide, een stof, die voor metingen van de plasmamembraanpotentiaal 
gebruikt wordt. Op grond van dit resulaat wordt geconcludeerd dat de plasmamembraan-
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potentiaal niet betrokken is bij accumulatie van fenarimol en imazalil. Vooralsnog blijft 
het mechanisme, dat verantwoordelijk is voor de verminderde accumulatie van de 
fungiciden, onopgehelderd. 
Hoofdstuk 5 geeft een beschrijving van een procedure om microsomale cytochroom P-
450 iso-enzymen uit Ustilago maydis te isoleren. Met behulp van verschilspectro-
fotometrie (type II spectra) werd gedemonstreerd dat de onderzochte DMIs met hun 
heterocyclische stikstof atoom een binding aangaan met het geoxideerde haem ijzer atoom 
in de protoporfyrine ring van de iso-enzymen. De DMI-concentraties, waarbij 50% 
verzadiging van de geinduceerde type II spectra optreedt (IC50-type II), correleerden 
echter niet met de fungitoxiteit van de azolen. De binding van koolmonoxide (CO) aan het 
gereduceerde cytochroom P450 werd slechts in geringe mate geremd door de onderzochte 
DMIs. De remming van de CO-binding correleerde echter niet met de fungitoxiciteit van 
de DMIs. Daarom werd geconcludeerd, dat de spectrofotometrische studies niet geschikt 
zijn voor de evaluatie van de toxiciteit van DMIs voor U. maydis. 
In hoofdstuk 6 wordt de interactie van verscheidene DMIs en experimentele stoffen met 
P45014DM van P. italicum bestudeerd met behulp van microsomale P450 iso-enzymen en 
celvrije extracten, die in staat zijn om vanuit [14C]mevalonaat ergosterol te synthetiseren 
(sterol 14a-demethylase toets). Overeenkomstig de resultaten, die verkregen waren met 
microsomale preparaten van U. maydis (Hoofdstuk 5), bleken noch de type II 
bindingsspectra noch het vermogen van CO om DMIs van microsomale P450 iso-enzymen 
te verdrijven bruikbaar om inzicht te krijgen in de fungitoxiciteit van de teststoffen. In 
tegenstelling hiermee gaf de sterol 14a-demethylase toets wel waardevolle informatie. De 
I50-waarden (concentraties van stoffen, waarbij de celvrije sterol synthese voor 50% 
geremd wordt) varieerden van 4,3xl0"9 tot 4,4xl0"5 M. De toets rangschikte de middelen 
in volgorde van fungitoxiciteit. De resultaten in hoofdstuk 6 ondersteunen de algemene 
mening dat de remmingscapaciteit van azool fungiciden beinvloed wordt door de Nj 
substituent van de azoolring. Structurele veranderingen in de Nt substituent van 
prochloraz hadden namelijk een duidelijk effect op de remming van de celvrije P45014DM-
activiteit. De remmingscapaciteit van de azolen wordt echter niet uitsluitend beinvloed 
door hun Nt substituent. Er werd namelijk ook aangetoond dat de aard van de azoolring 
eveneens effect heeft op de remmingscapaciteit. 
Hoofdstuk 7 beschrijft de ontwikkeling van een sterol 14a-demethylase toets met met 
celvrije extracten van de filamenteuze plant-pathogene schimmel Botrytis cinerea. De 
extracten werden verkregen door homogenisatie van jonge kiemlingen in een Bead-Beater 
apparaat. De C4-desmethylsterol-fractie vormde 39% van de totale hoeveelheid 
geproduceerde, niet-verzeepbare vetten en bestond uit drie verschillende sterolen, waarvan 
ergosterol het hoofdbestanddeel vormde. Het celvrije systeem had een pH-optimum voor 
synthese van C4-desmethylsterolen bij pH 7,3-7,4. De synthese van C4-desmethylsterolen 
werd sterk geremd door het imidazool-fungicide imazalil (IC50-waarde 9,lxl0"9 M). 
126 
De Botrytis toets werd vervolgens gebruikt om prochloraz en enkele prochloraz-
analogen te onderzoeken op intrinsieke remmingscapaciteit van sterol 14a-demethylase 
activiteit (Hoofdstuk 8). De IC30-waarden varieerden van 2,6xl0"9 tot 4,4xl0"7 M. De 
toetsstoffen werden ook onderzocht in celvrije extracten van Saccharomyces cerevisiae. 
De toetsstoffen waren in de gist-toets minder actief dan in die van Botrytis. De Botrytis-
toets is daarom geschikter om stoffen biochemisch te screenen op hun remmingscapaciteit 
voor P45014DM-activiteit dan de gist-toets. De resultaten bevestigen dat de remmende 
werking van prochloraz-analogen op P45014DM activiteit afhangt van de aard van de Ni 
substituent en de azoolring. Een onverwacht resultaat was, dat aanwezigheid van een 
amino-groep op de C2-plaats van de imidazool-ring van prochloraz een wijziging te weeg 
bracht in het werkingsmechanisme. De amino-gesubstitueerde analoog van prochloraz 
bleek een andere stap in de sterolbiosynthese te remmen. Dit werd ondersteund door het 
feit, dat laboratorium-gegenereerde triadimenol-resistente stammen van B. cinerea 
kruisresistentie vertoonden tegen triadimenol en prochloraz, maar niet tegen de amino-
gesubstitueerde prochloraz-analoog. Deze analoog was minder actief in de celvrije toetsen 
van P. italicum en S. cerevisiae. In gist remde deze stof de sterol biosynthese niet op een 
andere plaats in de synthese-route, maar alleen de P45014DM activiteit. Deze resultaten 
geven aan, dat biochemische screeningstoetsen bij voorkeur dienen te worden uitgevoerd 
met celvrije extracten van het pathogeen, waartegen men fungiciden wil ontwikkelen. 
Geconcludeerd wordt, dat de selectieve fungitoxiciteit van DMIs voor een deel bepaald 
wordt door hun intrinsieke remmingscapaciteit van de P45014DM-activiteit. Vervolgstudies 
moeten uitwijzen welke andere mechanismen bij de selectieve fungitoxiciteit betrokken 
zijn. 
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